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Abstract 
Previous research has shown that subjects working 12h shift schedules 
(18.00-06.00h) offshore for 2 weeks adapt to the night shift. However, if 
adaptation occurs, shift workers will be out of synchrony when they return 
home to day life with consequent problems of poor night sleep and reduced 
daytime alertness. 
A total of 17 subjects working two shift schedules were studied offshore; 
18.00-06.00h and 19.00-07.00h 2-3 weeks night of shift. Differences were 
observed in circadian adaptation to the night shift, and this was reflected by 
differences in sleep duration and quality that was observed between the two 
groups. Sleep appeared to be worse in those working 19.00-07.00h 
compared to the 18.00-06.00h shift schedule. These differences between the 
two shift schedules may be due to differences in morning light exposure 
countering circadian adaptation to night shift work. 
This project investigated the effect of light treatment to hasten circadian 
adaptation in offshore shift workers by determining circadian status (using the 
timing of the rhythm of urinary 6-sulphatoxymelatonin) and sleep (by 
actigraphy and sleep diaries). Light was administered with a portable light 
box (Litebook®). After completion of their night shift (day 1) subjects wore 
specialised sunglasses until 13.00h. On day 2 subjects wore sunglasses 
until 13.00h and then received light treatment for 1 h. For the following 3 days 
the sunglasses and light treatment were scheduled an hour earlier each day. 
The light regimen was timed to phase advance the melatonin rhythm. 
The findings effectively demonstrated the importance of appropriately timed 
bright light to hasten circadian adaptation upon returning home onshore. A 
significance difference (p<0.05) in actigraphic sleep duration onshore was 
observed when comparing the no light treatment leg against the light 
treatment leg. In conclusion, light treatment appropriately timed can be 
beneficial to aid circadian adaptation after working a night shift. 
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1.1. Biological rhythms 
The earth's rotation around its axis generates daily environmental rhythms. 
Life on earth has evolved mechanisms to allow our body's physiology to 
adjust to, and predict these environmental changes. Biological rhythms 
make up the essential components of these physiological homeostatic 
mechanisms. Simple organisms, such as Neurospora, through to complex 
organisms such as humans all show robust biological rhythms (review, 
Ronneberg et al., 2003). Biological clocks impose a structure that enables 
organisms to change behaviour priorities in relation to the time of day, month 
or year. 
Biological rhythms are classified by their periodicity, which is often related to 
a particular environmental cycle. Examples of biological rhythms are 
ultradian rhythms, which are short cycles, such as the rapid eye movement 
(REM) cycle in sleep; they have a period of less than 24 hours. Infradian 
rhythms are biological rhythms with a period longer than 24 hours. Examples 
include the oestrous cycle and the human menstrual cycle. Circannual 
rhythms are cycles occurring approximately once a year e. g. bird migration 
and hibernation. Circadian rhythms are those that occur over a 24 hour 
period. The term "circadian" comes from the Latin circa, "around", and diem, 
"day", meaning literally "about a day". 
1.2. Circadian rhythms 
In most organisms the possession of a circadian clock allows the adjustment 
of physiological mechanisms to the varying demands of the solar cycle. 
Circadian rhythms are endogenous, that is they are internally generated, but 
they can also be affected exogenously (by external factors) e. g. light. The 
environmental factors that entrain or synchronise a rhythm to a given 
periodicity are referred to as zeitgebers, German for `time-giver' (review, 
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Arendt, 1998). The most potent entraining agent of the circadian system for 
all organisms is the light-dark environment at dawn and dusk (review, 
Ronneberg and Foster, 1997). Under constant conditions, and in the 
absence of time cues, the periodicity of the circadian clock and its output 
circadian rhythms is slightly longer than 24h, approximately 24.2-24.3h in 
sighted individuals (Middleton and Stone, 1996; Czeisler et al., 1999; Wright 
et al., 2001). The period is genetically determined and referred to as tau (i). 
Examples of different r's include -23.25h for patients with the advanced 
phase syndrome (Jones et al., 1999) and longer r's seen in the totally blind 
subjects (Lockley et al., 1997). 
1.2.1. Circadian entrainment 
Entrainment of the circadian timing system to light-dark cycles is known as 
photoentrainment (Freedman et al., 1999). Human circadian rhythms are 
synchronised to the 24h day mostly by light dark cycles (Czeisler, 1995) but 
to a lesser extent by other time cues e. g. social cues, sleep time and 
exercise (Mistlberger and Skene, 2005). 
If the endogenous period of circadian rhythms is longer than 24h, 
synchronisation requires a phase advance of the clock by this amount; if less 
than 24h, the clock must be delayed each day to remain entrained. In 
blindness, in continuous darkness or very dim light conditions below a 
particular light intensity (<10 lux) and in the absence of other major time 
cues, human circadian rhythms free run (Broadway and Arendt, 1986; 
Kennaway and Van Dorp, 1991; Middleton and Stone, 1996; Lockley et al., 
1997; Arendt, 1998b; Hack et al., 2003; Wright et al., 2005). The length of 
tau therefore relates to the amount that is required to phase shift each day. 
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1.2.2. Circadian rhythm characteristics 
The amplitude, period, duration and acrophase are important characteristics 
of a circadian rhythm, illustrated in Figure 1-1. 
Amplitude 
Period 
..,,.,.,. ... .......... ...... 
Acrophase 
(time of peak. ) Nadir 
(time of minimum) 
Figure 1-1: Schematic diagram of the characteristics of a circadian rhythm 
Time 
The mesor is the average value around which the variable oscillates. The 
amplitude is the difference between the peak (or trough) and the mean value 
of the wave. The period is the time elapsed for one complete oscillation or 
cycle. The acrophase is the time at which the peak of a rhythm occurs and 
the nadir is the lowest value of an oscillatory function. These are all important 
characteristics of a circadian rhythm (Shanahan et al., 1997). 
Circadian rhythms, illustrated diagrammatically in Figure 1-2, of plasma 
melatonin, core body temperature (CBT), subjective alertness, task 
performance (reaction time in secs) and triacylglycerol (TAG) are from 
humans being held in constant routine conditions (i. e. controlled light, 
temperature, posture, activity, meals, fluid intake, awake). The essence of 
the constant routine is therefore to reduce or eliminate all periodic changes in 
behaviour, in addition to maintaining a constant environment (review, Duffy 
and Dijk, 2002). Lighting must be controlled due to studies showing that light 
exposure to levels of 100 lux or more will substantially phase shift circadian 




controlled as this may shift the human circadian clock (Buxton et al., 1997) as 
well as modifying rhythm amplitudes and/or profiles. 
The peak in the melatonin rhythm, shown by the dotted line, and the low- 
point of the temperature rhythm are within 1h of each other. The low point of 
the temperature rhythm is shortly after the melatonin peak, and the peak in 
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Figure 1-2: Examples of circadian rhythms (review, Rajaratnam and Arendt, 2001). 
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1.3. Circadian physiology 
The fundamental components of the human circadian timing system consist 
of the eye, providing photoreceptors for light entrainment, the 
suprachiasmatic nuclei (SCN), the central pacemaker and output parameters, 
of which one is melatonin production from the pineal gland. These are 
schematically represented in Figure 1-3. 
SCN 
N31YTHM T4fN j 
EYE e 
iiE: PRO UCTION 
SLEEP-WAKE T MPERATU4E 
ANU OT14EIR RHYTHMIC FUNCTIONS 
Figure 1-3: Output pathways of the SCN, (review, Arendt, 1995). 
1.3.1. Location of the clock 
By careful lesioning in the frontal part of the hypothalamus Stephan and 
Zucker (1972) identified a small cluster of cells known as the SCN. Loss of 
the SCN abolished the oestrous cycle and circadian rhythms in behaviour 
such as drinking and locomotion (Stephan and Zucker, 1972). 
Many strategies have been used to study the function of the clock, one of 
these includes ablation of the SCN, which has been shown to abolish 
rhythms in vivo (Ralph and Menaker, 1988; Tousson and Meissl, 2004). The 
host SCN is ablated, which results in loss of rhythmicity. Some rhythms can 
then be restored by the implantation of a donor clock (Ralph and Lehman, 
1991). Transplantation of the SCN, enables some disrupted rhythms to be 
restored (Ralph and Menaker, 1988). For example, rhythmicity of a hamster 
with a lesioned SCN can be restored with an SCN graft, but the period of the 
restored rhythm is determined by the donor SCN tissue, so that the recipient 
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hamster exhibits the of the donor hamster, at least in locomotor activity 
(Ralph and Menaker, 1988). 
1.3.2. Suprachiasmatic nuclei 
The central pacemaker, or `clock', is located in the SCN of the hypothalamus 
and this generates circadian rhythms (Moore and Eichler, 1972; Stephan and 
Zucker, 1972). The SCN is a paired structure and is situated immediately 
above the optic chiasm, on either side of the third ventricle. It has 2 
subdivisions, the core which receives primary and secondary visual afferents, 
and contains neurons producing vasoactive intestinal polypeptide (VIP) and 
gastrin releasing peptide (review, Moore and Leak, 2002). Each nucleus 
contains approximately 10,000 tightly packed neurons (Van Esseveldt et al., 
2000). VIP has been identified as one of the main neurotransmitters of SCN 
neurons (review, Reghunandanan and Reghunandanan, 2006). The shell 
largely surrounds the core, and receives input from non-visual sources and 
contains neurones producing arginine vasopressin (AVP) and calretinin (Leak 
and Moore, 2001). 
The SCN of the hypothalamus is the dominant circadian pacemaker in the 
mammalian brain, controlling the rest-activity cycle and virtually all other 
circadian functions (Stephan and Zucker, 1972), e. g. melatonin and cortisol 
rhythms, to provide a foundation for the successful elaboration of adaptive 
sleep and waking behaviour (Moore et al., 2002). Independent circadian 
oscillators exist in most cells and are coordinated by the SCN (review 
Kalsbeek et al., 2006). 
1.3.3. Clock genes 
The molecular clock of mammals is composed of three period genes and two 
cryptochrome genes and these are thought to form the primary components 
of the auto regulatory negative feedback loop that constitutes the molecular 
clock of mammals (Albrecht and Eichele, 2003). 
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This negative feedback mechanism is illustrated in Figure 1-4. CLOCK 
(yellow) and BMAL1 (pink) are proteins of the positive limb and drive the 
expression of Per, Cry and Rev-erba genes in the nucleus. PER (red) and 
CRY (light green) proteins in the nucleus inhibit CLOCK/BMAL1 action by a 
yet unknown mechanism and thereby down-regulate their own expression 
and that of Rev-erba (dark green). When REV-ERBa protein is absent, 
Bmall (and possibly also Clock) genes are derepressed and hence 
transcribed to produce new CLOCK/BMAL1 transcription factors that 
reinitiate a new circadian cycle. Clock proteins are post translationally 
modified; casein kinase IF- (CKIE), for example, phosphorylates PER2. 
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Figure 1-4: Molecular clock pathways (Albrecht and Eichele, 2003) 
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A typical circadian cycle would begin with activation of Per (and Cry) 
transcription by CLOCK/BMAL1 in the early morning. Transcript levels peak 
around noon and protein levels in the cytoplasm reach a peak approximately 
2 hours later. PER shuttles between the cytoplasm and the nucleus. In the 
cytoplasm, it is degraded following hyperphosphorylation and in the nucleus it 
complexes with CRY and thereby blocks CLOCK/BMAL1 function resulting in 
termination of Per and Cry transcription. At some point when too much PER 
is degraded in the cytoplasm, PER concentration in the nucleus is too low to 
keep up negative feedback and the cycle reinitiates (Albrecht and Eichele, 
2003). 
The process begins when CLOCK and BMAL1 proteins dimerize to drive the 
transcription of the Per (Perl, Per2, and Per3) and Cry (Cryl and Cry2) 
genes. In turn, Per and Cry are translocated to the cytoplasm and translated 
into their respective proteins. Throughout the day, PER and CRY proteins 
rise within the cell cytoplasm. When levels of PER and CRY reach a 
threshold, they form heterodimers, feed back to the cell nucleus and 
negatively regulate CLOCK: BMAL1 mediated transcription of their own 
genes, as illustrated in Figure 1-4. 
Light exposure during the subjective night produces phase shifts of locomotor 
activity rhythms (Pittendrigh and Daan, 1976). It is widely accepted that 
resetting of the mammalian circadian clock by light involves acute induction 
of Perl and Per2 genes (Dunlap, 1999; Lowrey and Takahashi, 2000). 
1.4. Circadian photoreception 




1.4.1. The eye 
Light enters the eye via through the cornea; this is an external transparent 
surface. Once the light has traveled through the cornea, it passes through 
the aqueous humour before reaching the back of the retina. As illustrated in 
Figure 1-5. The retina is a highly differentiated neuroectodermal tissue. 
Macroscopic examinations show that the retina consists of two distinct 
regions (the macular area, which is specialized for vision) and the peripheral 
retina. Microscopic examinations show that the macular area can be further 
sub-divided into the fovea and the foveola (review, Bonnel et al., 2003). Light 
is then focused onto the retina, the light sensitive layer of the eye, which 
contains light detecting cells called photoreceptors. 
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Figure 1-5: Anatomy of the eye (www. astrosurf. com/re/eve anatomy. ipg). 
1.4.2. Visual photoreception 
The mammalian retina contains two types of photoreceptors, which are 
responsible for image formation, and these are known as rods and cones 
(Figure 1-6). 
Cones are adapted to phototopic (daytime) conditions. Blue cones are short 
wavelength absorbers (S-cones), green cones are medium wavelength 
absorbers (M-cones) and red cones are long wavelength absorbers (L- 
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cones). The difference in their absorption properties allow us to perceive 
colour. Rods are sensitive to dim light, allowing night vision. Rods are the 
major component of the peripheral retina, with a maximal density around the 













col Is - 
nerve fiber layer - 
Figure 1-6: Schematic diagram of the human retina, (adapted from Foster, 2005) 
1.4.3. Retina to the SCN 
The rods and cones of the outer retina detect light, with the cells of the inner 
retina providing the initial stages of the visual processing, before ganglion 
cells (RGC) convey information to the brain via optic nerves. A small number 
of mammalian retinal ganglion cells act as photoreceptors for regulating 
certain non-image forming photo responses (Roenneberg and Foster, 1997; 
Hattar et al., 2002). These intrinsically photosensitive RGC express the 
novel photopigment melanopsin (Gooley et al., 2001; Hattar et al., 2002). 
The photic information detected in the eye is conveyed from the RGC to the 
SCN primarily via a monosynaptic pathway, the retinohypothalamic tract 
(RHT) (Klein and Moore, 1979). The RHT which projects into the ventral 
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SCN is made up of a distinct, relatively small set of RGCs (Moore and 
Eichler, 1972). The primary neurotransmitter of the RHT is glutamate (review, 
Hannibal, 2002). The first stage of light detection involves the absorption of a 
photon by 11 -cis-retinaldehyde, and the photoisomerization of this molecule 
to the all-trans state. This allows the opsin to trigger a phototransduction 
cascade that ultimately changes the cell's electrical activity. All opsin- 
vitamin-A photopigments have a characteristic absorption profile, which 
allows them to be identified on the basis of their spectral responses to light. 
1.4.3.1. Melanopsin 
Melanopsin expressing RGC relay information to the master circadian clock 
in the SCN and to other brain regions that mediate a range of non-visual 
responses to light (Hattar et al., 2002; Gooley et al., 2003). The non-visual 
effects are reported to be wavelength dependent such that short wavelength 
monochromatic light (e. g. 460 nm) is more effective than 555 nm light (long 
wavelength light). The data are consistent with the hypothesis that the non- 
visual effects are in part mediated by the recently discovered photopigment 
melanopsin which is expressed in light sensitive RGC (Brainard et al., 2001; 
Thapan et al., 2001). 
Melanopsin is known to have a peak spectral sensitivity at approximately 480 
nm that is distinct from the peak sensitivity of the rods and cones but it 
remains unclear to what extent the short-wavelength cones, with a peak 
sensitivity at 420 nm, contribute to these non-visual effects (Qiu et al., 2005). 
Melanopsin has some of the characteristics of invertebrate photopigments 
and it has been proposed that melanopsin is a bistable pigment. This implies 
that it has photosensory functions at shorter wavelengths and the ability to 
isomerise to regenerate bleached chromophore when subsequently exposed 
to longer wavelength light (Melyan et al., 2005). 
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1.4.4. Intergeniculated leaflet and geniculohypothalamic tract 
Studies have indicated the presence of a large number of neurotransmitters 
in the SCN (Scott and Rusak, 1996; Hardeland et al., 2006). Two of the 
major incoming pathways that have been identified innervating the SCN; 
include the RHT and the geniculohypothalamic tract (GHT) (Sadun et al., 
1984; Johnson et al., 1989). 
The intergeniculated leaflet (IGL) is characterised by a population of 
neuropeptide Y (NPY) neurons coexisting with GABA containing neurones 
that project to the SCN core. The geniculohypothalamic tract (GHT) is a 
projection from the IGL to the SCN. The IGL also receives input from the 
SCN (Moore and Speh, 1994). The integrity of the GHT is not necessary for 
photic entrainment of circadian rhythms (Pickard et al., 1987) although 
lesions of the GHT cause change in circadian rhythmicity by slowing rate of 
entrainment after phase shift, reducing the magnitude of phase advances 
and reducing the free-running period under constant light conditions 
(Johnson et al., 1989). 
1.4.4.1. Glutamate 
The signalling pathway from the retina to the SCN comprises the activation of 
photoreceptors in the retina, glutamate release in the SCN from terminals of 
the RHT and subsequent resetting of the pacemaker. Light causes the 
release of glutamate, which initiates a signal transduction cascade in SCN 
neurones (Golombek et al., 2004). 
Electrophysiology has also provided evidence that glutamate excites the 
SCN neurons (Bos and Mirmiran, 1993). It is thought that glutamate, 
released by the RHT, acts on N-methyl d-aspartate (NMDA) receptors on 
postsynaptic cells in the SCN (review, Hannibal, 2002). 
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The RHT also projects to other regions of the brain, such as the lateral 
hypothalamic area, the anterior hypothalamic area and the retrochiasmatic 
area (Johnson et al., 1988). The retinal ganglion cells projecting to the SCN 
also project to the intergeniculate leaflet (IGL) of the thalamus, pretectal area 
(PTA), subparaventricular zone (SPZ) and ventrolateral preoptic nucleus of 
the hypothalamus (Pickard, 1985). 
1.4.5. Y-aminobutyric acid 
GABA (Y-aminobutyric acid) is the major transmitter in the SCN and GABA is 
found in at least half of all pre-synaptic terminals in the SCN (Hardeland et 
al., 2006). With an abundance of GABA and GABA receptors in the SCN, 
this suggests a prominent role for this transmitter (Moore and Eichler, 1972). 
Administration of GABA agonists causes phase shifts of behaviour during the 
day and alters photic regulation of circadian systems during the night (Ralph 
and Menaker, 1989) thus highlighting its importance as an endogenous 
neurotransmitter. 
1.4.6. Vasointestinal peptide 
The anatomical organization of vasointestinal peptide (VIP) and its receptors 
provided early indications that this peptide may be important for circadian 
function. Studies in the rat revealed that the SCN had large amounts of VIP 
and VIP receptor-containing neurons (Roberts et al., 1980; Besson et al., 
1986; Vertongen et al., 1998). These VIP-neurons are primarily located in 
the ventrolateral aspect of the nucleus (Abrahamson and Moore, 2001). 
Neurons in this region receive retinal input from the RHT and express both 
VIP and GABA (Kalsbeek et al., 2006). 
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1.5. Pineal gland 
The pineal gland produces the hormone melatonin. The pineal gland is a 
small neuroendocrine gland located between the mesencephalon and the 
diencephalon of the brain. It consists mainly of pinealocytes and its normal 
weight in humans is approximately 50-200 mg (Arendt, 1995). 
The influence of the pineal gland on the circadian system seems to be more 
important in lower vertebrates than in mammals (Arendt, 1998b). The very 
earliest indication that the pineal gland contained a biologically active 
substance came from work showing that bovine pineal extracts applied to 
frog skin could produce a skin lightening response (McCord and Allen, 1917). 
In non-mammalian vertebrates, the melatonin rhythm is necessary for clock 
function; in several species pinealectomy results in attenuation of free 
running daily rhythms, and rhythmic melatonin infusions restore rhythmicity 
(Vanecek, 1998). Pinealectomy abolishes the rhythm of circulating melatonin 
in mammals, including humans (Arendt, 1995). Pinealectomy also abolishes 
the ability of the organism to respond to changing day length in photoperiodic 
species and suitable melatonin administration is able to replace lost time 
cues (Arendt, 1998b). 
In humans the main functions of the pineal gland are transmission of 
information concerning day length or photoperiod via melatonin for the 
organisation of seasonal responses, transmission of information concerning 
phase and strength of the daily light-dark cycle for appropriate 
synchronisation of the circadian system. The pineal gland also has effects 
on physiological and behavioural rhythms such as sleep, temperature and 
reproduction (Arendt, 1995). 




1.5.1. Melatonin synthesis 
Melatonin is synthesised from dietary tryptophan, which is first converted to 
5-hydroxytryptophan by tryptophan-5-hydroxylase, and then into 5- 
hydroxytryptamine (5-HT, serotonin) by 5-HTP-decarboxylase. 5-HT is 
converted to N-acetylserotonin (NAS) by serotonin-N-acetyltransferase 
(AANAT), this is the rate limiting step of melatonin synthesis. NAS is 
converted to melatonin by hydroxyindole-O-methyltransferase (Axelrod and 
Weissbach, 1960; Klein, 1985). The pathway of melatonin synthesis is 
illustrated in Figure 1-7. 
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Figure 1-7: Synthesis pathway of melatonin (www. endocrine-source. com) 
i 
Melatonin is often referred to as the `hormone of the night' as its synthesis is 
inhibited by light and it is normally produced during the dark phase. The 
secretion of melatonin from the pineal is probably the most direct peripheral 
link to the central circadian clock (review, Arendt, 2005). Melatonin produced 
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in the pineal gland acts as an endocrine hormone since it is released into the 
blood and more recently reported to diffuse into the cerebrospinal fluid (CSF) 
(Tricoire et al., 2002). 
1.5.2. Melatonin rhythm 
In most species, including humans (in the right circumstances), melatonin 
secretion is related to the length of the night, the longer the night, the longer 
the duration of secretion (Arendt, 1998b). The pattern of melatonin secretion 
changes with day length so that the duration of melatonin secretion can be 
used as a seasonal time cue by photoperiodic species such as sheep and 
hamsters (Arendt, 1998b). 
1.5.3. Melatonin receptors 
Melatonin is a lipophilic molecule which readily crosses the blood-brain 
barrier, and lacks any group which would be significantly ionized at 
physiological pH. It is a rather flexible molecule with a number of atoms 
around which rotation is possible, with the indole ring forming a plane of 
symmetry. For such a small and simple molecule, melatonin shows 
remarkably high affinity binding to its receptors (review, Sudgen et al., 2004). 
Melatonin receptors have been identified and characterised in a number of 
tissues by in-vitro autoradiography and conventional binding assays using 
[1251] iodomelatonin (I-MEL) as a ligand (Vanecek, 1998). 
The structural motif of a melatonin receptor consists of 7 membrane 
spanning domains connected by a series of extracellular and intracellular 
loops. The ability of melatonin to bind to, activate, and modulate its own 
receptors depends on the interaction of melatonin with specific amino acids 
and/or domains. There are two principal melatonin receptors (MT1, MT2) 
which have been discovered. MT1 and MT2 are both G-protein coupled 
receptors. MT1 is expressed in the SCN of the hypothalamus and cardiac 
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vessels and MT2 receptors are mainly found in the cerebellum, SCN, retina, 
kidney, ovary, cardiac vessels (Witt-Enderby et al., 2003). Radioligand 
binding studies in the rat SCN have found an inverse relationship between 
receptor density and serum melatonin levels (Gauer et al., 1993; Tenn and 
Niles, 1993). 
In normal adults the night time peak concentration (acrophase) of plasma 
melatonin occurs between 02.00h and 04.00h. The nadir of core body 
temperature occurs within 1h of the peak of melatonin together with the peak 
of fatigue and the trough in ability to perform certain tasks, and this 
association may be part causal (Arendt, 2005). Whether you are a morning 
or evening type ('lark or owl') also affects when the peak of night time 
melatonin is going to occur. Morning types have been shown to have a 
significantly earlier peak in melatonin and temperature rhythm with an earlier 
bed and wake-time when compared to evening types (Baehr et al., 1999; 
Duffy et al., 2001; Mongrain et al., 2004). This suggests that time of day 
preference may be influenced by the circadian clock driving these 
physiological daily rhythms. There is also high inter-individual variability in 
levels of nocturnal endogenous melatonin (Arendt, 1988) and in the 
pharmacokinetics of exogenous melatonin (Aldous et al., 1985). 
Melatonin in addition to blood, saliva, and urine has been detected in the 
CSF of mammals and in peripheral tissues (Arendt et al., 1977; Martin et al., 
1992; Reiter and Tan, 2002). Melatonin is metabolised primarily in the liver 
but also in the kidney, undergoing hydroxylation via the P450 enzyme 
CYP1A (Facciolä et al., 2001; Skene et al., 2001) and then conjugation 
producing 6-sulphatoxymelatonin (aMT6s) and glucuronide (minor 
metabolite), its urinary concentration accounts for 50-90% of administered 
melatonin (review, Arendt, 1995). 
35 
Chapter 1 
1.5.4. Marker of the circadian clock 
The melatonin rhythm, illustrated in Figure 1-8, is arguably the best marker of 
the circadian phase (review, Klerman, 2005). In laboratory and field studies 
the rhythm of urinary 6-sulphatoxymelatonin (aMT6s) the primary urinary 
metabolite of melatonin correlates well with plasma melatonin (Arendt et al., 
1985; Bojkowski et al., 1987; Ross et al., 1995). The acrophase of aMT6s 
occurs approximately 2h after the peak of melatonin production. Melatonin is 
a good marker of circadian phase because it has a few `masking' factors. 
Light suppresses the synthesis of melatonin, hence clinical trials and in- 
house laboratory studies are conducted in dim light to exclude this masking 
effect. Posture is also known to have a small effect on melatonin 
concentrations hence subjects are asked to stay in a semi-recombinant 
position during a laboratory constant routine (Deacon and Arendt, 1994). 
so 
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Figure 1-8: Schematic plasma melatonin profile, including parameters of the rhythm (adapted 
from Arendt and Skene, 2005). 
The time of the onset of melatonin synthesis in dim light (dim light melatonin 
onset (DLMO), measured in saliva or plasma) and maximum (acrophase) are 
frequently used as markers for the phase of the circadian clock (Burgess et 
al., 2002) and see Figure 1-8. 
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1.5.4.1. Light induced melatonin suppression 
Light has two main effects on melatonin, it is able to phase shift the circadian 
clock and hence the melatonin rhythm and secondly light is able to acutely 
suppress nocturnal melatonin. The discovery that high intensity bright (2500 
lux) light can cause melatonin suppression (Lewy et al., 1980) triggered 
studies investigating the phase shifting effects of artificial high-intensity light 
(review, Eastman et al., 1995). More recently the effects of lower intensities 
have been investigated and it is clear that domestic intensity illumination (ca 
100 lux) has substantial effects on suppression and phase shifting of 
melatonin (Zeitzer et al., 2000). It is well established in animals and humans 
that light pulses can shift the phase of circadian rhythms, and that the 
direction (advance or delay) and magnitude (hours) of the shift depends on 
when the light is applied within the circadian cycle. It is known that suitably 
timed morning light phase advances the whole melatonin rhythm, while 
evening light may phase delay the rhythm (Broadway and Arendt, 1986; 
Czeisler et al., 1989). 
1.6. Light phase response curve 
The light phase response curve (PRC) plots the relationship between a timed 
light pulse and the phase shift it produces. It describes how the response of 
the circadian timing system to light varies with phase. The entrained 
circadian pacemaker is in equilibrium with a light-dark (LD) cycle. Each daily 
pulse occurs at the phase when a light pulse induces a phase shift that is 
equal to the difference between the free running period (-c) and the period of 
the zeitgeber (Johnson, 1999). There are two different types of PRCs that 
can be generated, type 1 (or weak resetting) and type 0 (strong resetting). 
Type 1 is a low amplitude PRC that displays relatively small phase shifts 
(usually less than 6h) and has a continuous transition between delays and 
advances. A type 0 is a high amplitude PRC with phase shifts up to 12h in 
size (Johnson, 1999). The amplitude of the PRC directly depends on 
strength of the stimulus. 
37 
Chapter 1 
The PRC to light (Figure 1-9) indicates that phase-shifting responses are 
reduced during the subjective day. Phase shifts are plotted on the abscissa. 
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Figure 1-9: Illustration of a light PRC (Khalsa et al., 2003). 
Typically, a light PRC is generated from laboratory animals free-running in 
constant conditions. The free running period is divided into 24 circadian 
hours to mark the x-axis; circadian time (CT) 0 corresponds to the beginning 
of the subjective day (lights on in a 12h light dark cycle), and CT12 
corresponds to the beginning of the subjective night. The largest phase 
shifts are obtained when light is given during the subjective night, with phase 
delays induced by light at the beginning of the night and phase advances by 
light at the end of the night. Light during the subjective day has little phase- 
shifting effect. Khalsa et al. (2003), showed no evidence of a significant dead 
zone in their study. However the existence, or not, of a dead zone in the light 
PRC is controversial in human studies. Phase advances diminish gradually 
during the course of the early subjective day, ultimately yielding to gradually 
increasing phase delays in the subjective night. Increasing the intensity or 
duration of the light pulse can increase the magnitude of the phase shift 
(Eastman and Martin, 1999). 
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1.6.1. Light PRC studies 
There have been 5 previous reports of a light PRC in humans. The first was 
conducted by Honma and Honma (1988) which revealed a PRC without a 
significant phase delay region. These results were inconsistent with later 
reports from other laboratories that have routinely demonstrated phase 
delays to single light pulses. Czeisler et al. (1989) showed phase delays as 
large as 12h when the stimulus was centred near the CBT minimum (3 day 
light pulse, not a single light pulse, which may explain the large phase shifts, 
plus this protocol involved displacing the sleep period). Minors et al. (1991) 
showed a poorly defined delay region of the PRC, using single light pulses of 
5000 and 9000 lux. Jewett et al. (1994) presented analysis of strong, weak, 
and critical bright-light resetting trials in humans, and they were the first to 
report not only phase but also amplitude data. Van Cauter et al. (1994) only 
reported shifts for a region spanning less than the circadian cycle. Khalsa et 
al. (2003) studied entrained subjects under constant routine conditions, and 
administered a 6.7h bright light (-10,000 lux) at different circadian phases. 
PRCs are hard to compare, as each study has often used a different number 
of light pulses at varying light intensities, each at different circadian times in 
order to produce the phase shift required. PRCs are beneficial as `they can 
be used to predict the timing of light treatment to enable adaptation to 
environmental changes, such as those seen in shift work and transmeridian 
travel' (Rajaratnam and Arendt, 2001) and studies have used this knowledge 
to develop bright light treatment to speed up adaptation to shifts in night 
workers and time zone travellers (section 1.6.1). 
1.7. Shift work 
Shift work encompasses work outside the conventional daytime and thereby 
covers fixed evening and night work, roster work, and rotating shift work. 
Akerstedt defined shift work as "an arrangement of work hours which 
employs two or more teams (shifts) of workers in order to extend the hours of 
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operation beyond that of conventional office hours" (Akerstedt, 1990). In the 
UK shift work is the way of life for approximately 12% of the working 
population as illustrated in Table 1-1. 
Type of Shift work Population Population (%) 
All shift workers 3,551,000 12.0 
Rotating shifts 2,722,000 9.2 
Permanent night shifts 343.000 1.2 
Sometimes nights, sometimes days 449,000 1.5 
Weekend shifts 37,000 0.1 
Table 1-1: Percentage of UK working population working shifts (UK Annual Labour Force 
Surveys, Office for National Statistics, 2005). 
1.7.1. Shift work and light 
Light has been suggested as a counter measure against night work 
impairment of sleep and alertness (Czeisler et al., 1990). This is because 
light is the most powerful zeitgeber. Light has the ability to both phase 
advance and delay the circadian clock (section 1.4.5.1) and this knowledge 
may benefit shift workers through the use of appropriately timed light therapy, 
together with the appropriate avoidance of conflicting light, which could 
impede adaptation when adaptation is desirable. It is possible that bright 
light may be sufficiently powerful to overcome all other synchronisers, and 
shift workers' sleep habits may be largely irrelevant in determining the 
effectiveness of bright light intervention (Horowitz et al., 2001). 
1.7.2. Simulated shift work 
Simulated shift work allows a controlled laboratory protocol to be followed, 
physiological markers can be measured, meal times, exercise and sleep 
patterns can all be controlled, as all of these may mask the effects that are 
being investigated e. g. the effect of the light treatment. The appropriate use 
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of high intensity light can increase the rate of circadian adaptation. Several 
night shift simulation studies have successfully used light to phase shift 
rhythms to realign to the new shifted sleep period (review, Burgess et al., 
2002). Table 1-2 outlines simulated night shift studies which have studied 
the effects of light on circadian timing. 
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INTERVENTION OUTPUT MEASURES RESULTS 
STUDY 
BY; 
  54 subjects participated in DLMO   Both fixed sleep and bright (Horowitz 
a shift work simulation of 4 measured light conditions significantly et al., 
ay and 3 night shifts. before and phase delayed DLMO. 2001) 
  Subjects received 2,500 after the night   Treatments combined 
ux or 150 lux during night shifts dditively, with light leading to 
hifts and were scheduled to arger phase shifts. 
Jeep (at home in darkened 
bedrooms) from 08.00 - 
16.00h (fixed sleep). 
  Study investigated whether CBT, DLMO   Melatonin produced larger (Sharkey 
elatonin can facilitate phase phase advances than placebo and 
shifts in a simulated night- in DLMO and temperature Charmane, 
work protocol. rhythms. 2002) 
  Thirty two subjects slept in   Average phase advances (± 
he afternoons/evenings SD) of the DLMO were 1.7 ± 
efore night work (h advance 1.2h (placebo), 3.0 ± 1.1 h (0.5 
f the sleep schedule). mg), and 3.9 ± 0.5 h (3.0 mg). 
  67 subjects in 5 DLMO   With bright light during the (Crowley 
onsecutive simulated night assessed night shift, almost all of the et al., 
shifts (23.00-07.00h) and before and participants achieved complete 2003) 
hen slept at home (08.30- after the night e-entrainment. The phase 
15.30h) in darkened shifts Jelay shift was so large that 
edrooms. (baseline and arker sunglasses and 
  Participants wore final), and 7h elatonin could not increase its 
unglasses whilst outside was added to magnitude. 
luring the day. Participants estimate   Recommend the combination 
ook placebo or melatonin temperature of intermittent bright light during 
1.8 mg sustained release) minimum he night shift, sunglasses (as 
efore daytime sleep. (Tmin). ark as possible) during the 
  During the night shifts, commute home. 
articipants were exposed to 
moving (delaying) pattern 
f intermittent bright light 
, approximately 
5000 lux). 
  24 male subjects had their CBT, sleep   The CBT rhythm phase (Eastman, 
Jeep schedules shifted 12h diaries and shifted, usually approximately 1992) 
o accommodate eight or mood 2h/day, in 21 of 24 subjects. 
ore consecutive simulated questionnaires   In the subjects whose 
fight shifts. They were emperature rhythms shifted, 
xposed to artificial 5,000 lux, he direction of shift (advance or 
to 6h durations) each night, delay) depended on the timing 
lept at home in very dark of light exposure relative to their 
edrooms during the day, baseline temperature phase, 
and wore dark welders consistent with a PRC. 
goggles whenever they went 
outside during daylight 
" 12 nursing night shift staff. Alertness   Most significant improvement (Yoon et 
  Study consisted of 3 measured by n sleep was seen in the group al., 2002) 
reatment procedures; room visual with light treatment and 
ight, bright light (10,000 lux) analogue sunglasses. 
nd bright light and scale. Sleep 
unglasses. diaries and 
acti ra h. 
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 6 subjects received 4 hour CBT   Treatment group delayed by (Dawson 
light pulse, 6,000 lux between 5-6hrs. and 
4.00-04.00 h light pulse on   Control group delayed 2-3hrs Campbell, 
he first night shift and then 1991) 
Jim light for the remainder of 
he study. 
 7 subjects in control group 
ere under dim light 
onditions for the entire 
duration of the study. 
  12 subjects (4 males and 8 Plasma   Basal plasma NEFAs were (Ribeiro et 
females) studied on three glucose, non- ower immediately after the al., 1998) 
ccasions at the same clock esterified fatty phase shift (P < 0.05). 
ime (13.30h), but at different acids Incremental (difference from 
ody clock times, after (NEFAs), basal) TAG responses were 
onsuming test meals, first in TAGs, insulin, ignificantly higher (P < 0.05) 
heir normal environment, and urinary immediately after the phase 
econdly after a forced 9h aMT6s. shift compared with baseline. 
hase advance (body clock wo-day post-phase shift 
ime approximately 22.30h) esponses showed partial 
nd then again 2 days later in eversion to baseline values. 
he normal environment. This study suggested that it 
akes at least 2 days to adapt to 
ating meals on a simulated 
iight shift, 
  This study was designed Plasma   Significantly higher (Hampton 
o investigate postprandial glucose, ostprandial glucose responses et al., 
esponses to a mixed meal in insulin, were observed in the last 4h of 1996) 
simulated shift work triacylglycerol he study after the phase shift 
onditions. 9 normal healthy (TAG) han before. Peak plasma TAG 
subjects were studied on two evels occurred 5h 
ccasions at the same clock ostprandially before the phase 
ime (13.30h) after shift. Postprandial rises in 
onsuming test meals, first in lasma TAG were significantly 
heir normal environment and elayed after the phase shift. 
econdly after a9h phase 
dvance (body clock time 
22.30h). 
  Volunteers were initially   Bright light delayed the (Deacon 
subjected to a gradual 9-h MT6s rhythm in all subjects. and 
delay phase shift over 5 days With the subsequent 9h Arendt, 
D1-D5) using a combination dvance shift two subjects 1996) 
of bright light and elayed and five phase 
darkness/sleep. Melatonin advanced with both MT and 
reatment was timed to phase elatonin and bright light. 
dvance and bright light to Melatonin consistently improved 
phase delay. ubjective sleep, alertness and 
erformance even in the 
resence of inappropriate bright 
ight and before phase 
eadaptation had occurred. 
  Simulated night work field CBT   Intermittent bright light 
(Baehr et 
tudy included 8 consecutive groups had significantly larger al., 1999) 
fight shifts followed by hase delays than dim light 
Jaytime sleep/dark periods groups, and 94% of subjects 
delayed 9h from baseline). who received bright light had 
  33 subjects in a2x2 phase shifts 
large enough for 




ntermittent bright light (6 each daytime sleep. 
ulses each, 40-min long   Exercise did not affect phase 
ach, at 5,000 lx) versus dim hilts; neither facilitating nor 
ight and 2) intermittent nhibiting phase shifts produced 
xercise (6 bouts, 15-min by bright light. 
ong, at 50-60% of maximum 
ieart rate) versus no 
xercise. 
Table 1-2: Summary of simulated shift work studies that have studied the effects of light on 
circadian timing. 
1.7.3. Field studies of shift work and bright light 
Intense artificial light can shift the phase of human circadian rhythms (section 
1.4.5) and has been successfully used to induce phase shifts and to improve 
sleep, performance and alertness (Czeisler et al., 1990; Dawson and 
Campbell, 1991; Deacon and Arendt, 1996). Bright light as a counter 
measure for circadian desynchrony has been used in the field, though the 
number of studies are limited. 
One of the first field studies to use light to help subjects adapt back to the 
day shift after working nights was conducted by Midwinter and Arendt (1991) 
in Antarctica. The study involved 11 healthy men, mean age 21-33 years 
with and without morning and evening bright light treatment (2500 lux) 
between 08.00-09.00h and 16.00-17.00h. The acrophase of the melatonin 
rhythm was significantly delayed from 5.22h to 14.54h in summer and 8.73h 
to 13.23h in winter during a week of night shift work. The study 
demonstrated the importance of light treatment to shift the circadian clock to 
aid readaptation. 
Field studies on NASA astronauts carried out by Stewart et al. (1995) used 
light as a counter measure to help adaptation to shift work. The study 
involved NASA astronauts (18 subjects, mean age 37 ± 11 years) and 
ground crew using long duration high intensity light exposures (light 3000- 
12,000 lux) to produce an adaptive phase delay shift of 3-9h. Light treatment 
was administered a week prior to launch along with a slow or rapid shift in 
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sleep to pre-adapt the workers to the shift schedules required during the 
mission. Light treatment began 3 to 4 nights before the first night shift, during 
the first half of the subjective night to induce large phase delays. Light 
treatment had beneficial effects on night shift personnel. Subjects in the light 
treatment group rated their speed of work, concentration, and alertness while 
on duty significantly higher than the control group who did not receive light 
treatment. 
Deacon and Arendt (1996) subjected 8 healthy volunteers to pulses of 
moderately bright light (1,200 lux) day 1: 18.00-03.00h, day 2: 21.00-06.00h 
and day 3: 24.00-09.00h. As a result of the light pulses a progressive shift in 
rhythms was evident, with a maximal shift in aMT6s of just over 9 hours. 
A study conducted by Lowden et al. (2004) showed a clear effect of bright 
light during breaks on night shift alertness, sleep and melatonin levels. 
Eighteen workers at a truck production plant were exposed to either bright 
light (2500 lux) during breaks or normal light for 4 consecutive weeks. In the 
study 20-minute breaks were initiated by 67% of the workers between 03.00- 
04.00h. The results showed that bright light administration significantly 
suppressed melatonin levels during night work and most strongly at 02.00h. 
The results suggested that intermittent bright light combined with normal 
work light exposure strengthens the photic drive as opposed to continuous 
normal work light conditions. The study showed positive results of bright light 
during night work on alertness and sleep. This gives further support for the 
use of light for night work, with total sleep time being positively affected by 
light exposure (Lowden et al., 2004). 
These studies described above demonstrate the abilities of appropriately 
timed light to help shift work adaptation in the field using the knowledge that 
has been acquired in laboratory studies (section 1.6.2). 
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1.7.4. Shift schedules operated offshore 
A number of different shift schedules are operated offshore which have a 
variety of impacts on adaptation to night shift. One of the most common shift 
schedules operated offshore is the 12h shift from 18.00-06.00h for 2 weeks. 
Barnes et al. (1 998a) have shown that the aMT6s rhythm of oil rig workers on 
this 2-week night shift (18.00-06.00h) adapts to the shift by phase delay. 
Another shift schedule is the 12h shift from 12.00-00.00h for 1 week followed 
by a 12h shift from 00.00-12.00h for 1 week, called a swing shift. When this 
shift was studied in the winter (November) months, no adaptation of the 
aMT6s rhythm was seen in the night shift (Barnes et al., 1998b). On the 
other hand when this shift was studied in spring (March) there was a 
significant phase advance of the rhythm during the night shift (Barnes et al., 
1998b). Gibbs et al. (2002) studied a swing shift schedule of 7 nights 18.00- 
06.00h followed by 7 days 06.00-18.00h. A significant difference was found 
between the mean aMT6s acrophase at the start and the end of the night 
shift week. Most subjects adapted to the night shift but there was a wide 
inter-individual variation when readapting back to day shift. 
1.7.5. Studies using light and melatonin on offshore shift workers 
Bjorvatn et al. (1998) studied adjustment to 14 days of consecutive night 
work on a North Sea oil platform and the readjustment to day life at home, 
using the Karolinska sleep/wake diary during April and May. The subjective 
ratings from the study indicated that workers adapted to night work within a 
few days and had more problems re-adapting to day life offshore as had 
previously been found in Antarctic field studies, (Midwinter and Arendt, 1991; 
Ross et al., 1995). The platform workers adapted to night work within a few 
days as indicated by the rapid reduction of night work sleepiness, and by the 
gradual delay of bedtime. Readaption to day life was slower and more 
difficult adding to the evidence of complete adaptation to night work. It was 
concluded that the lack of conflicting exposure to daylight in the morning may 
have facilitated the rapid adjustment to night work. 
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A later study was conducted by Bjorvatn et al. (1999) on oil rig workers in the 
North Sea, with subjects working for 2 weeks on a 12h day; 07.00-19.00h, 
followed by 2 weeks off. The study used bright light treatment where the light 
exposure was scheduled on an individual basis on the assumption that the 
CBT nadir was located 2h before the subject's habitual time of awakening. 
The light treatment (10,000 lux white light) consisted of 30 minutes per day 
and was applied during the first 4 nights of the night shift and the first 4 days 
following the return home. Between subjects, the start of bright light 
exposure ranged from 03.30h to 05.30h during the first night of the night shift, 
and from 14.00h to 15.30h during the first day at home. Subjects were told to 
avoid outdoor light exposure after the scheduled bright light treatment. The 
study concluded that a few days of scheduled exposure to bright light could 
be used to facilitate adaptation back to day life following their return home. 
In a more recent study Bjorvatn et al. (2006) studied the adaptation and 
readaptation processes from one week of nights followed by one week of 
days on an offshore oilrig, in a placebo controlled crossover field study. 
Seventeen male subjects were studied, using both subjective and objective 
measures, Karolinska sleepiness scale (KSS), simple serial reaction time 
test, sleep diary and actigraphy. Subjective and objective measures 
improved gradually during night work. The return to day work after one week 
of nights led to increases in subjective sleepiness. 
Bjorvatn et al. (2007) also evaluated the effects of bright light and melatonin 
on adaptation to night work offshore. Seventeen subjects working a 
schedule of 2 weeks on a 12h shift schedule, with the first week on night shift 
(19.00-07.00h) and the second week on day shift (07.00-19.00h) (swing shift 
schedule) participated in a randomized controlled crossover design. 
Subjects received a placebo, melatonin (3 mg, 1h before bedtime), or bright 
light (30-minute exposure, individually scheduled) during the first 4 days on 
the night shift and during the first 4 days on the day shift. Subjective and 
objective measures of sleepiness (KSS and a simple serial reaction-time test) 
and sleep (diary and actigraphy) were obtained. Subjective measures 
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indicated that melatonin modestly reduced sleepiness at work during the day 
shift and increased sleep by 15-20 minutes per day. Melatonin and bright 
light modestly improved sleep and sleepiness in this field study. 
These studies demonstrate the use of light intervention to encourage phase 
adaptation in shift workers. 
1.7.6. Adaptation to the night shift 
Circadian adaptation in terms of adapting to a night shift or a new time zone 
can be defined as a significant shift of the melatonin rhythm into the daytime 
(Nowak et al., 1987). Exceptions to the general rule that shift workers do not 
adapt to night work have been shown to occur where night workers work and 
sleep at unusual isolated locations such as offshore oilrigs or Antarctic 
stations (Broadway and Arendt, 1988; Midwinter and Arendt, 1991; Ross et 
al., 1995; Barnes et al., 1998a; Gibbs et al., 2002). In these unusual work 
environments, workers are less subject to the external light dark cycle and 
competing social demands. Moreover there also seems to be a large inter- 
individual variability in shift workers who actually adapt to shift work in a 
`normal' environment (Burgess et al., 2002). 
Offshore North Sea oil installations are located far enough North (61 °N) to 
study the effects of the presence (in summer) and absence (in winter) of 
natural bright light during the night shift. Light exposure during the winter 
period on night shift has been reported to range between 50 and 400 lux and 
consisted of only artificial light (Barnes et al., 1998b). Exposure during the 
summer period on night shift ranged between 50 and 2000 lux (Barnes et al., 
1998b). Studies in Antarctica (Broadway and Arendt, 1988; Midwinter and 
Arendt, 1991) have shown that different seasons influence the ability of shift 
workers to adapt to night shift. 
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1.7.6.1. Individual differences and adaptation 
Individual differences in the ability to adapt to a night shift, and hence adapt 
the internal body clock to sleep at a new time schedule are influenced by 
many factors. Evening types (whose Tmin occurs at a later clock time) 
generally work better at night work as they have later bedtimes already, 
hence they do not have to shift the timing of their sleep period as much as 
those who are morning types (whose Tmin occurs at an earlier clock time) 
(Duffy et al., 2001) and who have to shift their sleep period further in 
comparison to evening types. Secondly, evening types are known to be 
capable of larger phase delays than morning types, which allows evening 
types to adapt to the night shift faster than morning types (Mitchell et at., 
1997). Most recently, Gibbs et al. (2007) have shown that initial phase, early 
or late, at the beginning of night shift can predict both rate of adaptation to 
nights (18.00-06.00h) but also rate and direction of re-adaptation to days 
(06.00-18.00h). 
1.7.6.2. Age and adaptation 
Age also influences the rate at which one can adapt to the night shift. Older 
people tend to have an earlier sleep-wake cycle compared to young people, 
with respect to clock time (Duffy and Czeisler, 2002). Therefore older night 
shift workers would have to shift their sleep-wake cycle further to adapt to the 
night shift compared to younger night shift workers (Dijk et al., 1999). Older 
people have been shown to wake up at an earlier circadian phase of the 
body temperature and plasma melatonin rhythm (Dijk et al., 1999; Duffy and 
Czeisler, 2002). Wake maintenance and sleep initiation are not markedly 
affected by age except that sleep latencies are longer in older people when 
sleep initiation is attempted in the early morning (Dijk et al., 1999). Sleep in 
older people is particularly disrupted when scheduled on the rising limb of the 
temperature rhythm, indicating that the sleep of older people is more 




1.8. Shift work and its effect on health 
The general consensus is that shift work is associated with greater health 
problems than `normal' day work (Harrington, 2001). Night shift workers are 
required to work and eat at the `wrong' phase of their circadian cycle. This 
results in complaints of sleepiness, reduced performance and disturbed sleep 
due to lack of adjustment of the circadian timing system (Akerstedt and 
Gillberg, 1990; Kecklund and Akerstedt, 1993; Bjorvatn et al., 1999). During 
consecutive night shifts, the internal circadian rhythms gradually shift to 
adapt to the new schedule (Crowley et al., 2003). Attempts to sleep at 
inappropriate phases of the circadian cycle, for example during the declining 
phase of melatonin and rising phase of core body temperature, usually 
results in shorter sleep episodes and more awakenings (Kecklund and 
Akerstedt, 1995). 
Night and rotating shift workers are most likely to report disrupted eating 
habits and poorer diets than those who work day or afternoon shifts, as well 
as a higher prevalence of gastric and peptic ulcers, gastritis and constipation 
(Gordon et al., 1986). However there has been no report of a link between 
shift work, eating and disease (Knutsson, 1989). Lennernas et al. (1995) 
reported that energy intake and the quality of food intake (% of energy from 
macronutrient and density of micronutrients) were not affected by shift work. 
Recently an association between increased risk of cancer and shift work has 
been reported due to the hypothesis of exposure to light at night and 
suppression of melatonin (Schernhammer et at., 2006). 
1.8.1. Shift work and cardiovascular disease 
Shift work has been long associated with cardiovascular disease (CVD). 
1.8.1.1. Epidemiology 
Heart and circulatory disease is the UK's biggest killer. In 2002, CVD caused 
39% of deaths in the UK, and killed just fewer than 238,000 people. 
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Coronary heart disease (CHD), the main form of CVD, caused over 117,000 
deaths a year in the UK; approximately one in five deaths in men and one in 
six deaths in women. Death rates for CHD have been falling rapidly in the 
UK since the late 1970s. Despite this, death rates from CHD in the UK are 
still amongst the highest in Western Europe (www. heartstats. org British Heart 
Foundation statistics website). 
1.8.1.2. Circadian aspects of CVD 
Circadian control of normal physiology will inevitably lead to circadian 
variation in disease. The increased risk of heart disease in those who work 
shifts is thought to be due to the disruption of internal circadian mechanisms 
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Figure 1-10: Circadian mechanisms of CHD (review, Hastings et al., 2003). 
Circadian oscillators in the vascular endothelium, smooth muscle and 
myocardium, are based on clock gene feedback loops, they are synchronized 
by signals from the SCN. As a result infarctions, ischemia and strokes can 
be seen as consequences of actions of the circadian system in the vascular 
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tissues, as illustrated in Figure 1-10 (review, Hastings et al., 2003). For 
example, heart attack and strokes show a pronounced morning peak 
associated with changes in blood pressure, cardiac output etc. Acute 
myocardial infarction (AMI) is 40% higher in the morning. Peripheral 
oscillators contribute to the circadian prevalence of CVD (Hastings et al., 
2003). A number of studies have shown that the incidence of all subtypes of 
stroke (lacunar, thrombotic, and hemorrhagic stroke) has a significant 
circadian rhythm, with a higher frequency between 06.00h and 24.00h, and a 
lower frequency from midnight to 06.00h (Gallerani et al., 1996; Lago et al., 
1998). 
1.8.1.3. Shift work and heart disease 
The causes of CVD are multifactorial. The psychosocial factors of sedentary 
work, monotonous or other stressful work conditions, passive smoking, and 
shift work have also been identified as occupational risk factors (Kristensen, 
1989). Shift workers are known to have an increased risk of heart disease 
(Hampton et al., 1996; Steenland and Fine, 1996; Tenkanen et al., 1997; 
Nicholson and D'Auria, 1999) of approximately 40% (Boggild and Knutsson, 
1999). Sociotemporal patterns, lack of social support, stress, behaviour and 
biochemical changes are all thought to contribute to this risk factor (Boggild 
and Knutsson, 1999). 
Triacylglyercol concentrations are an independent risk factor for heart 
disease (Austin, 1997; Boggild and Knutsson, 1999). Night shift workers are 
reported to have an approximately 1.5 fold higher incidence of heart disease 
risk (Boggild and Knutsson, 1999) and also demonstrate higher TAG levels 
compared with matched day workers (Lund et al., 2001; Morgan et al., 2003). 
Simulated shift work studies have also demonstrated this same principle 
(Ribeiro et al., 1998; Sopowski et al., 2001). If shift workers repeatedly 
consume meals at night, during the time of maximal insulin insensitivity, the 
cumulative postprandial effects may predispose individuals to display other 
abnormalities of the metabolic syndrome (Morgan et al., 2003). One study 
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found that cholesterol correlated with the distribution of meals and cholesterol 
levels were higher when a larger proportion of the diet was ingested at night 
(Lennernas et al., 1994). 
Several studies have confirmed the well-known clinical experience that the 
onset of both myocardial infarction and angina pectoris is more common in 
the early morning. This chronobiological rhythm has been explained by a 
mismatch between oxygen supply and oxygen requirement at time of 
awakening (Boggild and Knutsson, 1999). A study conducted by Karlsson et 
al. (2001) concluded that obesity, high triacylglycerol (TAG) levels and low 
concentrations of high density lipoprotein (HDL) cholesterol seem to cluster 
more often in shift workers. There is strong evidence showing that the 
metabolic syndrome is a combination of obesity, dyslipidemia, with high TAG 
and low HDL cholesterol and glucose intolerance, which are all risk factors 
for heart disease (Haffner, 1999). Knuttson and Boggild. (2000) reported that 
these factors appear to cluster together more often in shift workers than day 
workers. It has been claimed that when people make a decision to apply for 
shift work, they have probably estimated their ability to withstand irregular 
work hours and therefore differ in terms of health from those choosing not to 
apply (Kivimaki et al., 2006). 
1.8.2. Insulin resistance 
Insulin resistance is the condition in which normal amounts of insulin are 
inadequate to produce a normal insulin response from fat, muscle and liver 
cells (Bonadonna et al., 1993). Insulin resistance refers to a reduced ability 
to utilise insulin to control glycaemia. In insulin-sensitive individuals, insulin 
promotes glucose uptake in target tissues and inhibits glucose production by 
the liver. Insulin resistance in muscle reduces glucose uptake whereas 
insulin resistance in liver reduces glucose storage, with both effects serving 
to elevate blood glucose. It is known that insulin sensitivity is lower during 
the night than in the day (Van Cauter et al., 1992). High plasma levels of 
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insulin and glucose due to insulin resistance often lead to the metabolic 
syndrome and type II diabetes (Balkau, 2005). 
1.8.3. Metabolic syndrome 
Clinical conditions including hypertension, truncal obesity, dyslipidaemia and 
insulin resistance (Nakamura et al., 1997; Ha and Park, 2005) are 
collectively known as the `metabolic syndrome'. The metabolic syndrome is 
poorly understood because it is multifactorial including environmental, 
genetic and epigenetic aspects (Magliano et al., 2006). It has been shown 
under experimental conditions, that following an abrupt change in the timing 
of sleep and work, postprandial glucose and lipid tolerance and insulin 
secretion are significantly altered, to an extent that may contribute to 
atherogenesis and hence cardiovascular disease (Foret et al., 1998; Ribeiro 
et al., 1998; Morgan et al., 2003) (as well as metabolic syndrome). These 
findings suggest that it takes at least 2 days to adapt to eating meals on a 
simulated night shift. 
1.8.3.1. Shift work, the metabolic syndrome and insulin 
resistance 
Shift work is associated with the metabolic syndrome (Assman et al., 1999). 
These problems are believed to be due largely to desynchrony of circadian 
rhythms (Lund et al., 2001) although health problems, which arise from shift 
work are multi-factorial Collectively all these factors may contribute to the 
health risks associated with shift work. 
1.8.4. Shift work and sleep 
The sleep-wake cycle is one of the most important circadian rhythms. Sleep 
is usually initiated when body temperature is falling (Dijk and von Schantz, 
2005; Waterhouse et al., 2005). Shift work that includes night work is 
associated with shortened sleep and increased sleepiness (Akerstedt, 2003). 
55 
Chapter 1 
One reason for night shift sleepiness is that the individual is required to work 
at the nadir of the well-established circadian pattern of wakefulness. 
Alertness, performance and metabolism peak in the late afternoon, and reach 
a nadir in the early morning. The period of maximum alertness will also 
strongly interfere with sleep, whereas the nadir of CBT will equally promote 
sleep (Akerstedt and Gillberg, 1981; Czeisler et al., 1990). 
1.8.5. Sleep problems in shift workers 
Health problems associated with shift workers may be mediated directly by 
sleep problems as well as desynchrony. Shift workers are known to sleep 
less than day workers and to be more fatigued (Akerstedt, 1990; Ohayon et 
al., 2002). However, there is limited knowledge on a possible relationship 
between lack of sleep and CVD, although sleep apnoea syndrome is a risk 
factor for CVD (Boggild and Knutsson, 1999). 
The majority (60-70%) of shift workers complain about their sleep; most of 
them report difficulties falling and staying asleep, poor quality of sleep, short 
duration of sleep and difficulties staying awake (Knauth et al., 1980; Marquie 
and Foret, 1999). Sleep after night work is usually shorter and more 
fragmented than sleep after day work (Wyatt and Marriott, 1953; Smith et al., 
1982; Ahasan et al., 2001). Sleep after the night shift is usually initiated 1h 
after the termination of the shift (Knauth et al., 1981; Tepas, 1982), and 
studies using sleep diaries of workers have shown that the sleep period 
during the day is 1-4h shorter than that of sleep at night (Torsvall et al., 1989; 
Tepas and Carvalhais, 1990). Sleep studies have also reported that the 
total sleep duration is related to the body temperature rhythm at bedtime 
(Czeisler et al., 1980; Gillberg and Akerstedt, 1982). Sleep difficulties may 
be partly social but there is a strong circadian influence on sleep latency that 
makes early initiation of sleep difficult following a night shift (review, Ahasan 
et al., 2001). 
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Sleep in shift workers can be altered by both endogenous (i. e. circadian, 
metabolic, hormonal) and exogenous (traffic, children playing, household 
noise) factors. Social stress factors (disruption of family organisation, 
parenting role) also contribute to sleep fragility in shift workers (Barton et al., 
1995; Ahasan et al., 2001). In the day, there is a reduction of the `deep 
sleep', which is essential for recovering from physical fatigue (Akerstedt, 
1984) 
1.8.6. Stress and shift work 
Another consequence of shift work is problems in family life, as the work 
hours interfere with social activities and family responsibilities. 
Shift work reduces both the time available for family and recreation, and 
potentially leads to social isolation and subsequent stress. Married night 
workers with family commitments typically do not retain a day sleep regime 
during their off duty break, as they want to interact with day-orientated family, 
rather than being awake when everyone else is asleep (Monk, 2000). Stress 
is probably one of the key elements in the relationship between shift work 
and health problems (Boggild and Knutsson, 1999). 
Work efficiency during the night is also not the same as during the day. 
Wakefulness and activity is associated with daylight, whilst rest and sleep is 
associated with the night. The circadian fall in psycho-physical performance 
at night, in association with sleep deficit and strong feelings of fatigue, 
decreases the work efficiency of the night worker and increases the 
possibility of errors and accidents (Kelly and Schneider, 1982; Folkard et al., 
2006). 
1.8.7. Shift work and cancer 
Recently there has been a hypothesis that has linked shift work and cancer, 
due to light exposure suppressing melatonin levels at night (Blask et al., 
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2005; Schernhammer et al., 2006). This mechanism has been supported by 
animal studies (Van den Heiligenberg et al., 1999; Blask et al., 2005) and 
longitudinal and retrospective studies (Davis et al., 2001; Schernhammer et 
al., 2001). 
1.8.7.1. Animal studies 
Several experimental animal studies have provided evidence for an 
association between melatonin levels and the risk of breast cancer. For 
example, rodent studies found that pinealectomy increased tumour growth 
(Tamarkin et al., 1981) and that constant light exposure had growth- 
promoting effects on chemically induced tumours (Van den Heiligenberg et 
al., 1999). More recently a study by Blask et al. (2005) showed that rats 
bearing rat hepatomas or human breast cancer xenografts that were exposed 
to increasing intensities of white light during each 12h dark period resulted in 
a dose-dependent suppression of nocturnal melatonin blood levels and a 
stimulation of tumour growth and linoleic acid uptake/metabolism by the 
mitogenic molecule 13-hydroxyoctadecadienoic acid. 
1.8.7.2. Circadian mechanisms and cancer 
The biological mechanism underlying the association of light at night and 
breast cancer is assumed to be the suppression of normal nocturnal 
melatonin production in the pineal gland. The result is decreased levels of 
melatonin in the blood. Melatonin synthesis is regulated via the retina by the 
light/dark cycle (section 1.4.1) and influences the biological regulation of 
circadian rhythms, sleep and probably tumour growth (Blask et al., 2005). 
Filipski et al. (2006) demonstrated that rhythms of clock genes per2 and 
reverb-a were suppressed in the liver and in the tumour of jet lagged mice. 
This functional disturbance of the molecular clock resulted in down regulation 
of p53 and over expression of c-Myc, two effects which may favour cancer 
growth. These results indicated that the circadian system could play an 
important role in malignant growth control. 
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Women who are totally blind with no light perception are known to have a 
decreased risk of breast cancer, of approximately 50% (Hahn, 1991; 
Feychting et al., 1998) thus giving some support for this claim. However 
those who are blind may lead a different type of lifestyle which may 
contribute to the reduced risk. 
1.8.7.3. Epidemiological studies 
Persons who engage in night work, as a result of desynchrony, may have 
altered melatonin levels and reproductive hormone profiles that could 
increase the risk of hormone related diseases such as breast cancer (Davis 
et al., 2001; Hansen, 2001; Moser et al., 2006; Schernhammer et al., 2006). 
However this is largely speculative at present. There are numerous factors 
which affect the relative risk of developing breast cancer; these are shown in 
Figure 1-11. 
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Figure 1-11: Factors affecting the breast cancer risk (Moser et al., 2006). 
Hansen (2001) looked at 7035 Danish women aged between 30-54 years, 




positive trend of increasing duration of work at night with a 1.5 fold increase 
in risk for primary breast cancer, in those who had worked for at least half a 
year in any trade with predominantly night work. 
Davis et al. (2001) investigated the relationship between light exposures at 
night to see if it was associated with an increased risk of breast cancer. They 
assessed sleep habits and the bedroom environment of those who had 
worked the "graveyard shift", which was defined as work beginning after 
19.00 h and leaving work before 09.00h. The findings showed that breast 
cancer risk was increased in subjects who frequently did not sleep during the 
period of night where melatonin levels are at their highest. The graveyard 
shift was associated with increased risk of breast cancer (OR=1.6; 95% 
CI=1.0-2.5) with a trend of increased risk with increasing duration of doing 
shifts and with more hours per week of the graveyard shift. The study 
concluded, without the use of light measures, that the results provide 
evidence that exposure to light at night may be associated with an increased 
risk of developing breast cancer. 
Schernhammer et al. (2001) conducted one of the largest cohort studies in 
this field. They investigated the relationship between breast cancers and 
working on rotating night shifts during 10 years of follow up in 78,562 women 
from the Nurses' Health study. A moderate increase in breast cancer risk 
was observed among women who had worked 1-14 years or 15-29 years on 
rotating night shifts. The study concluded that women who had worked at 
least 3 nights per month, in addition to days and evenings in that month, 
appeared to have a moderately increased risk of breast cancer after 
extended periods of working rotating night shifts. 
More recently Schwartzbaum et al. (2007) has reported that night shift work 
is not linked to an increased risk of breast cancer or prostate cancer. 
Schwartzbaum et al. (2007) came to this conclusion after analysing 20 years 
worth of data that compared people who reported jobs that required night 
shift work. Altogether 2,102,126 male and 1,148,661 female workers were 
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identified who worked in both 1960 and 1970. Their jobs were classified 
according to the percentage of shift workers, and they were followed from 
1971 through 1989 or until they were diagnosed with cancer or died. There 
is much controversy and debate in this subject area. 
1.8.8. Summary of shift work and its effect on health 
There is substantial evidence suggesting that night shift work is detrimental 
to health. The increased risk of disease may be related to desynchronisation 
of internal bodily rhythms from the 24h light-dark cycle and/or from internal 
desynchronisation. This thesis investigates the utilisation of light treatment to 
reduce the time of circadian desynchronisation. 
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1.9. Objectives of the study 
With the support of the industry regulator (Health and Safety Executive) and 
the UK petrochemical industry offshore operators, this project was 
established with the following objectives: 
1.9.1. Shift schedule effect on sleep and adaptation 
Adaptation to the 18.00-06.00h 2 week night shift offshore has been 
documented in previous studies (Barnes et al., 1998a). The 19.00-07.00h 2 
week night shift has previously been unreported in terms of adaptation. 
The aims and hypothesis of the study were to: 
  Investigate the effects of shift schedule timing on sleep, circadian timing 
and light exposure. Two shift schedules; 2 weeks 18.00-06.00h and 2-3 
weeks 19.00-07.00h were studied in the summer (chapter 3). 
The null hypothesis stated there will be no effect of shift schedule timing 
on sleep and circadian adaptation. 
1.9.2. Light box study 
Previous studies (Broadway et al., 1987; Eastmann and Martin, 1999; Revell 
et al., 2005) have shown that light in the morning can phase advance the 
circadian system. The Litebook® is a small portable light treatment device: 
whether or not the light box could cause a phase shift was investigated. 
The aims and hypothesis of the study were to: 
  To investigate the ability of a light box to phase advance the melatonin 
rhythm in healthy young male volunteers in controlled laboratory 
conditions (chapter 4). The aim of the study was to investigate the 
effects of a single bright light pulse to change the time of the internal 
clock (shift circadian phase). 
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  The null hypothesis stated there would be no effect of light treatment on 
the phase of melatonin (aMT6s acrophase, DLMO and DLMOff). 
1.9.3. Light treatment in offshore shift workers 
Adaptation to the night shift is beneficial in terms of sleep and cognitive 
performance, however as a result of this adaptation problems arise at the 
end of the night shift concerning readapting back to day shift/home life. The 
use of light treatment, appropriately timed, at home may alleviate/reduce the 
physiological and behavioural problems caused by circadian rhythm 
disturbance. 
The aims and hypothesis of the study were: 
  To assess the use of timed light treatment to hasten circadian adaptation 
of offshore adapted night shift workers when they return home to day life 
and improve subjective and objective sleep (chapter 5). 
The null hypothesis stated there would be no effect of light treatment on 
the phase of melatonin and subjective and objective sleep. 
Secondary objective: Light exposure and aMT6s excretion 
Subjects who have fully adapted to the night shift will return home onshore 
with their aMT6s rhythm peaking during the day. Light exposure during the 
day will probably suppress the subject's aMT6s rhythm. 
The aims and hypothesis of the study were: 
  To assess the effects of light exposure on the total production of 
melatonin (as aMT6s) upon returning home onshore (chapter 6). 
The null hypothesis stated there would be no effect of light exposure on 
the suppression of aMT6s. 
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2. MATERIALS AND METHODS 
2.1. Light and activity analysis by actigraphy 
Light and activity data were collected by the use of an Actiwatch-L 
(Cambridge Neurotechnology Ltd), shown in Figure 2-1. This is a wrist type 
monitor, which is worn on the non-dominant wrist, outside the clothing. 
Measurements of light and activity were taken in one-minute epochs. The 
data is transferred telemetrically and analysed using Cambridge 
Neurotechnology software packages (Sleep Analysis 5, version 5.42). Light 
exposure (measured in lux) was calculated in half hourly bins, sleep periods 
were identified by use of sleep diaries (Section 2.6). The following 
parameters were studied: sleep efficiency, sleep latency, fragmentation 
index, sleep onset, offset and sleep duration. 
Figure 2-1: Diagram of an Actiwatch-L 
2.2. Assessment of diurnal preference 
The Horne Ostberg (HÖ) morningness-eveningness sleep questionnaire 
(Appendix A) is designed to assess the diurnal preference of individuals 
(Horne and Ostberg, 1976). The questionnaire is able to identify differences 
in sleep and wake preference (chronotype) on the basis of score. Subjects 
answer a series of questions, the overall score is tallied up and diurnal 
preference is indicated as follows: 
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Hb score Diurnal Preference 
16-30 Extreme evening type 
31-41 Moderately evening type 
42-58 Neither type 
59-69 Moderately morning type 
70-80 Extreme morning type 
2.3. Mood assessment 
Subjective alertness, anxiety, mood and energy were self-rated using a visual 
analogue scale by marking a point on a 10 cm line of paper. The following 










Sleep diaries (Appendix B) were completed throughout the duration of the 
studies. The diaries obtained the following information: 
1. Date (date woke up on) 
2. Time of retiring to bed (e. g. 23: 00h) 
3. Time of trying to sleep (e. g. 23: 15h) 
4. How long it took to fall asleep (minutes) 
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5. Number of night awakenings 
6. The total duration of night awakenings (minutes) 
7. Time of awaking 
8. Time of getting up 
9. Sleep quality rated on a scale of 1-9 (1 best ever sleep, 9 worst 
ever sleep). 
10. Naps, time and duration 
2.5. General principles of radioimmunoassay 
Radioimmunoassay (RIA) is an in-vitro method of measurement, whereby a 
fixed amount of radioactively labelled antigen is allowed to react with a fixed 
but limited number of specific antibodies in such relative concentrations that 
only 50% approximately of the added label is bound to the antibody fraction. 
Once equilibrium is reached during the incubation period, the portion of the 
label, which is bound to antibody, is separated, e. g. using charcoal that binds 
to free antigen. A distribution between bound and free antigen is shown for 
different concentrations of unlabelled antigen. If a quantity of unlabelled 
antigen, present in either a standard solution or sample, is added to the 
mixture of labelled antigen and antibody before incubation commences, the 
unlabelled antigen will complete with the labelled antigen for the binding sites 
on the limited number of antibodies present. This results in fewer labelled 
antigen molecules being bound by the antibody which in turn results in there 
being fewer counts in the antibody bound fraction. The more unlabelled 
antigen molecules present, the fewer the labelled molecules will be bound to 
the antibody. The bound and unbound antigens are separated and the 
radioactivity in either bound or unbound fractions is counted. The samples 
are compared to a standard curve, which is constructed using a set of aMT6s 
or melatonin standards of a known concentration. The radioactivity is 




2.6. Radioimmunoassay of melatonin in human saliva 
Salivary melatonin was determined by RIA with a protocol modified from 
English et al (1993). 
2.6.1. Sample collection 
A non-citrated cotton Salivette (Starstedt Ltd, Leicester, UK) was used to 
collect saliva. The samples were immediately frozen upon collection and 
stored at -20°C until analysis. 
2.6.2. Reagents 
Tricine buffer (0.1 M): The assay buffer was freshly prepared each week. 
This buffer consisted of tricine (0.1 mol/I), 0.9% NaCl and 0.2% gelatin, made 
up in double glass-distilled water (DGDW) to give a stock solution of pH 5.5, 
this was adjusted to pH 8.0 by IM NaOH and stirred on a heater to 50°C for 
30 mins to dissolve the gelatin. 
Antiserum: The antimelatonin antiserum used in the assay was supplied 
freeze dried. Rabbit anti-melatonin antibody (product no: AB/R/031) was 
obtained from Stockgrand Ltd, University of Surrey, UK. These aliquots (50 pl 
aliquot to 10 ml tricine buffer) were reconstituted to achieve a final working 
solution of 1: 30,000. 
Separation system for bound and unbound antigen: The solid phase, 
double antibody coated cellulose suspension was purchased from IDS, 
Bolden, Tyne and Wear, UK (product no. AA-SAC-1). A solid phase second 
antibody-coated cellulose suspension (SAC-CEL) was used. Brij/Saline 
solution (0.15 M NaCl, 2% Brij 35) was used as a detergent to wash the 
suspension. 
Radiolabelled melatonin: 1251-2-iodomelatonin was purchased from 




iodomelatonin was diluted in tricine buffer to give approximately 10,000 cpm 
in 100 iii. 
Melatonin standard: this was supplied by Sigma Ltd (Bedford, UK). The 
melatonin stock solution was made up to 1 mg/ml by dissolving 10 mg 
melatonin in 0.5 ml absolute ethanol and adjusting the volume to 10 ml with 
DGDW. 
The working standard was freshly prepared from the stock solution, as 
follows: 
100 pl of stock solution (1 mg/ml) to 100 ml DGDW to give 1 pg/ml 
500 pl of 1 pg/ml solution to 50 ml DGDW to give 10 ng/ml 








200 pg/mI (p1) 
0 500 0 
1 495 5 
2 490 10 
4 480 20 
8 460 40 
14 430 70 
20 400 100 
40 300 200 
100 0 500 
Table 2-1: Preparation of melatonin assay standards. 
2.6.3. RIA procedure 
Duplicate tubes were prepared for all samples, standards; total count tubes, 
non-specific binding and quality control (QC) samples, zero binding tubes (0 
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pg/ml melatonin) were prepared in quadruplicate. Saliva samples were 
thawed and centrifuged at 3000 rpm for 10 mins. 500 pl aliquots of saliva 
samples and QCs were incubated with 100 pl of antiserum, the samples 
were vortexed and left to incubate for 30 mins at room temperature. 100 pl of 
1251-2-iodomelatonin was added to each sample and incubated overnight at 
4°C. The free and antibody bound fractions were separated using solid- 
phase antibody precipitating system (100 pl of SAC-CEL). The assay was 
intermittently mixed for 1h at room temperature. Then 100 pl Brij/Saline 
solution was added to each of the tubes and centrifuged at 3000 rpm for 4°C 
(Beckman J6 centrifuge, Beckman-Coulter, High Wycombe, UK). The 
supernatant was discarded and concentrations of samples were measured in 
a gamma counter from the standard curve using a "RIACaIc" program, 
RIAcalc Wallac International, Finland. 
The RIACalc program automatically determines the percentage of the total 
counts bound or free, and plots this as a function of known concentrations of 
melatonin standards. A curve is fitted through the standard points based on 
the smoothing spline calculation method. This fits a continuous curve to 
each pair of standard points using the conventional methods of least 
squares, but in addition, it calculates the best-fitting curve with the minimum 
number of turning points and is as smooth as possible. The concentrations 
of the unknown samples are determined from this curve by extrapolation. 
Quality Controls (QCs) were included in each assay to assess intra-assay 
and inter-assay variation. Quality control samples contain known 
concentrations of the antigen. A range of QCs were used to read low, 
medium and high across the standard curve. Comparison of the QC values 
at the start and the end of each assay was performed to ensure that there 
was no assay drift; variation in measured values due to reagents not being 
added at the same interval to all tubes and subsequent variation of 
incubation times. Comparison of the QCs after the standard curve were used 
to ensure there was minimal inter and intra-assay variation, and that the 
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assay results are reliable, with a tolerance of variation of <15% was 
accepted. 
2.6.4. Calculation of dim light melatonin onset 
The dim light melatonin onset (DLMO) was calculated using the twice 
individual baseline value method. 
For example, if baseline values for 3 time points were 20: 00h- 5 pg/ml, 
20: 30h -5.3 pg/ml and 21: 00h -6 pg/ml for an individual, the mean of these 
3 time points (5.4 pg/ml) is the mean baseline value. Twice the baseline is 
thus 10.8 pg/ml. The time associated with this value is between time point 
21: 00h (6 pg/ml) and 21: 30h (13.2 pg/ml). The change in melatonin 
concentrations during this period is calculated as (13.2-6) and the change in 
concentration per min is ((13.2-6)/30). The number of minutes after the start 
of this time period (21: 00h) that the twice baseline value occurs was 
calculated as follows: 
No. of mins = (twice baseline value-lowest melatonin concentration in time 
period) / (change in melatonin concentration)/mins. 
In this example (10.8-6) / [(13.2-6)/30] = 20 mins 
The number of mins is then added to the start time period 21: 00h + 20 mins = 
21: 20 h (h: mins) = (21.33 decimal h). Therefore, the DLMO calculated using 
the twice baseline method in this example occurs at 21: 20h (21.33 decimal 
h). 
2.7. RIA of 6-suiphatoxymelatonin (aMT6s) in human urine 
The urinary melatonin metabolite aMT6s was measured by a specific 




2.7.1. Sample collection 
Circadian status was determined by measurement of the aMT6s rhythm in 
urine. All urine was collected every time the subject urinated using the urine 
collection protocol (Appendix C). The time and volume of urine was 
recorded, a5 ml sample was aliquoted into a sample collection tube and 
frozen until further analysis. 
2.7.2. Reagents: 
Tricine buffer (0.11M): The assay buffer was freshly prepared each week. 
The buffer consisted of tricine (0.1 mol/l), 0.9% NaCl and 0.1% gelatin made 
up in double glass-distilled water (DGDW) to give a stock solution, this was 
adjusted to pH 5.5 by 1M NaOH and heated to 50°C for 30 mins to dissolve 
the gelatin. 
Antiserum: Specific polyclonal sheep anti-aMT6s antiserum was supplied 
freeze dried by Stockgrand Ltd, University of Surrey and was reconstituted 
with 1 ml DGDW and 9 ml of tricine buffer to provide an intermediate dilution 
of 1: 100.50 pl aliquots were stored at -20°C. 50 pl aliquots were diluted up 
to 20 ml with tricine buffer and provided enough antiserum for 100 assay 
tubes at an initial dilution 1: 20,000. 
Radiolabel: 1251-aMT6s was prepared and provided by Stockgrand Ltd, 
University of Surrey, UK. It was diluted in buffer to give approximately 
10,000 cpm in 100 pl. 
Charcoal stripped urine: This was provided by Stockgrand Ltd in freeze- 
dried vials (100 pl) and was reconstituted with 25 ml of tricine buffer to give a 
dilution of 1: 250. 
aMT6s standards: 500 pg aMT6s was supplied by Stockgrand Ltd at 100 
pg/ml diluted 1: 250 in charcoal stripped urine and this was stored at 4°C. 
Standards were further diluted for the standard curve. 
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Separation system: dextran coated charcoal containing 2% activated 
charcoal (product code C5260) was suspended in tricine with 0.02% dextran 
(product code D1390, Sigma Ltd, UK) and stirred overnight at 4°C. 
2.7.3. RIA Procedure 
Urine samples were diluted 1: 250 with tricine buffer by use of an automatic 
diluter (Hamilton Microlab, USA). Urine samples, QC's and standards in 500 
pl aliquots were incubated with 200 pl of anti-aMT6s antiserum, which binds 
to the antigen present in the sample and/or to radioactive label. The reaction 
was incubated at room temperature for 30 mins. 100 pl of 1251-aMT6s was 
then added, mixed and the assay incubated overnight at 4°C. The free 
fraction of aMT6s was separated by addition of charcoal, which before 
adding was continually stirred for 5 mins to ensure that it was suspended 
properly in the buffer. The tubes were incubated at 4°C for 15 mins and then 
centrifuged for 3,500 rpm for 15 mins at 4°C. The supernatant was discarded 
and the radioactivity of the pellet counted by a gamma counter, by way of 
counts per minute (cpm). The measured radioactivity is associated with the 
free antigen proportional to the concentration of the test antigen, when 
measured against standards. The standard aMT6s concentrations are shown 




200 /ml I 
aMT6s free urine 
1: 250 I 
aMT6s concentration 
n /ml 
0 500 0 
5 495 0.5 
10 490 1 
20 480 2 
40 460 4 
70 430 7 
100 400 10 
200 300 20 
500 0 50 
Table 2-2: Preparation of aMT6s assay standards. 
2.7.4. Cosinor Analysis 
Cosinor analysis is a curve fitting procedure that assumes the rhythm is 
sinusoidal in shape and fits the best fitting cosine curve to the data. Software 
to do this analysis was obtained from Dr D Minors, Manchester University, 
UK. This method of analysis makes two estimates of `goodness of fit', which 
are then used to determine the validity of the cosinor-derived parameters of 
the acrophase (peak time) and amplitude. The first is the percentage 
variability in the data accounted for by the cosine curve and is given as a 
percentage rhythm (%R). A 100% rhythm would mean all the points fall on 
the curve so the larger the percentage rhythm the better the fit. The analysis 
also checks the likelihood of the data points fitting a straight line as opposed 
to a cosine curve, or how probable it is that the data could fit the cosine curve 
by chance. A `significant fit' to the cosine curve is deemed to be when there 
is <5% probability that the data would fit a straight line i. e. p<0.05 (Nelson et 
al., 1979). Acrophase values were only accepted if the cosinor fit was 
significant at the 95% level or if the fit was significant at >80% level and the 




2.8. Statistical analyses 
Methods for statistical analysis will be detailed in each chapter separately. 
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3. THE EFFECTS OF CIRCADIAN ADAPTATION ON OFFSHORE SLEEP 
3.1. Introduction 
Shiftwork leads to desynchronisation of internal biological rhythms and as a 
result there are problems of physiology (e. g. digestive problems) and 
behaviour (e. g. sleep) (section 1.8). Sleep is one of the major complaints 
that are associated with working night shifts (section 1.8). The majority (60- 
70%) of night shift workers complain about their sleep; most of them report 
difficulties falling and staying asleep, poor quality of sleep, short sleep 
duration and difficulties staying awake (Knauth et al., 1980; Marquie and 
Foret, 1999). Attempts to sleep during the day at inappropriate phases of the 
circadian cycle, for example during the declining phase of melatonin and 
rising phase of core body temperature, usually results in shorter sleep 
episodes, more awakenings, night time sleepiness and reduced performance 
(Akerstedt and Gillberg, 1990; Kecklund and Akerstedt, 1993; Bjorvatn et al., 
1999). 
Complete circadian adaptation to the night shift is rare (section 1.7.6). It is 
observed in situations where night shift workers work and sleep in isolated 
locations such as Antarctica (Broadway and Arendt, 1988; Midwinter and 
Arendt, 1991; Ross et al., 1995) and on offshore oil installations (Barnes et 
al., 1998a; Gibbs et al., 2002). In these situations social influences, which 
can impede night shift adaptation, are removed. Inappropriate morning bright 
light exposure, which counters adaptation (Eastman et al., 1994; Koller et al., 
1994) can be minimised when workers do not have to travel home after night 
work. Nevertheless the presence of early morning natural light (in summer) 
may hinder and its absence (in winter) may aid adaptation to the night shift. 
Daily rhythms in sleep and waking performance are generated by the 
interplay of multiple external and internal rhythms. These rhythms include the 
light-dark and social cycles, to circadian oscillators and homeostatic factors 
which are driven primarily by sleep-wake behaviour (section 1.2.1). Internal 
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oscillators contribute to variation in many aspects of sleep and wakefulness 
(e. g., sleep timing and duration and performance parameters, including 
attention and memory) (Dijk and von Schantz, 2005). With respect to the 
relationship between circadian adpatation and sleep, there is ample evidence 
for a close temporal relationship between the melatonin secretory phase, 
thermoregulation and circadian sleep propensity (Cajochen et al., 2003). 
Therefore if these factors are not carefully aligned then the duration and 
quality of sleep will be affected. 
Due to the circadian sleep propensity rhythm, sleep after working night shift 
is reported to be more fragmented and of shorter duration due to the 
unadapted internal biological clock (Wyatt and Marriott, 1953; Smith et al., 
1982; Torsvall et al., 1989; Akerstedt, 2003). Compared to those working 
night shifts onshore, the reasons for improved night shift sleep quality 
offshore might be that there are no family or lifestyle disturbances. Home 
and family duties may also explain why day time sleep is reduced in onshore 
night shift workers; offshore there is less to do in free time (watch TV or go to 
the gym) and therefore there is more time that can be dedicated to sleeping. 
3.2. Aims and hypothesis 
This study evaluated sleep (subjective and actigraphic), light exposure 
(actigraphy) and circadian phase (using the urinary metabolite of melatonin, 
6-suiphatoxymelatonin, aMT6s) on 2 shift schedules differing by only one 
hour in work start and finish time, 18.00-06.00h and 19.00-07.00h, but with 
potential of different natural light exposure. 
The null hypothesis stated there will be no effect of shift schedules on sleep 
and circadian adaptation. 
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3.3. Study design and methods 
Methodologies specific to this study are outlined here, for full details see 
chapter 2, Materials and Methods. Individual methods are cross referenced. 
3.3.1. Subject recruitment 
Ethical permission was obtained from the University of Surrey Ethics 
Committee (Ethics number: ace/2002/95SBLS). Five offshore installations 
were used in the North Sea, at geographical latitudes 58,59 and 60°N. 
Subjects were free of medications indicated by the protocol exclusion criteria, 
and gave written informed consent. 
3.3.1.1. Summer 19.00-07.00h subjects 
Ten subjects were studied in the summer months (May-August, 2005) for the 
last 7 days of a2 or 3 week night shift, 19.00-07.00h, on 3 offshore 
installations at 60°N. They were aged 46 ± 10 years (mean ± SD), with a 
body mass index (BMI) of 27.9 ± 2.3kg/m2, and a HÖ score of 57 ± 8. 
3.3.1.2. Summer 18.00-06.00h subjects 
Seven subjects were studied in the summer months (May-August, 2003) for 
the last 7 days of a2 week night shift, 18.00-06.00h, on 2 offshore 
installations at 60°N. They were aged 41 ± 12 years (mean ± SD), with a 
BM I of 26.6 ± 3.6 kg/m2, and a HÖ score of 56 ± 9. 
3.3.2. Study design 
Subjects kept daily sleep diaries and wore Actiwatch-L's to monitor light and 
activity/sleep (epoch length 1 mins) throughout the last week offshore of a2 
or 3 week night shift. Sequential urine samples (approximately every 4 
hours and over the sleep period) (Appendix C) were collected throughout the 
last 3 days offshore (72h). Circadian phase was determined by measuring 
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urinary aMT6s (section 2.2.3) and calculating the peak time of excretion by 
cosinor analysis (section 2.2.4). 
3.3.3. Statistics 
Statistical analysis: correlations were done by Pearson's r. Other statistics 
were sleep analysis by RM-ANOVA (Statistica), and aMT6s data by unpaired 
Student's t-test (Prism) or otherwise as stated in the text. 
3.4. Results 
Sleep and circadian adaptation between two offshore shift schedules (18.00- 
06.00h and 19.00-07.00h) for the last week offshore of a two or three week 
night shift was compared. No significant difference was observed between 
the two shift schedules in terms of age, BMI and HÖ score. 
3.4.1. Summer, 19.00-07.00h subjects 
3.4.1.1. Circadian adaptation 
The mean aMT6s acrophase for the adapted subjects working the 19.00- 
07.00h shift schedule during the summer was 14.6 ± 0.55h, mean ± SEM 
(N=7). Two of the ten subjects did not adapt to the night shift as their peak 
aMT6s acrophase was outside of the sleep period. These subjects CT-01 
and CT-02 had offshore acrophases of 4.3 ± 0.22h and 5.3 ± 0.29h 
respectively. One other subject was excluded due to insufficient data (one 
data point only) and the possibility of being free-running or non-adapted with 
an acrophase of 18.4h. He was excluded from further analysis. 
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3.4.1.2. Actigraphic and subjective sleep 
Objective sleep parameters derived from actigraphy and subjective sleep 
parameters derived from sleep diaries are shown below in Table 3-1, for 
those working 19.00-07.00h. 
Adapted Non-adapted 
N=7 N=2 
Sleep Parameters Mean SEM Mean SEM 
Sleep Duration (Dec. h) 5.71 0.27 4.24 0.39 
Sleep Efficiency (%) 77.9 2.3 80.8 5.1 
Fragmentation Index 36.3 5.7 25.8 6.2 
N Sleep Onset (Dec. h) 9.51 0.31 10.76 0.11 
0 Sleep Offset (Dec. h) 16.27 0.37 16.11 0.04 
Sleep Latency (Dec. h) 0.40 0.08 0.16 0.04 
4) Sleep Duration (Dec. h) 6.58 0.57 5.15 0.23 
0 Sleep Onset (Dec. h) 9.28 0.35 10.57 0.11 
Sleep Offset (Dec. h) 16.41 0.36 16.11 0.06 
CO Sleep Latency (Dec. h) 0.13 0.02 0.14 0.05 
Table 3-1: Objective sleep and subjective sleep parameters for the last 6 days of a2 or 3 
week nightshift for adapted (N=7) and non-adapted (N=2) subjects working a 19.00-07.00h 
shift schedule. 
3.4.1.3. Circadian adaptation and sleep duration 
Sleep duration determined by actigraphy for the last 6 days of a2 or 3 week 
night shift was shorter in non-adaptors (4.69 ± 0.20h, 3.78 ± 0.41h), than 
adaptors (5.71 ± 0.20h, N=7) with no other differences in the objective and 
subjective sleep parameters studied. These differences between adapted 

















Figure 3-1: Sleep duration between non-adapted subjects (blue squares (CT-01) and red 
triangles (CT-02)) and adapted subjects (white blocks, mean ± SEM) (N=7). 
3.4.1.4. Circadian adaptation and light exposure 
Light exposure profiles (analysed in half-hourly bins) derived from actigraphy 
data showed that there were differences between adapted (N=7) and non- 
adapted (N=2) subjects working the 19.00-07.00h shift schedule. Adapted 
subjects had higher mean light levels at night (01.30-02.30h, 121 ± 27 lux) 
and lower light exposure in the morning between 09.30-11.00h (15 ±8 lux) 
compared to non-adaptors (5 ±1 and 145 ± 49 lux respectively). These 
differences between adapted and non-adapted light exposure profiles are 
illustrated in Figure 3-2. 
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Figure 3-2: Light exposure between non-adapted subjects (blue triangles (CT-01) and red 
squares (CT-02)) and adapted subjects (white blocks, mean ± SEM, N=7). Light exposure 
on the y-axis is on a log scale. 
3.4.1.5. Circadian adaptation and age 
The two subjects (CT-01 and CT-02) who did not adapt to the nightshift were 
aged 54 and 65 years. Those who did adapt to the night shift had a mean 
age of 43.3 ± 7.4 years (mean ± SD). 
3.4.1.6. Diurnal preference (HÖ) and adaptation 
For those working 19.00-07.00h in the summer months a significant 
correlation (r= -0.60, p=0.01) was seen between mean aMT6s acrophase for 
the last 2 days offshore and HÖ score, which evaluates morningness and 
eveningness. Early aMT6s acrophases were associated with morningness. 














Figure 3-3: Relationship of individual HÖ scores with aMT6s acrophases for subjects 
working 19.00-07.00h in summer (N=9, r=-0.60, p=0.01). One subject was excluded due to 
no HÖ score. 
3.4.2. Summer, 18.00-06.00h subjects 
3.4.2.1. Circadian adaptation 
All of the 7 subjects working 18.00-06.00h during the summer were adapted, 
with a mean aMT6s acrophase of 11.7 ± 0.77h (N=7). 
3.4.2.2. Actigraphic and subjective sleep 
Objective sleep parameters derived from actigraphy and subjective sleep 
parameters derived from sleep diaries are shown below in Table 3-2. 
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Sleep Parameters Mean SEM 
Sleep Duration Dec. h) 6.60 0.30 
Slee p Efficiency % 82.2 2.2 
4) Frag mentation Index 36.0 2.7 
as :6 _ cn Slee p Onset Dec. h) 9.23 0.37 
0 Slee p Offset Dec. h) 16.48 0.24 
Sleep Latency Dec. h) 0.35 0.13 
Sleep Duration Dec h) 7.09 0.16 . 0 Slee p Onset Dec. h) 9.13 0.38 as as in Slee p Offset Dec. h 16.80 0.19 
Sleep Latency Dec. h) 0.31 0.12 
Table 3-2: Objective and subjective sleep parameters (N=7) for the last 6 days of a2 or 3 
week night shift for subjects working 18.00-06.00h in the summer. 
3.4.3. Comparison between 18.00-06.00h and 19.00-07.00h shift 
schedule 
3.4.3.1. Subject demographics 
Diurnal preference did not differ significantly between the two groups with 
mean HÖ scores of 57 ±2 and 56 ±4 for the 18.00-06.00h and 19.00-07.00h 
subjects respectively. There were no significant differences in age or BMI 
between the two groups or for those working 2 or 3 weeks of a 19.00-07.00h 
night shift. 
3.4.3.2. Diurnal preference and adaptation 
No significant correlation (r=-0.48, p=0.08) was observed when both shift 
schedule groups (18.00-06.00h and 19.00-07.00h) were analysed together 
between HÖ score and aMT6s acrophase. 
3.4.3.3. Circadian adaptation 
Circadian adaptation to the night shift was observed in all the subjects 




19.00-07.00h shift schedules. Significant differences were observed 
between the mean aMT6s acrophase for subjects working 18.00-06.00h, 
which was 11.7 ± 0.77h (N=7), and adapted subjects working 19.00-07.00h, 













Figure 3-4: Mean aMT6s acrophase for the last 3 days offshore of a2 or 3-week night shift. 
(", individual data; -, mean aMT6s acrophase) for adapted subjects working 18.00-06.00h 
(N=7) and adapted subjects working 19.00-07.00h (N=7). 
3.4.3.4. Actigraphic sleep parameters 
Actigraphy analysis of the last 6 days of night shift offshore showed 
significant differences in sleep duration between the two shift schedules. The 
sleep duration for adapted subjects working 19.00-07.00h (5.71 ± 0.27h 
mean ± SEM, decimal hours) was significantly shorter than for those working 
18.00-06.00h, where actual sleep time was 6.60 ± 0.30h. There was a 
significant difference in sleep duration between the two groups (F(1,12)= 6.20, 
p<0.05, two way RM-ANOVA) illustrated in Figure 3-5. 
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Figure 3-5: Sleep duration (mean ± SEM) working 18.00-06.00h (circles) and 19.00-07.00h 
(squares) shift schedules on the last 6 days of the night shift. 
All other derived actigrahic sleep parameters were not significantly different 
between the two groups, but those working 18.00-06.00h, along with higher 
sleep duration tended to have higher sleep efficiency (82.2 ± 2.2%) 
compared to 78.6 ± 2.4% for those working 19.00-07.00h. There were no 
differences in fragmentation index (36.0 ± 2.7 and 36.3 ± 5.7), sleep latency 
(0.35 ± 0.13h and 0.40 ± 0.08h), sleep onset (9.23 ± 0.37h and 9.51 ± 0.31h) 
and offset (16.48 ± 0.24h and 16.27 ± 0.37h), for the 18.00-06.00h and 
19.00-07.00h shifts respectively. Although, whilst not significant, the workers 
on the 19.00-07.00h shift schedule went to bed later and thus may have been 
exposed to more morning light (section 3.4.3.5). 
3.4.3.5. Subjective sleep 
Subjective sleep from sleep diaries showed slight trends for improved sleep 
in the 18.00-06.00h shift schedule compared to 19.00-07.00h. Sleep 
duration was 7.09 ± 0.16h and 6.58 ± 0.57h, sleep onset, 9.13 ± 0.38h and 
9.28 ± 0.35h, sleep offset, 16.80 ± 0.19h and 16.41 ± 0.36h, and sleep 
85 
Chapter 3 
latency, 0.31 ± 0.12h and 0.13 ± 0.02h for those working 18.00-06.00h and 
19.00-07.00h, respectively. 
3.4.3.6. Light exposure 
There was a trend observed with subjects working 19.00-07.00h compared to 
1800-0600h. This group were exposed to more morning light between 07.30- 
10.30h, where mean light exposure (± SEM) was 56 ± 22 lux, in comparison 
to subjects working 18: 00-06: 00 h (N=6, one subject was excluded due to the 
actiwatch not being worn during the night) where mean light exposure was 17 
± 15 lux. (F(l, 14)=3.80, p=0.07, two way-ANOVA, time and group as factors) 











Time (Dec. h) 
Figure 3-6: Light exposure (mean ± SEM) between 07.30 and 10.30h for the 6 days of a 
night shift for those working 19.00-07.00h (squares) and 18.00-06.00h (circles) in summer. 
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3.4.3.7. Phase angle 
The phase angle between sleep onset and aMT6s acrophase differed 
between the two shift schedules. Adapted subjects working 18: 00-06: 00 h 
had a smaller phase angle difference (aMT6s acrophase - sleep onset) of 
2.47 ± 0.7 h compared to the 19: 00-07: 00 h shift schedule whose phase 
angle difference was 5.09 ± 0.46 h (p<0.01, unpaired Student's t-test). 
3.4.4. Circadian adaptation and sleep 
The effects of circadian adaptation on sleep offshore in summer were 
analysed. The data of both shift schedules (18.00-06.00h and 19.00-07.00h) 
has been combined. 
3.4.4.1. Objective sleep onset and sleep duration 
Actigraphic sleep onset time significantly negatively correlated with sleep 
duration (p=0.01), illustrated in Figure 3-7. Those subjects (working both 
19.00-07.00h and 18.00-06.00h in the summer) who start the timing of their 
sleep earlier have a longer sleep duration than those who start their sleep at 















Figure 3-7: Correlation of actigraphic sleep onset time and sleep duration (N=17, r=-0.48, 
p<0.05). Subjects were studied in the summer months 19.00-07.00h, N=10 and 18.00- 
06.00h N=7. 
3.4.4.2. Objective sleep onset and sleep efficiency 
Sleep duration and sleep efficiency are related sleep parameters. Long 
sleep duration should correlate with high sleep efficiency. There was a 
significant negative correlation between sleep duration and sleep efficiency, 
(r=-0.53. p=0.03. Subjects who had an earlier sleep onset had a higher sleep 
efficiency (Figure 3-8). 
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Figure 3-8: Correlation of sleep onset and sleep efficiency, (N=17, r=-0.53, p=0.03). 
Subjects were studied in the summer months, 19.00-07.00h, N=10 and 18.00-06.00h, N=7. 
There were no differences in other actigraphic sleep parameters studied such 
as sleep latency and fragmentation index. 
3.4.4.3. Age and circadian phase 
Age significantly correlated (p<0.001) with circadian phase (as assessed by 
aMT6s acrophase). The older the subject the earlier was their aMT6s 
acrophase. This is graphically shown in Figure 3-9. 
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Figure 3-9: Correlation of age and circadian phase (N=15, r=-0.77, p=0.001). Two subjects 
provided no age data and were excluded. 
Age also significantly correlates with phase angle (aMT6s acrophase - sleep 
onset), with older subjects having an earlier phase angle compared to those 
who are younger, non-adapted and adapted p=0.003. 
3.5. Discussion 
This chapter addresses the implications of shift schedule timing in terms of 
adaptation to the night shift, sleep and light exposure. The latter may directly 
influence adaptation and therefore influence the quality of sleep during the 
night shift. Previous studies have shown that numerous factors influence 
circadian adaptation to the night shift; these include timing of work schedule 
(Barnes et al, 1998a and b), season (Barnes et al, 1998b), light exposure 
(Koller et al., 1994; Dumont et al., 2001), age (Harma et al., 1994) and diurnal 
preference (Crowley et al., 2003; Mongrain et al., 2004). The results show 
significant differences between the 18.00-06.00h and 19.00-07.00h shift 
schedule in terms of timing of aMT6s acrophase and sleep. 
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3.5.1. Circadian adaptation (aMT6s acrophase) 
The timing of the aMT6s acrophase was significantly later in the 19.00- 
07.00h shift schedule compared to the 18.00-06.00h schedule. This may be 
due firstly to a later bedtime in the 19.00-07.00h shift and secondly that 
working on the 19.00-07.00h shift leads to an increased amount of morning 
light exposure (07.30-10.30h). In the case of adapted subjects this would 
phase delay the circadian clock and the aMT6s rhythm to a later timing 
(Eastman and Martin, 1999). For non-adapters, however, this morning light 
would fall on the phase advance portion of the light PRC (Khalsa et al., 2003) 
and would counter any circadian adaptation. 
3.5.2. Circadian adaptation and sleep 
A partial explanation for the shorter sleep that was observed in the subjects 
on the 19.00-07.00h shift schedule, may be that two subjects did not adapt to 
the night shift (aMT6s acrophase 4.3h and 5.3h), whereas adapted subjects' 
mean acrophase was 14.6 ± 0.55h. However, sleep was also significantly 
shorter in those subjects who were adapted to the night shift working 19.00- 
07.00h compared to those working 18.00-06.00h. When looking at the light 
exposure of the two unadapted individuals working 19.00-07.00h compared 
to the adapted subjects, it is clear that these two subjects had lower light 
exposure around midnight and higher light exposure in the early morning. 
The mean light exposure between the two shift scheules indicated, as 
expected, that those working 19.00-07.00h were exposed to a greater 
amount of morning light between 07.30-10.30h due to the shift schedule 
finishing an hour later. Research investigating adaptation to night shifts has 
shown improved adaptation in those who avoid morning bright light 
(Eastman et al., 1994; Koller et al., 1994). Morning bright light would be 
expected to be most extreme in the summer months in comparison to winter. 
In night shift workers sleep duration and sleep efficiency correlate well with 
sleep onset time; this may be predominantly due to the influence of the 




higher drive to sleep in the morning (subjective night, period of melatonin 
production), than those who are only partially or non-adapted. This was 
clearly shown by unadapted subjects CT-01 and CT-02 who went to bed later 
(10.60h and 10.92h compared to the 9.51 h bedtime seen in adapted subjects 
working the 19.00-07.00h shift schedule). The circadian influence on sleep 
has been determined in several studies using forced desynchronisation 
(Czeisler et al., 1980; Dijk et al., 1999). The present field data reinforce 
these laboratory observations. 
3.5.3. Circadian adaptation and age 
Harma et at. (1994) reported that age significantly affected adjustment to 
night work (rectal temperature minimum and sleepiness were used as phase 
markers). The circadian system is most sensitive to light in the short (blue) 
wavelength region (Brainard et at., 2001; Thapan et at., 2001) and the 
reduced transmission of short wavelength light with age (Herijevic et al., 
2005) may result in reduced responsiveness of the circadian system to light. 
Ageing is characterised by changes in both sleep quality and circadian phase 
(Badia et at., 1991; Bliwise, 1993). The two non-adapters with very short 
sleep, working the 19.00-07.00h shift schedule were older than those who 
had adapted to the night shift and this factor may also have played a role. 
Morningness increases with age (Akerstedt and Torsvall, 1981; Jones et al., 
1999; Taillard et al., 1999). The current findings of those working the 19.00- 
07.00h shift shedule show that If subjects are more morning-like, the timing 
of the aMT6s acrophase is earlier during the night shift. This does not seem 
to apply to the 18.00-06.00h shift schedule in this small number of subjects. 
If subjects adapt to the night shift by phase delaying, morning types have 
further to shift the timing of their aMT6s rhythm to adapt to the night shift. 
This may be one underlying reason why morning types find it harder to adapt 
to the night shift (Griefahn et al., 2002). 
92 
Chapter 3 
3.5.4. Age and aMT6s phase angle 
Duffy et at. (1991) investigated the effects of ageing on melatonin and sleep. 
Their results showed that older subjects in comparison to younger subjects 
have an overall endogenous circadian rhythm of plasma melatonin that is at 
an earlier clock time in healthy older subjects than in younger subjects, but 
that the melatonin rhythm occurs later within the habitual sleep episode in 
older subjects. This does not seem to apply the present shift work study. 
Forced desynchrony protocols (Dijk and Czeisler, 1994) showed that when 
sleep is initiated approximately 6h before the endogenous circadian 
temperature minimum, sleep will be undisturbed for 8h. 
The melatonin maximum is close to the core body temperature minimum 
(Cagnacci et al., 1992) and the aMT6s acrophase is approximately 2h later 
than the melatonin peak (Ross et al., 1995). Therefore theoretically subjects 
working the 19.00-07.00h shift schedule, in view of their phase angle 
difference between aMT6s acrophase and sleep onset (5.09h) should have 
had higher sleep duration, and in comparison to the 18.00-06.00h shift 
schedule where the phase angle difference was only 2.47h and sleep was 
initiated close to the (theoretical) melatonin peak. This was not the case in 
the present study, however in neither schedule was the phase angle 
difference optimal for sleep duration. 
3.5.5. Circadian adaptation and individual differences 
Individual differences in night shift adaptation have been consistently 
observed Gibbs et al. (2007) (section 1.8.6.1). Some individuals clearly have 
difficulties handling shift work; and employers should take this into account. 
The issue of fatigue and safety can be seen as of paramount importance. 
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3.5.6. Advantages and disadvantages of the different shift schedules 
If sleep is indeed worse when subjects are working 19.00-07.00h in 
comparison to 18.00-06.00h in the summer, a change in shift schedule by 
one hour could have huge benefits in terms of adaptation to the night shift. If 
adaptation to the night shift occurs then a better quality of sleep in terms of 
sleep duration, sleep efficiency and fragmentation index will follow. Maybe a 
compromise between the two shift schedules is to work 18.00-06.00h in the 
summer and 19.00-07.00h in the winter. This opinion is not shared by all, 
Tucker et al. (1998) reported in onshore shift workers that earlier (06.00h) 
onshore shift changeovers had deleterious effects on night sleeps, but were 
beneficial to day sleeps, whereas the effects were reversed when 
changeovers are later (07.00h). 
The difference in actigraphic sleep duration between 18.00-06.00h and 
19.00-07.00h appears to be due largely to a later bedtime but similar wake 
up time for 19.00-07.00h, compounded by two non-adaptors in the latter 
schedule. The difference in sleep duration overall was substantial (0.89h) 
between adapted subjects. If a simple change of schedule by one hour is 
sufficient to increase sleep time and thus decrease sleep deprivation, this 
may well have considerable benefits for health and safety. 
3.6. Conclusions 
In conclusion, circadian phase was later and objective sleep appeared to be 
worse in those working 19.00-07.00h compared to those working the 18.00- 
06.00h shift schedule. The differences observed between the two schedules 
may relate to differences in morning light exposure countering circadian 
adaptation to the night shift and to the later bedtime in the 19.00-07.00h 
schedule. The 2 week 18.00-06.00h schedule allows for full adaptation to the 
night shift, as previously reported by Barnes et al. (1998a), whilst in the 
19.00-07.00h shift schedule only 80% of subjects studied adapted to the 
night shift. This implies that the timing of the shift schedule may put a strain 
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on those who are pre-disposed to problems adapting to the night shift (e. g. 
older people, extreme morning types). Smith et al. (2005) proposed a path 
model of hypothesied effects on shift work, sleep and fatigue. They 
proposed a series of factors which will effect shift work outcomes, these 
include age and experience, morningness-eveningness and workload. 
Clearly the timing of schedules is also an important factor. 
It could be predicted that the differences observed will be more prominent in 
summer compared to winter particularly at high latitudes with large changes 
in day length. In this scenario a simple change of schedule by one hour may 
have substantial benefits for sleep and health of offshore workers. 
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4. PHASE SHIFTING EFFECT OF A PORTABLE LIGHT BOX IN 
CONTROLLED LABORATORY CONDITIONS 
4.1. Introduction 
Light resets the circadian rhythm system and enables us to synchronise our 
daily biological rhythms to the light-dark cycle. Light has two main effects on 
melatonin, firstly it is able to phase shift the circadian clock and hence the 
melatonin rhythm (an output of the clock) and secondly light is able acutely to 
suppress nocturnal melatonin (section 1.5.4.1). The discovery that high 
intensity `bright light' (-2500 lux) completely suppressed nocturnal melatonin 
secretion (Lewy et al., 1980) led to the idea that bright light could be used to 
used to phase shift the circadian system. It is well established in animals and 
humans that light pulses can shift the phase of circadian rhythms. The 
direction of the phase shift (advance or delay) and magnitude (hours) of the 
shift depends on when the light is applied within the circadian cycle (section 
1.6). Previous studies (Broadway et al., 1987; Eastman and Martin, 1999; 
Khalsa et at., 2003; Eastman et al., 2005; Revell et al., 2005) have shown 
that suitably timed morning light phase advances the circadian system, while 
evening light may phase delay the rhythm (section 1.5.4.1). 
With this knowledge it is possible to manipulate the timing of the circadian 
system to benefit situations where circadian rhythms are misaligned, for 
example when experiencing jet-lag or after shift work. In these situations 
people suffer from fatigue, poor performance and their sleep is disrupted due 
to their body clock being out of phase with the light dark cycle (Akerstedt and 
Gillberg, 1990; Kecklund and Akerstedt, 1993; Bjorvatn et al., 1999) (section 
1.8). 
4.2. Aims and hypotheses 
This in-house laboratory study was designed to investigate the ability of light 
delivered by a portable light box to change the time of the internal clock (shift 
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circadian phase). The effects of a single bright light pulse (3000 lux, 
irradiance 1000 pW/cm2) provided by a portable light box (Litebooko, Alberta, 
Canada) on phase advancing the melatonin circadian rhythm in healthy 
young male volunteers were ascertained. 
The null hypothesis stated that there would be no effect of light administration 
on the phase of melatonin rhythm (aMT6s acrophase, DLMO and DLMOff), 
whilst the alternative hypothesis stated that there will be a significant effect of 
light administration on the phase of melatonin. 
4.3. Methods 
4.3.1. Subjects 
Ten healthy male volunteers, mean age 26.3 ± 6.3 years (age ± SD) with a 
BMI of 24.0 ± 2.4 kg/m2 and a HÖ score of 46 ±5 participated in the study. 
Ethical permission was obtained prior to the study from the University of 
Surrey Advisory Committee on Ethics (ACE/2002/95/SBLS). Before starting 
the study subjects were asked to complete the HO (Appendix A). Extreme 
morning types (larks) (HÖ>69) and extreme evening types (owls) (HÖ<31) 
were excluded from the study. Other exclusion criteria included taking any 
sleeping medication, and drugs such as antidepressants, barbiturates, 
benzodiazepines and ß-blockers, which are known to affect melatonin 
production. Subjects were also excluded if they had undertaken shift work or 
took a trans-meridian flight within 2 weeks of commencement of the study. 
4.3.2. Pre-study protocol 
Subjects were required to keep a regular sleep-wake cycle for 7 nights prior 
to the study (between 23.00-07.00h) and kept daily sleep diaries (Appendix 
B). Subjects also wore Actiwatch-Ls to measure light exposure and monitor 
activity (section 2.1) for the 7 days prior to and throughout the study. Twenty- 
four hours prior to the start and during the study, subjects were required to 
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avoid bright light and refrain from heavy exercise, alcohol and caffeine 
consumption. 
4.3.3. Study 
The study was conducted in the Clinical Investigation Unit (CIU), School of 
Biomedical and Molecular Sciences at the University of Surrey, Guildford, 
Surrey, UK, by Penny Owens (PhD student) and Dr. Shelagh Hampton, and 
the data was analysed by myself. The unit is fully equipped with a kitchen, 
sleeping and toilet/shower facilities. Meals and non-caffeinated drinks were 
provided during the study. The subjects were supervised by the researchers 
at all times during the study. 
The volunteers were provided with information sheets about the study and 
required to fill in a medical questionnaire (Appendix D). Subjects were then 
reimbursed for their time and inconvenience with a payment of £250 upon 
completion of both study legs. Subjects that did not complete the study 
received payment pro rata. All volunteer information was kept coded and 
held in the strictest confidence and in compliance with the Data Protection 
Act (1998). 
The study consisted of two legs in a randomised crossover design, one study 
leg with light administration (07.00-08.00h) and the other study leg as a "no 
light" control. Environmental light exposure was kept constant through the 
whole study in the CIU, except during the light exposure periods and sleep 
times. Light levels (at eye level in the direction of gaze) were approximately 
10 lux. Each study leg was a maximum of 5 days long during which time the 
subjects were confined to the CIU. In each leg, days 1 (D1) and 2 (D2) were 
baseline days with no extra light exposure. On day 3 (D3) subjects received 
light or no light, days 4 (D4) and days 5 (D5) following light administration, 
were post stimulus assessment days. The two study legs were separated by 
a period of at least two weeks. The protocol is illustrated in Figure 4-1. 
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Figure 4-1: Experimental 5 day protocol of the light box study 
Subjects arrived at the CIU at 17.00h on day 1 and remained in the CIU until 
12.00h on day 4. Subjects were asked to remain in a sedentary or semi- 
recumbent position throughout the study, except during the sleep period 
(supine wearing eye masks, 0 lux 23.00-07.00h). Since the subjects were in 
a sedentary or semi-recumbent position, they were provided with equipment 
to be able to urinate in situ. However, subjects were allowed to get up and go 
to toilet to defaecate. Since during the waking periods subjects remained in a 
semi recumbent position on each day of the study, the subjects were 
instructed to move their legs and perform basic stretching exercises every 2 
hours. During the study all meals and non-caffeinated drinks were supplied 
and water was provided ad libitum throughout. Breakfast was served at 
07.00h on days 2,3 and 4; lunch was served at 12.00h on days 2,3 and 4 
and dinner was provided at 19.00h on days 1,2 and 3. On day 4 at 12.00h 
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when the subjects left the CIU, sunglasses were worn (Litebook®) at all times 
to avoid natural light exposure until 12.00h on day 5. These sunglasses 
block 95% of incident light and 99% of UV-A and UV-B. 
4.3.3.1. Light administration 
On the light administration leg light was given on day 3: a1h light stimulus of 
3000 lux from the portable light box (see Figure 4-2). Light was administered 
at an approximation of the subject's circadian time (CT) 1-4h, at 07.00h for 
one hour. The light box is a small (less than 17.5cm x 17.5cm x 3.8cm) light 
emitting diode (LED) light therapy device delivering polychromatic white- 
appearing light of known composition, with enhanced blue spectra (460-480 
nm). The graph in Figure 4-2 shows the spectral power distribution of the 
light box. The light box delivered light in a visible range 400-480 nm, Figure 













Figure 4-2: Portable light box (Litebook) used to deliver the light (left) and the spectral 
power distribution of the light box (right). 
Researchers continuously monitored the subjects to ensure the correct 
amount of light reached the subjects' retina (a distance of 70cm was 
maintained). The protocol allowed the subjects to read during the light 
exposure. In the "no light" condition exactly the same procedure was carried 
out with the light box as in the light administration condition, but the light was 
not switched on. The correct orientation (i. e. positioning of the light box with 
respect to the subjects eyes) was ensured by the researchers to guarantee 
that the correct amount of light was being delivered to the subject's retina. 
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The intensity of the light at eye level (-3000 lux) was also measured using a 
power meter (Macam Photometric Ltd, Livingstone, Scotland). The subjects 
were asked to report any side-effects or discomfort to the investigators 
immediately. 
4.3.4. Determination of circadian phase and phase shift 
4.3.4.1. Salivary melatonin and urinary aMT6s 
Salivary melatonin was measured by RIA with reagents supplied from 
Stockgrand Ltd, with a protocol modified by English et al., (1993). A non- 
citrated cotton Salivette (Starstedt Ltd, Leicester, UK) was used to collect 
saliva (section 2.2). The samples were immediately frozen upon collection 
and stored at -20°C until analysis. Saliva samples were collected at 30 
minute intervals between 07.00-12.00h and 17.00-23.00h on days 1-4 and 
between 07.00-12.00h on day 5, as illustrated in Figure 4-1. Sample 
collection ended at 12.00h on day 5. 
Urinary aMT6s was measured by RIA) (Arendt et al., 1985, modified by 
Aldous and Arendt, 1988) (section 2.2). Sequentially timed urine samples 
were collected in separate containers at each time of urination starting from 
07.00h on day 1, until 12.00h on day 5 of the study. Urinary aMT6s 
(acrophase) and salivary melatonin (DLMO and DLMOff) were measured to 
assess the pre- and post- light stimulus circadian phase positions of the 
melatonin rhythm under controlled sleep and wake conditions. 
Subjects continued to collect sequential urine samples (4 hourly) (Appendix 
C) and saliva samples for 78h following light treatment. On day 4, the 
subjects left the CIU at 12.00h and carried out whatever activities they chose. 
Sunglasses were worn at all times, except during sleeping, until day 5. 
Activity was restricted with subjects being instructed not to exercise upon 
leaving the laboratory during saliva sample collection between 17.00-23.00h. 
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4.3.5. Statistical analysis 
P values of <0.05 were accepted as statistically significant. Paired Student's 
t-test (Prism, version 5) was carried out to determine significant differences in 
the effect of light treatment on circadian phase of aMT6s, DLMO and 
DLMOff. The data of the saliva was an average of three points to help 




4.4.1. Sleep diary data subjective sleep 
4.4.1.1. Sleep onset during light administration 
Sleep onset time (Dec. h) determined by sleep diaries completed during the 
week prior to starting the light administration leg is shown in Table 4-1. 
Subjects N1 N2 N3 N4 N5 N6 N7 Mean N3-N7 SEM 
1 22.95 0.98 22.88 23.22 22.70 23.32 22.80 22.98 0.12 
2 02.75 04.53 25.10 0.35 0.27 23.85 1.42 24.60 0.29 
3 1.52 23.55 23.10 23.33 23.43 23.37 23.45 23.34 0.06 
4 
5 0.50 0.50 23.13 22.93 0.07 23.12 23.10 23.27 0.20 
6 1.08 25.23 0.25 23.42 23.17 23.38 23.48 23.54 0.19 
7 1.15 24.00 23.52 23.28 23.40 24.00 23.53 23.55 0.12 
8 
9 23.93 23.52 23.23 23.43 22.93 23.72 23.65 23.39 0.14 
10 1.00 1.63 23.50 22.98 23.78 23.22 23.13 23.32 0.14 
Mean 23.50 0.16 
Table 4-1: Sleep diary sleep onset (Dec. h, N=8) for the 7 days preceding the laboratory 
study on the light administration leg (grey boxes = subject did not participate in this leg). 
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4.4.1.2. Sleep offset during light administration 
Sleep offset time (Dec. h) determined by sleep diaries completed during the 
week prior to starting the light administration leg, shown in Table 4-2. 
Subjects Ni N2 N3 N4 N5 N6 N7 Mean N3-N7 SEM 
1 7.45 7.98 7.08 7.22 7.05 7.35 7.25 7.19 0.06 
2 8.00 9.00 7.50 7.00 7.00 5.93 7.00 6.89 0.26 
3 10.00 8.00 6.88 7.90 7.67 8.33 7.48 7.65 0.24 
4 
5 9.17 10.50 7.20 7.25 6.98 6.83 7.85 7.22 0.17 
6 9.50 9.50 7.50 8.45 7.50 7.50 7.00 7.59 0.24 
7 7.25 8.23 8.02 6.98 6.97 8.00 7.00 7.39 0.25 
8 
9 7.50 7.72 7.45 7.15 7.33 11.77 8.48 8.44 0.86 
10 10.00 7.50 7.75 8.00 8.25 7.08 6.97 7.61 0.25 
Mean 7.50 0.29 
Table 4-2: Sleep diary sleep offset (Dec. h, N=8) for the 7 days preceding the laboratory 
study on the light administration leg, (grey boxes = subject did not participate in this leg). 
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4.4.1.3. Sleep onset during control condition 
Sleep onset time (Dec. h) determined by sleep diaries completed during the 
week prior to starting the control condition, shown in Table 4-3. 
Subjects Ni N2 N3 N4 N5 N6 N7 Mean N3-N7 SEM 
1 02.30 23.52 23.53 22.67 24.63 22.05 23.48 23.27 0.44 
2 25.52 6.05 23.07 23.60 23.92 23.72 0.50 23.76 0.23 
3 3.00 22.75 22.97 24.52 23.78 23.80 23.62 23.74 0.25 
4 25.53 1.58 23.02 22.85 0.08 0.00 23.08 23.41 0.26 
5 
6 0.50 1.48 23.82 24.25 24.50 0.47 022 24.25 0.12 
7 02.50 02.61 0.80 24.25 24.37 23.80 Nd 24.31 0.18 
8 23.13 0.32 22.78 22.50 23.53 23.28 23.33 23.09 0.19 
9 
10 
Mean 1 23.67 1 0.24 
Table 4-3: Sleep diary sleep onset (Dec. h, N=7) for the 7 days preceding the laboratory 
study during the control condition on the no light treatment leg (nd = no data, grey boxes = 
subject did not participate in this leg). 
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4.4.1.4. Sleep offset during control condition 
Sleep offset time (Dec. h) determined by sleep diaries completed during the 
week prior to starting the control condition, shown in Table 4-4. 
Subjects Ni N2 N3 N4 N5 N6 N7 Mean N3-N7 SEM 
1 10.98 8.42 7.75 7.75 7.67 7.33 7.33 7.57 0.10 
2 6.97 8.35 7.00 7.47 7.50 7.75 7.50 7.44 0.12 
3 10.25 8.33 7.83 8.25 8.28 7.50 7.33 7.84 0.19 
4 8.17 7.17 6.92 7.08 7.33 7.02 7.15 7.10 0.07 
5 
6 8.50 10.75 6.95 7.75 8.75 6.97 7.00 7.48 0.35 
7 7.97 7.50 7.00 8.17 7.17 7.92 Nd 7.56 0.25 
8 7.17 7.63 6.33 6.17 5.92 5.97 5.95 6.07 0.08 
9 
10 
Mean 7.29 0.17 
Table 4-4: Sleep diary sleep offset (Dec. h, N=7) for the 7 days preceding the laboratory 
study on the no light treatment leg (grey boxes = subject did not participate in this leg, Nd = 
no data). 
On the light administration leg for the 5 days prior to the study, subjects had 
a sleep onset time of 23.50 ± 0.16h (mean decimal time ± SEM), with a sleep 
offset of 7.50 ± 0.29h. During the control condition subjects for the last 5 
days prior to the study had a sleep onset time of 23.67 ± 0.24h and a sleep 
offset of 7.29 ± 0.17h. The first two days of the sleep diaries were excluded 
as these were weekend nights and were not deemed representative of the 
subject's sleep-wake cycle. 
4.4.2. Salivary DLMO 
During the light treatment leg the mean DLMO on night 2 (N2) was 21 . 
80 ± 




0.25h was observed. During the "control" no-light administration session a 
non-significant phase delay of the DLMO was observed between N2 (21.36 ± 
0.39h) compared to N3 where a DLMO of 21.68 ± 0.40h was observed. N2 
was used as the baseline night to compare against N3 to ascertain the 
amount of phase shift. It was assumed that the second baseline night (N2) 
would be more consistent as subjects had been in dim light for over 24h, 
therefore previous light exposure would affect the DLMO less than if N1 was 
used. 
Individual DLMO (Dec. h) for each subject is shown in Table 4-5 for the light 
(N=5) and no light treatment legs (N=5) for N1-N3. 
LIGHT NO LIGHT 
Subject Ni N2 N3 Ni N2 N3 
1 Nd Nd Nd Nd 21.11 20.24 
2 22.33 23.00 22.45 Nd Nd Nd 
3 21.56 21.19 21.11 21.05 21.01 21.42 
4 22.23 22.34 22.33 
5 22.18 21.23 21.08 
6 21.46 22.35 21.46 22.24 22.11 22.06 
7 Nd Nd Nd Nd Nd Nd 
8 22.47 20.22 22.33 
9 21.32 21.24 21.50 
10 Nd Nd Nd 
Mean 21.77 21.80 21.52 22.00 21.36 21.68 
SEM 0.20 0.37 0.25 0.32 0.39 0.40 
Table 4-5: Individual DLMO (Dec. h) for subjects during N1, N2 and N3 of the two study legs 
(light treatment and no light treatment). For subjects 7 and 10 DLMO could not be 
determined on the light treatment leg (Nd= no data, grey boxes = subject did not participate 
in this leg). 
Individual data for the light administration and control no light administration 
leg is shown graphically in Figure 4-3 (a) and (b) respectively. Not all 
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subjects phase advanced their DLMO, in response to the light exposure, 
subjects 2,3,5 and 6 phase advanced whilst subject 9 showed a phase 
delay. The DLMO of subjects 1,7 and 10 could not be ascertained after 
measuring the samples as a clear onset was not visible. 
In the no light treatment leg the DLMO of subjects 3 and 8 phase delayed 
whilst subjects 1 phase advanced. Subjects 4 and 6 also phase advanced, 


























Figure 4-3: Plots of individual data for DLMO for N2 and N3, for the light treatment leg (a) 
and no light treatment leg (b). 
4.4.3. Salivary DLMOff 
In the light administration leg, a non significant phase advance (p=0.06, 
paired Student's t-test) was observed between the mean DLMOff on D2 
which was 8.69 ± 0.26h (mean ± SEM) compared to D4 where a DLMOff of 
7.68 ± 0.15h was observed. In the light treatment leg all subjects with a 
measurable DLMOff (2,3,5,6 and 7) phase advanced, except one subject 
(9) who phase delayed their timing of DLMOff. In the control no light 
treatment leg no shift in phase of the DLMOff was observed between D2, 
8.93 ± 0.27h compared to D4 where a DLMOff of 8.91 ± 0.25h was observed. 
The individual DLMOff (h) for each subject is shown in Table 4-6 for the Light 
(N=7) and no light treatment legs (N=7) for D2-4, and shown graphically in 




LIGHT NO LIGHT 
Subject D2 D3 D4 D2 D3 D4 
1 Nd Nd Nd 7.51 9.10 8.12 
2 9.50 8.45 7.54 Nd Nd Nd 
3 8.20 7.20 7.05 9.26 11.16 7.29 
4 8.20 9.08 9.49 
5 11.28 10.37 9.38 
6 7.05 7.56 7.01 9.54 9.58 10.15 
7 9.23 8.53 7.09 7.25 8.04 
8 11.54 8.16 9.51 
9 7.52 10.00 8.00 
10 Nd Nd Nd 
Mean 8.69 8.46 7.68 8.93 9.31 8.91 
SEM 0.26 0.21 0.15 0.27 0.21 0.25 
Table 4-6: Individual DLMOff (Dec. h) for subjects for D2,3 and 4 of the two study legs (light 

























Figure 4-4: Plots individual data for DLMOff for D2 and D4, for the light treatment leg (a) and 
(b) control no light treatment leg. 
4.4.4. Urinary aMT6s acrophase 
Individual aMT6s acrophases for each subject are shown in Table 4-7 for the 
light administration and the control no light administration legs of the study for 
N1-3. In the light administration leg three out of eight subjects phase 
advanced, however subjects 2,3,5,6,7 and 10 phase delayed (Figure 4- 
5a). 
In the control no light treatment leg a significant phase delay (p=0.001, paired 
Students t-test) was observed in all subjects between the aMT6s acrophase 
on N2, (3.8 ± 0.16h) compared to N3 (5.9 ± 0.47h) (Figure 4-5b). 
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LIGHT NO LIGHT 
Subject Ni N2 N3 Ni N2 N3 
1 2.3 9.8 4.7 3.4 3.6 4.2 
2 Nd 5.0 5.3 Nd 4.0 6.9 
3 3.6 2.3 3.4 3.4 3.2 4.5 
4 Nd 4.0 7.0 
5 2.7 4.3 2.7 
6 7.5 3.4 4.2 Nd 3.4 6.5 
7 3.9 3.9 4.8 4.8 4.5 7.0 
8 9.0 3.8 5.0 
9 5.8 6.3 3.9 
10 3.6 3.3 3.6 
Mean 4.1 4.6 4.0 5.2 3.8 5.9 
SEM 0.66 0.85 0.24 1.00 0.16 0.47 
Table 4-7: Individual aMT6s acrophases (Dec. h) for subjects for N1, N2 and N3 of the two 
study legs (light treatment (N=8) and no light treatment (N=7) (grey boxes = subject did not 
participate in this leg). 
Figure 4-7 shows individual aMT6s acrophase data for light treatment and 
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4.5.1. Sleep diary data subjective sleep 
It is clear from the sleep diary data (section 4.3.1) that subjects did not 
comply as well as they could have with the pre-study instructions of retiring to 
bed at 23.00h and arising at 7.00h. Most subjects went to bed later than was 
instructed. Therefore it is possible that subjects would phase advance their 
circadian timing in the CIU because upon starting the study in the CIU they 
went to bed at 23.00h. This may explain why a phase advance in DLMOff 
(D2-D4) was unexpectedly observed in the control no light treatment leg. 
Human tau is on average longer than 24h and in dim light (<10 lux) a natural 
phase delay of the melatonin rhythm would be expected. 
4.5.2. Effect of light administration 
A small phase advance, though not statistically significant (p=0.06) was seen 
between baseline DLMOff (D2) and post light stimulus day (D4) illustrated in 
Figure 4-4a. A mean phase advance was also observed with the DLMO and 
aMT6s data, though again this was not significant. Moreover, the light 
treatment leg appeared to prevent the phase delay that was observed in the 
aMT6s rhythm that was present in the no light condition. A large inter 
individual variability in response was observed in response to the light 
between individuals. 
Differences in the amount of phase shifting were present between the three 
melatonin measurements. A larger phase advance was observed between 
the baseline DLMOff and post light stimulus day compared to the phase shift 
in DLMO. This observation has been previously reported by Warman et al., 
2003. A single light pulse as administered in the morning is more likely to 
affect the offset of melatonin secretion than the onset (Gordijn et al., 1999; 
Warman et al., 2003). This difference in phase shifts between DLMO and 
DLMOff has been previously attributed to the presence of two oscillators, 
morning (M) and evening (E), which through coupling form the circadian 
pacemaker. It has been proposed that the melatonin offset, a phase marker 
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for the M oscillator, is more sensitive to phase advancing light pulses 
whereas melatonin onset, a phase marker for the E oscillator, is more 
responsive to phase delaying light pulses (Illnerova and Vanecek, 1982). 
The light treatment protocol was designed to phase advance the circadian 
system and hence its output markers (DLMO, DLMOff and aMT6s 
acrophase). Not all subjects shifted in the same direction (advance or delay). 
In some subjects phase delays were observed in both DLMO and DLMOff. 
Firstly this could be explained by subject's individual timing of their phase 
markers and highlights the importance of correctly timing the light exposure 
to cause a phase advance. Secondly perhaps the phase markers were not 
sufficient to resolve a small phase shift. Unfortunately completed data sets 
were not obtained from all subjects that participated in the study. It is thus 
difficult to draw any firm conclusions from the analysis of the saliva and urine 
samples. 
4.5.3. Effect of control "no light" 
In the control no light treatment leg a mean delay was seen in the aMT6s 
data and no phase shift was observed in DLMOff between baseline and post 
stimulus days. A phase delay was what one would expect to observe, as the 
human tau is on average just slightly longer than 24h (Middleton and Stone, 
1996; Czeisler et al., 1999; Wright et al., 2001). 
The results of the aMT6s data in the no light condition demonstrate the ability 
of the light box to phase shift, because the light treatment was able to 
counter the delay seen in the no-light condition. 
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4.5.4. Limitations of the study 
4.5.4.1. Measurement of salivary melatonin 
In a few of the subjects' salivary melatonin profiles it was impossible to 
determine a DLMO or DLMOff value as the plotted results for these subjects 
were very spiky. A clear onset or offset was not visible even with smoothing. 
This is the reason why some subjects had urinary aMT6s data and no DLMO 
and DLMOff values. This effect may have been influenced by the meals 
consumed but also if subjects had not rinsed their mouths out correctly. 
Secondly salivettes were used to collect the saliva samples, and it is now 
known that these produce some interference with the assay, as there is 
suppression of binding by unknown factors related to the salivette. It is 
difficult to know how much sample has been collected by the salivettes and 
they are expensive to use, thus in view of these various problems the use of 
salivettes has limitations. 
4.5.5. Timed light administration 
During the light administration session both phase advances and phase 
delays of the melatonin rhythms were observed. This may have been 
caused by the light not being administered at the correct circadian time to 
cause a maximum phase advance. As the timing of the melatonin rhythm 
was not assessed before the study, the timing of the morning light may not 
been optimal to cause a maximum phase advance the internal clock. 
4.5.5.1. Light exposure 
Light exposure the day before the CIU study could not be controlled, so the 
baseline N1 may have been influenced by environmental light exposure. As 
a result the N2 data was considered to be a more accurate representation of 
the melatonin onset time, and was used for statistical analysis. Other 
limitations of the study are that saliva samples were collected outside in the 
field. Bright natural light suppresses melatonin (Lewy et al., 1980), and 
subjects may have not have been wearing their sunglasses. It is also known 
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that posture, exercise (Buxton et al., 1997) and food affect melatonin 
production, and as a result field data collected from D5 was disregarded. 
4.5.5.2. Power of the study 
The present study was underpowered by the small sample size. Taking the 
observed DLMOff on the light administration leg as a measure of the phase 
shift and performing post hoc calculations revealed that the present study 
was underpowered with a power of 0.36 for 7 subjects included in the present 
study (Lenth, 2006; Power and Sample Size computer software). For the 
statistical power to reach 0.80 (80%), sample size calculations revealed that 
12 subjects needed to be included in the study. Further work should aim to 
study more subjects in order to confirm the results. 
4.5.5.3. Protocol design 
A more suitable protocol, although more time consuming would have been to 
assess the subjects' circadian phase prior to the main study which has been 
done in previous studies (Thapan et al., 2001; Herljevic et al., 2005). Timing 
of the light administration could be individualised to ensure that the light was 
given at the correct circadian time to give a phase advance. 
4.5.6. Applications 
Previous laboratory and field studies have used light to treat circadian rhythm 
misalignment caused, for example by jet lag and shift work and has utilised 
light up to 10,000 lux (section 1.8.3). It is known that the phase shifting effect 
of light on the internal clock is dose dependent, with a response curve where 
maximum shift occurs at approximately 3000 lux (Zeitzer et al., 2000). 
Despite its limitations the present study has demonstrated that the Litebook® 
producing 3000 lux may have the ability to phase shift the timing of the 
internal circadian system. It is a drug free approach to adjusting the internal 




In conclusion, the present study failed to show any significant shift in phase 
as measured by salivary melatonin DLMO and DLMOFF after administration 
of the Litebook® for one hour in the morning. However the delay in aMT6s 
acrophase in the control (no light) condition from N2 to N3 was prevented by 
light treatment. Studying more subjects is necessary to confirm the present 
findings. Comparison of the phase shifting effect of light on the individual 
aMT6s acrophase times and DLMO and DLMOff showed a combination of 
phase advances and phase delays following light exposure. 
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5. INVESTIGATING THE USE OF LIGHT TREATMENT TO HASTEN 
CIRCADIAN ADAPTATION IN OFFSHORE SHIFT WORKERS 
5.1. Introduction 
Previous research (Barnes et al., 1998a; Gibbs et at., 2002) has shown that 
subjects working 18.00-06.00h shift schedules offshore adapt to a night shift. 
If shift workers fully adapt to a night shift offshore they will be out of 
synchrony in their home environment for the few first days, with consequent 
problems of poor night sleep, reduced daytime alertness and performance 
and possible digestive problems (section 1.8). Factors such as season, 
length and timing of the shift, sleep/wake pattern (as this indirectly affects 
light exposure) and light exposure may all affect circadian adaptation. The 
use of light treatment appropriately timed, at home, may alleviate/reduce the 
physiological and behavioural problems caused by circadian rhythm 
disturbance experienced following night shift work. 
Light has been suggested as a counter measure against night work 
impairment of sleep and alertness (Czeisler et al., 1990). Intense artificial 
light can shift the phase of the human circadian timing system and has been 
successfully used to induce phase shifts in circadian rhythms and to improve 
sleep, performance and alertness (section 1.5.4.1). Bright light as a counter 
measure for circadian desynchrony has been used in field studies of shift 
workers, though the number of studies are limited (section 1.7.5). 
5.2. Aims and hypothesis 
The aim of this study was to investigate circadian adaptation in offshore night 
shift workers returning to day life at home. The study assessed the ability of 
light treatment to shift the circadian rhythm of urinary aMT6s, to improve 




The null hypothesis stated that there will be no difference in the timing of the 
aMT6s circadian rhythm in the light and no light treatment conditions. 
Secondly there will be no difference in the objective and subjective sleep at 




Ethical permission was obtained from the University of Surrey Ethics 
Committee (Ethics number: ACE/2002/95SBLS). Before starting the study, 
written informed consent was obtained from all volunteers. Subjects 
completed the HO questionnaire prior to starting the study (Appendix A). 
Subjects had to be working a2 or 3-week night shift, not be taking 
antidepressants, ß-blockers, sleeping medication or any medication that is 
known to affect melatonin production (such as barbiturates, antipsychotics, 
benzodiazepines etc). 
5.3.2. Study design 
Subjects were studied for the last 7 days offshore of a2 or 3-week 19.00- 
07.00h night shift or a 18.00-06.00h night shift and for 14 days upon returning 
home onshore, or in some circumstances when working a day shift offshore 
following a night shift. 
Subjects completed daily sleep diaries (Appendix B) for 21 days (last 7 days 
offshore and 14 days at home). Daily mood was also assessed for 21 days 
by completing a questionnaire within an hour of awakening (section 2.3). 
Subjects wore an Actiwatch-L for 21 days. Light exposure and activity were 
recorded by the Actiwatch-L in one-minute epochs. Subjects were asked to 
keep the Actiwatch-L exposed all the time, i. e. not covered by clothing. 
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Subjects also collected sequential urines approximately 4 hourly during the 
day and an overnight collection, for the last 3 days offshore, the first 7 days 
onshore and day 12 onshore. For those working one week of nights followed 
by one week of days, urine collection occurred on the last 3 days of the night 
shift and the following 7 consecutive days afterwards. 
5.3.3. Light treatment protocol 
5.3.3.1.19.00-07.00h subjects 
The study was a randomised crossover design with 2 legs, one where the 
subject received timed light treatment and wore sunglasses at appropriate 
times upon returning home in a light control and light treatment condition 
(Table 5-1), and the second leg where the sample collection protocol was the 
same but light treatment was not given and sunglasses were not worn. 
Light treatment was administered by the use of a light box, Litebook® (Figure 
4-1). Day 1 was the day the subjects returned onshore, and they were asked 
to wear specialised sunglasses (Litebook®) from the end of their night shift 
until 13.00h on Day 1. On Day 2 subjects wore sunglasses from wake up 
until 13.00h and then received light treatment by sitting in front of the 
Litebook® for 1 h, according to instructions (Appendix M. For the following 3 
days (Days 3-5) the light treatment was scheduled an hour earlier each day 
with subjects wearing sunglasses as before until the beginning of light 
treatment. The protocol is shown in Table 5-1. 
Previous studies by Gibbs et al. (2002) showed that the peak of the aMT6s 
rhythm of subjects leaving the rig after working a1 week 18.00-06.00h night 
shift was 12.98 ± 0.50h (mean ± SEM). From the findings of these previous 
studies the light treatment protocol was designed. The timing of the light as 
presented in Table 5-1 was designed to cause a phase advance in the 





FROM -+ TO 
Light box treatment 
FROM --). TO 
Day I- travel home day end of shift --ý 13.00 In NO LIGHT TREATMENT 
Day 2- at home waking -13.00 h 13.00 h -p 14.00 h 
Day 3- at home waking - 12.00 h 12.00 h -ý 13.00 h 
Day 4- at home waking 11.00 h 11.00 h -ý 12.00 h 
Day 5- at home waking -ý 10.00 h 10.00 h -ý 11.00 h 
Table 5-1: Light treatment protocol used for the first days onshore to phase advance the 
circadian system to hasten adaptation back to day life. 
5.3.3.2.18.00-06.00h subjects 
Due to the results from the 19.00-07.00h study (section 5.4.1.1) it was 
decided that the light treatment should be individually timed to phase 
advance the circadian system. This study was not a crossover design as 
subjects completed the no light treatment leg first to allow aMT6s offshore to 
be analysed, and then in the second leg the light treatment was appropriately 
timed to phase advance the circadian system if the aMT6s acrophase was 
before 15.00h and to phase delay the circadian system if the aMT6s peak 
was later than 15.00h. Subjects whose aMT6s acrophase was between 
11.00 to 15.00h followed the protocol as described in Table 5-1. Subjects 
whose aMT6s was between 15.00-17.00h started their light treatment on 
day2 at 14.00h for one hour, and those who aMT6s acrophase was between 
17.00-19.00h started their light treatment at 16.00h for one hour. For these 
subjects the timing of the light treatment was delayed by one hour each day. 
5.3.4. Subjects 
5.3.4.1.19.00-07.00h subjects (summer) 
Eight men aged 46 ± 11 years (mean ± SD), BMI 28.1 ± 2.5 kg/m2, HÖ 57 ± 
8, working a 19.00-07.00h shift schedule offshore, on an oilrig platform in the 
North Sea at 58°N for 14 or 21 consecutive nights were recruited during the 
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summer months (May-August, 2005). All subjects returned home onshore 
after finishing their night shift. 
5.3.4.2.18.00-06.00h subjects (winter) 
Eight men aged 47 ±7 years (mean ± SD), BMI 28.1 ± 2.1 kg/m2, HÖ 61 ± 4, 
working a 18.00-06.00h shift schedule offshore in the North Sea at 59°N for 
14 consecutive nights were recruited during the winter months (October- 
March). Two of the subjects worked one week of nights followed by one 
week of days offshore (CT-18 and CT-19), the 6 others returned home 
onshore after finishing their night shift. 
5.4. Results 
No significant difference was observed between the two shift schedules 
(18.00-06.00h and 19.00-07.00h) in terms of age, BMI and HÖ score. 
5.4.1. No light treatment leg 19.00-07.00h 
5.4.1.1. aMT6s analysis 
Urinary aMT6s was measured by RIA. Subjects' aMT6s acrophases were 
determined by cosinor analysis and are shown in Table 5-2 and Figure 5.1 




Das CT-01 CT-02 CT-05 CT-06 CT-07 CT-09 
aMT 6s acro hase De c. h) 
0 -3 4.5 Nd 12.4 12.9 Nd Nd 
-2 4.6 12.8 13.3 8.9 12.3 16.4 
o -1 3.9 Nd 17.1 Nd 18.6 13.7 
1 4.2 19.1 Nd 13.7 15.1 19.9 
2 1.7 12.9 19.8 Nd 12.3 19.2 
2 3 4.4 17.1 23.5 0.8 7.3 20.7 s 4 4.8 9.4 24.3 3.8 Nd 22.2 
c 5 4.2 5.8 3.2 22.6 4.1 23.0 
6 4.8 8.2 5.3 3.4 3.5 22.5 
7 Nd 9.1 4.1 Nd 3.7 Nd 
12 3.6 1.4 4.6 0.2 Nd 3.7 
Table 5-2: aMT6s acrophase (N=6) of subjects working a 19.00-07.00h shift schedule for the 
last 3 days offshore (days-3 to -1) and the first 7 days upon returning home onshore (days 1- 
7). CT-04 only completed the light treatment leg, and CT-08 completed the no light 
treatment leg, but did not collect any urine to calculate the timing of aMT6s. Nd = no data, 





















Figure 5-1: aMT6s acrophase for 10 days, last 3 days offshore followed by 7 days onshore of 
those working 19.00-07.00h (N=6) during the no light treatment leg. The vertical line on the 
graph indicates the end of the night shift. Each subject is coded by colour. 
Figure 5-1 shows the aMT6s acrophase times for 6 subjects for the last 3 
days offshore and the first 7 days upon returning home. The graph highlights 
the individual differences in aMT6s acrophase timing. The aMT6s acrophase 
times of the last day of the night shift offshore (day -1) range from 3.9h to 
18.6h. In addition, a large variation in the change in aMT6s timing onshore is 
seen when the aMT6s rhythm readapts back to active day life. 
The results from the no light treatment leg show that 3 subjects (CT-05, CT- 
06, CT-09) working offshore adapt back to active day life by phase delaying, 
as the aMT6s acrophase gets later and later in timing until it has realigned 
back to being produced during the night (02.00-04.00h), an example of this is 
illustrated in Figure 5-2. The other 2 subjects (CT-02 and CT-07) working 
offshore adapt back to active day life by phase advancing their aMT6s 
rhythm, the aMT6s acrophase gets earlier and earlier each day until 
readaptation has occurred. Subject CT-01 did not adapt to the night shift as 
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Figure 5-2: Sleep map of subject CT-05 (no light treatment leg, 19.00-07.00h shift) derived 
from sleep diary data, sleep periods are plotted in blue, wake in white, night awakenings are 
shown in red, and sleep latency in black, aMT6s acrophase times are shown by green 
circles. 
The aMT6s acrophase (green circles) of CT-05, as shown in Figure 5-2, 
clearly phase delays upon returning home to home life onshore (day 1) as 
the timing of the calculated acrophase gets later and later. 
5.4.1.2. Objective and subjective sleep 
Objective and subjective sleep parameters are shown in Table 5-3a and b, 
respectively, for the seven subjects working the 19.00-07.00h shift schedule. 
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(mean ± SEM) 
Onshore 
(mean ± SEM) 
Sleep Duration (Dec. h) 5.31 ± 0.26 6.26 ± 0.22 
Sleep Efficiency (%) 75.0 ± 2.3 79.0 ± 6.5 
Fragmentation Index 42.4 ± 4.5 35.1 ± 2.9 
Sleep Latency (Dec. h) 0.45 ± 0.06 0.42 ± 0.09 
(b) 
Offshore Onshore 
(mean ± SEM) (mean ± SEM) 
Sleep Duration (Dec. h) 6.27 ± 0.07 7.25 ± 0.13 
Sleep Latency (Dec. h) 0.20 ± 0.05 0.20 ± 0.06 
No. of night 
awaken awakenings/night 
1.4 ± 0.26 1.1 ± 0.26 
Duration of night 
awakenings Dec. h 
0.35 ± 0.11 0.31 ± 0.10 
Sleep Quality 5.1 ± 0.36 4.4 ± 0.42 
Table 5-3 (a) Mean objective (N=7) and (b) subjective sleep (N=7) parameters for both 
offshore (days -7 to -1) and onshore (days 1-14) for those working 19.00-07.00h shift 
schedule. One subject (CT-04) working the 19.00-07.00h shift schedule did not complete 
the no light treatment leg. 
No significant differences by Student's paired t-test were observed between 
the sleep offshore and sleep onshore in either objective or subjective 
parameters in the 19.00-07.00h shift schedule. Though in both objective and 
subjective sleep duration there was an increase observed in both of these 
measures, with objective sleep duration increasing from 5.31 ± 0.26h 
offshore to 6.26 ± 0.22h onshore, and subjective sleep from 6.27 ± 0.07h 
offshore increasing to 7.25 ± 0.13h onshore. 
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5.4.2. No light treatment 18.00-06.00h 
5.4.2.1. aMT6s analysis 
Subjects' aMT6s acrophases were determined by cosinor analysis and are 
shown in Table 5-4 and graphically in Figure 5-3 for the last 3 days offshore 
and 7 days upon returning home onshore. 
Subject Number 
Days CT-12 CT-13 CT-14 CT-15 CT-16 CT-17 CT-18 CT-19 
aMT6s acro hase Dec. h) 
0 -3 Nd Nd 12.5 Nd Nd Nd Nd Nd 
M -2 Nd 17.9 13.0 12.1 Nd 16.0 11.2 12.9 
-1 12.5 14.9 16.9 11.1 14.5 17.2 14.6 13.4 
1 10.5 12.9 19.9 22.9 16.5 13.1 11.0 4.0 
2 14.0 17.7 20.8 9.6 Nd 18.5 14.3 12.9 
2 3 22.3 17.3 22.2 Nd Nd 4.9 14.3 10.7 L 
0 4 9.1 21.1 23.9 21.3 1.0 23.5 17.6 13.5 
C 5 23.4 23.0 1.3 Nd 22.4 2.3 19.7 12.2 0 6 Nd Nd 2.0 21.1 0.6 Nd Nd 11.0 
7 Nd Nd Nd Nd Nd Nd Nd Nd 
12 Nd 5.8 2.0 4.0 Nd 23.0 2.7 22.5 
Table 5-4: aMT6s acrophase time (N=8) of subjects working 18.00-06.00h shift schedule for 
the last 3 days offshore (days -3 to -1) and the first 7 days upon returning home onshore 
(days 1-7). Nd = no data, due to subjects collecting an insufficient number of samples over 























-3 -2 -1 123456 
Days (Offshore-onshore) 
Figure 5-3: aMT6s acrophase for 10 days, the last 3 days offshore followed by 7 days 
onshore for those working 18.00-06.00h (N=8) during the no light treatment leg. The vertical 
line on the graph indicates the end of the night shift. Each subject is coded by colour. 
Seven subjects phase delayed the timing of their aMT6s rhythm. One 
subject, CT-18, does not appear to change phase working the 18.00-06.00h 
shift schedule. 
5.4.2.2. Objective and subjective sleep 
Objective and subjective sleep parameters are shown in Table 5-5 a and b 








Sleep Duration (Dec. h) 5.87 ± 0.08 6.26 ± 0.22 
Sleep Efficiency (%) 84.8 ± 0.73 82.3 ± 1.2 
Fragmentation Index 29.5 ± 1.5 28.7 ± 1.7 
Sleep Latency (Dec 
. h) 0.34 ± 0.09 0.40 ± 0.06 
(b) 
Offshore Onshore 
(mean ± SEM) (mean ± SEM) 
Sleep Duration (Dec. h) 6.85 ± 0.06 6.91 ± 0.08 
Sleep Latency (Dec. h) 0.17 ± 0.02 0.17 ± 0.02 
No. of night 
awaken awakenings/night 
1.2 ± 0.13 1.1 ± 0.15 
Duration of night 17 ±0 0 03 15 ±0 0 03 
awakenings Dec. h . . . . 
Sleep Quality 4.3 ± 0.19 4.7 ± 0.21 
Table 5-5a and b: Mean objective (N=8) and subjective sleep (N=8) parameters for both 
offshore (days -7 to -1) and onshore (days 1-14) for those working 18.00-06.00h shift 
schedule. 
No significant differences were observed in the sleep parameters shown in 
Table 5-5a and 5-5b between offshore and onshore in either objective or 
subjective measures for those working the 18.00-06.00h. 
5.4.3. Light treatment leg 19.00-07.00h subjects 
5.4.3.1. aMT6s analysis 
Subjects' aMT6s acrophases were determined by RIA and are shown in 
Table 5-6 and graphically in Figure 5-4 for the last 3 days offshore and 7 
days upon returning home onshore. 
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Days Subject Number 
CT-01 CT-02 CT-04 CT-05 CT-06 CT-07 CT-08 CT-09 
aMT6s acro hase Dec. h) 
-3 Nd Nd Nd Nd Nd Nd Nd Nd 
-2 6.5 5.6 13.9 17.3 16.3 14.3 13.6 14.7 
-1 6.6 4.9 13.4 17.6 11.7 12.1 14.5 14.4 
1 9.3 7.7 8.9 17.9 17.2 Nd 16.8 19.4 
2 7.9 5.2 12.3 20.9 Nd 12.6 18.6 15.1 
3 7.9 9.0 10.5 0.6 Nd 0.9 19.7 13.5 
4 8.3 7.4 6.5 3.0 Nd Nd 3.5 21.3 
5 6.6 7.8 5.5 3.1 3.9 Nd 22.6 1.3 
6 5.2 6.2 9.0 0.6 3.1 2.3 Nd 2.6 
7 4.6 8.8 6.9 Nd 2.4 2.4 Nd 1.3 
12 4.5 8.9 Nd Nd 1.9 Nd Nd 2.5 
Table 5-6: aMT6s acrophase (N=8) of subjects working the 19.00-07.00h shift schedule for 
the last 3 days offshore (days -3 to -1) and the first 7 days upon returning home onshore 
(days 1-7). Nd = no data, due to subjects collecting an insufficient number of samples over 






















Figure 5-4: aMT6s acrophase for 10 days, last 3 days offshore (Days -3 to -1) 
followed by 7 
days onshore (Days 1 to 7) of those working 19.00-07.00h (N=8) 
during the light treatment 
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leg. The vertical line on the graph indicates the end of the night shift. Each subject is coded 
by colour. 
Figure 5-4 shows the aMT6s acrophase times for the 8 subjects for the last 2 
days offshore and 7 days upon returning home. Three subjects adapt back 
to home life onshore by phase delaying their aMT6s rhythm (subjects CT-05, 
CT-08 and CT-09). Three subjects adapted back to home life by phase 
advancing their aMT6s rhythm (CT-04 and CT-07, CT-06) an example of this 
is illustrated in Figure 5-5. The other 2 subjects (CT-01 and CT-02) did not 
fully adapt to night shift offshore, hence the aMT6s acrophase did not change 





















Clock Time (h) 
0 Wake Sleep latency 
0 Sleep 
aMT6s acrophase 
Figure 5-5: Sleep map of subject CT-04 (light treatment leg, 19.00-07.00h) derived from 
sleep diary data, sleep periods are plotted in blue, wake in white, aMT6s acrophase times 
are shown by green circles. This subject unfortunately did not record night awakenings 
in 
his sleep diary. 
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The aMT6s acrophase (green circles) of CT-04, as shown in Figure 5-5, 
clearly phase advances upon returning to home life onshore (day 1) as the 
timing of the calculated acrophase gets earlier and earlier. 
5.4.4. No light treatment versus light treatment for the 19.00-07.00h 
night shift 
The average aMT6s acrophase for each day is plotted in Figure 5-6, 
excluding CT-01 and CT-02 who did not adapt to the night shift for those 










Figure 5-6: No light (black squares) versus light (black circles) aMT6s acrophase mean ± 
SEM for those working the 19.00-07.00h shift schedule (no light treatment N=5, light 
treatment N=6) for the last 3 days offshore (days -3 to -1) and the following 7 days onshore 
(days 1 to 7). Subjects CT-01 and CT-02 were excluded from this data set. 
The mean rate of adaptation between the light and no light treatment leg was 
calculated using the following equations: (mean aMT6s acrophase on day 5- 
mean aMT6s acrophase last day (day -1) offshore) / number of days. No 
significant differences by Student's paired t-test were observed in the rate of 
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adaptation between light and no light treatment leg for those subjects who 
had data for both legs. The mean rate of adaptation in the no light treatment 
leg (N=5) was 1.20 ± 0.04h/day (mean ± SEM). (CT-06 had no acrophase 
for the last day offshore, so the mean of the two preceding days was used for 
the calculation). For the light treatment leg (N=5) the mean rate of 
adaptation was 2.50 ± 0.28h/day. 
5.4.5. Light treatment leg 18.00-06.00h subjects 
5.4.5.1. aMT6s analysis 
Subjects' aMT6s acrophases were determined by cosinor analysis and are 
shown in Table 5-7 and graphically in Figure 5.4 for the last 3 days offshore 
and 7 days upon returning home onshore. 
Subject Number 
Days CT-12 CT-13 CT-14 CT-15 CT-16 CT-17 CT-18 CT-19 
aMT6s acro hase De c h) . 0 -3 Nd 18.9 Nd Nd Nd Nd Nd Nd 
-2 Nd 15.5 12.1 13.4 Nd 16.9 11.4 19.3 0 
-1 Nd 18.7 15.5 16.1 14.6 14.5 13.1 11.5 
1 Nd 16.8 23.3 18.1 20.3 Nd 9.6 10.1 
2 Nd 18 3 Nd 3 3 16 2 14 7 13.4 12.2 . . . . ; 3 Nd 22.8 Nd 9.6 2.4 19.0 16.3 12.5 
4 Nd 23.9 3.7 Nd Nd 8.5 13.9 15.0 
0 5 Nd 1.2 6.2 1.9 4.3 17.4 16.0 10.7 
Cn 6 Nd Nd 8.7 Nd Nd 1.7 Nd 16.7 C 7 Nd Nd 8.6 Nd Nd 7.0 Nd Nd 
12 Nd 0.6 Nd 2.5 4.3 7.9 Nd 16.3 
Table 5-7: aMT6s acrophase (Dec. h) (N=7) of subjects working 18.00-06.00h shift schedule 
for the last 3 days offshore (days -3 to -1) and the first 7 days upon returning home onshore 















Figure 5-8: No light (black squares) versus light (black circles) aMT6s acrophase (mean ± 
SEM) for those working the 18.00-06.00h shift schedule (no light treatment N=8, light 
treatment N=7) for the last 3 days offshore (days -2 to -1) and the following 7 days after the 
night shift (days 1 to 7). The vertical line on the graph indicates the end of the night shift. 
From inspection of Figure 5-8, it can be seen that there is no difference in 
aMT6s acrophase with or without light treatment from day -2 offshore to 
onshore day 2. From days 3-7 the light treatment leg acrophase appears to 
move at a greater rate back to its normal peak time (approximately 04.00h), 
when it is being produced during the night. 
However there were no differences observed in the rate of adaptation 
between the light and no light treatment legs. The mean rate of adaptation in 
the no light treatment leg was 1.46 ± 0.09h/day (N=8), compared to the light 
treatment leg where the mean rate of adaptation was 1.58 ± 0.42h/day (N=7). 
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5.4.7. Circadian timing of light 
In order to interpret the results the circadian time of when the first light pulse 
was delivered has been calculated for each individual. The peak of aMT6s is 
known to occur 2 hours after the peak of plasma melatonin (Bojkowski et al., 
1987). The melatonin acrophase for each subject (aMT6s acrophase time 
minus 2 hours) was calculated for the last day offshore on the light treatment 
leg (day -1). The melatonin acrophase for each subject is listed in Table 5-8. 















Table 5-8: Calculated melatonin acrophase from aMT6s acrophases from the last day 
offshore (day -1). Subjects CT-01 to CT-09 worked the 19.00-07.00h shift schedule whilst 
subjects CT-13 to CT-19 worked the 18.00-06.00h shift schedule. 
In Figures 5-7 and 5-8, each black bar represents a subject's melatonin 
acrophase for day -1 offshore as shown in Table 5-8. Along the x-axis is 
clock time. A typical melatonin profile is also shown; this profile has a 
melatonin acrophase of 13.00h. If subjects received light at 13.00h on day 2, 
it would be predicted that those subjects with bars on the left-hand side of the 
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typical melatonin profile would have received light timed to phase delay their 
melatonin rhythm. Whilst those subjects with black bars on the right-hand 
side would have received light timed to phase advance their melatonin 
rhythm. 
M to N O0OOO0 O 
VU0VUVU 
Clock time (Dec. h) 
Figure 5-9: A typical melatonin profile with an acrophase of 13.00h is shown. Subjects' 
(N=7) melatonin acrophases for the last day offshore (day -1) for those working the 19.00- 
07.00h shift schedule are illustrated by black bars. Subjects with bars on the left-hand side 
of the typical melatonin profile would have received light timed to phase delay their melatonin 
rhythm, whilst those on the right-hand side would have received light timed to phase 
advance their melatonin rhythm. Subjects CT-01 and CT-02 who were unadapted to the 
night shift are excluded. 
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Figure 5-10: A typical melatonin profile with an acrophase of 13.00h is shown. Subject's 
(N=7) melatonin profiles for the last day offshore (day -1) for those working the 18.00-06.00h 
shift schedule are illustrated by black bars. Subjects with bars on the left-hand side of the 
typical melatonin profile would have received light timed to phase delay their melatonin 
rhythm, whilst those on the right-hand side would have received light timed to phase 
advance their melatonin rhythm. 
From Figure 5-9 and 5-10 subjects CT-04, CT-06, CT-07, CT-09, CT-14, CT- 
16, CT-17, CT-18 and CT-19 received light approximately correctly timed to 
phase advance their melatonin rhythm. CT-04 received light at the correct 
time, but unfortunately did not complete the no light treatment leg. CT-06 
appeared to receive light at the correct time but upon closer inspection of the 
data this subject looks as if he was free-running as the aMT6s acrophase 
was constantly shifting. The sleep parameters both objective and subjective 
for these subjects are described and discussed in the following section. 
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5.4.8. Sleep during light and no light treatment 
5.4.8.1. Objective sleep 
Due to the small numbers in each shift schedule, the two shift schedules 
were combined. Days 6-14 were chosen for these analyses as this allows a 
direct comparison between the light and no light treatment leg. Days 2-5 
could have been affected directly by the light. The data of the two shift 
schedules were grouped together and analysis by paired t-test was 
performed. Individual mean sleep duration for days 6-14 for light and no light 






















CT-07 5.23 7.30 68.7 78.4 56.5 51.9 0.35 0.33 
CT-09 5.59 6.70 80.2 81.6 30.6 32.7 0.32 0.10 
CT-12 4.52 7.50 86.7 92.8 44.0 34.4 0.06 0.06 
CT-14 6.22 5.88 89.6 85.2 25.8 27.8 0.19 0.26 
CT-15 5.57 7.32 84.8 94.4 28.0 23.9 0.21 0.00 
CT-16 6.76 6.48 75.4 76.8 34.3 29.0 0.68 0.51 
CT-18 3.65 4.75 83.6 81.4 28.7 37.8 0.17 0.15 
CT-19 5.96 5.84 79.9 85.7 30.8 20.4 0.42 0.37 
Mean 5.44 6.47 81.1 84.5 34.8 32.2 0.30 0.22 
± SEM 0.35 0.33 2.2 2.5 2.5 3.5 0.06 0.06 
Table 5-9: Mean individual actigraphic sleep parameters (N=8) for the light and no light 
treatment leg for days 6-14 onshore. 
Mean actigraphic sleep duration after the light treatment (days 6-14) was 
significantly longer (6.47 ± 0.33h, mean ± SEM) compared to the no light 
condition (5.44 ± 0.35h; paired Student's t-test, p=0.04). No statistical 
differences were observed in the other sleep parameters shown in Table 5-9. 
However after the light treatment there was a trend for increased sleep 
140 
Chapter 5 
efficiency (84.5 ± 2.5%) compared to the no light condition (81.1 ± 2.2%). 
Mean actigraphic fragmentation index after the light treatment was less (32.2 
± 3.4) compared to the no light condition (34.8 ± 0.35). Mean actigraphic 
sleep latency after the light treatment was decreased (0.22 ± 0.06h) 
compared to the no light condition (0.30 ± 0.06h). 
5.4.9. Subjective sleep and mood assessment (sleep diaries) 



























CT-07 6.74 9.42 0.08 0.10 0.52 0.08 0.08 0.52 4.4 2.8 
CT-09 6.60 6.60 0.08 0.18 1.73 0.11 0.11 1.73 4.8 5.0 
CT-14 6.67 8.59 0.17 0.24 0.16 0.07 0.07 0.16 2.3 4.3 
CT-15 7.15 7.39 0.18 0.11 0.17 0.08 0.08 0.17 3.1 3.1 
CT-16 7.46 8.33 0.09 0.08 0.02 0.04 0.04 0.02 3.2 8.1 
CT-17 8.19 8.59 0.06 0.06 0.16 0.07 0.07 0.16 5.0 4.8 
CT-18 7.01 5.42 0.13 0.12 0.15 0.25 0.25 0.15 6.8 5.5 
CT-19 6.87 6.68 0.07 0.04 0.17 0.10 0.10 0.17 3.2 3.4 
Mean 7.09 7.63 0.11 0.12 0.39 0.10 0.10 0.39 4.1 4.6 
± SEM 0.19 0.47 0.02 0.02 0.20 0.02 0.02 0.20 0.5 0.6 
Table 5-10: Mean individual subjective sleep parameters (N=8) for the light and the no light 
treatment legs for days 6-14 onshore. 
No statistical difference was observed in the mean sleep duration, sleep 
latency and duration of night awakenings between the light and no light 
treatment leg. Individual mean sleep duration for days 6-14 for light and no 
light treatment leg is shown in Table 5-10. Individual mean sleep latency 
during no light treatment leg was 0.12 ± 0.02h, versus light treatment leg 0.11 
± 0.02h. Mean duration of night awakenings after the light treatment (days 6- 
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14) was decreased (0.10 ± 0.02h) compared to the no light condition (0.39 ± 
0.20h). 
No significant differences were seen in measurements of alertness (section 
2.3) between the no light and light treatment legs (days 6-14). For the no 
light treatment leg the average alertness on a scale of 1-10, with 10 being 
most alert, was 6.7 ± 0.3 compared to the light treatment leg which was 6.6 ± 
0.4. Also no significant differences in mood on a scale on 1 to 10,1 being 
sad and 10 being happy, were observed. For the no light treatment leg, the 
average mood was 7.0 ± 0.1 compared to 6.9 ± 0.1 on the light treatment leg. 
5.5. Discussion 
With increasing economic and social demands, we are rapidly evolving into 
the 24-h society where shift and night work and irregular working hours are 
becoming more common in many countries (Harma and Ilmarinen, 1999). 
This project assessed individual circadian phase of night shift workers 
offshore in order to time light treatment appropriately upon returning home 
onshore to aid adaptation. With those working 19.00-07.00h, at the end of 
the night shift the timing of the subjects' aMT6s rhythm was approximately 1- 
3h later than previously reported by Barnes et al. (1998a) for a 18.00-06.00h 
shift. 
Even with pre-assessment of individual response to night shift, it is difficult to 
predict the right timing of the light treatment. The protocol was initially timed 
to phase advance. Most subjects (N=10) received light treatment within a 
phase advance window. However given the large individual variability in 
response to night shift, others (N=4) did not receive correctly timed light. 
142 
Chapter 5 
5.5.1. aMT6s acrophase 
If light was correctly timed, then a significant difference (p=0.04) in 
actigraphic sleep duration was observed between the light and no light 
treatment legs. A study by Martin and Eastman (1998) clearly demonstrated 
the importance of circadian phase position and timing of light for shifting the 
body clock to readapt to the new sleep-wake cycle. The results from this 
study also support this observation. 
Greater individual differences are seen in the timing of the subjects' aMT6s 
acrophases after working the 19.00-07.00h night shift schedule compared to 
the 18.00-06.00h shift schedule. These inter-individual differences in the 
aMT6s acrophase offshore seem to be more pronounced than those 
previously observed for the 18.00-06.00h shift schedule (Barnes et al., 
1998a) where a quite consistent acrophase was reported at the end of a 2- 
week night shift. This may be due to the timing of the shift schedule, or 
factors such as season and light exposure could be affecting aMT6s 
adaptation offshore. 
The findings show that half the subjects studied on the no light treatment leg 
adapt back to home life onshore by phase delaying. This is the most natural 
way to readapt back following night shift work. This may be due to the timing 
of the aMT6s acrophase at the end of the night shift being a factor 
determining in which direction the subject shifts. The other half of the 
subjects adapted back to home life by phase advancing, which is the faster 
way to adapt back to active day life. Though not statistically tested, there 
may be a predictive trend for subjects with an initial later timing of the aMT6s 
rhythm on the last day offshore (day -1) to adapt back to home life onshore 
by phase delaying the timing of the aMT6s rhythm, whilst those with an 
earlier timing of the aMT6s rhythm would tend to adapt back to home life by 
phase advancing their aMT6s rhythm, as previously observed during a 





Significant improvement in objective sleep duration was observed in the light 
treatment condition in comparison to the no light treatment leg. Differences 
were also observed in other aspects of sleep but these were not significant. 
Objective and subjective sleep in those who received light at the correct time 
(N=8) may have improved because of more rapid circadian adaptation 
(although the differences were not statistically significant in this small number 
of subjects). Similar results were reported by Dawson and Campbell (1991) 
who investigated the use of light treatment for those who were working night 
shifts. Those who were exposed to a 4h light pulse averaged 62 minutes 
more sleep than the control group with no light. Significant differences 
between objective sleep were reported, but there was no significant increase 
in the sleep efficiency leg in comparison to the no light control, therefore 
though the sleep was of longer duration, the sleep quality was not better. 
Other studies have reported similar findings; Ross et al. (1995) used light 
treatment in a field study in subjects who were working night shifts in 
Antarctica. They reported improvement in sleep latency with bright light 
treatment. Lastly Bjorvatn et al. (1999) investigated offshore shift workers 
working 2 weeks of nights, and reported that bright light treatment (-10,000 
lux) which was scheduled individually to phase delay the circadian rhythm 
reduced self-rated sleepiness. 
5.5.3. Limitations of the study 
5.5.3.1. Expectations of the study 
The subjects recruited in this field study were motivated to try out the bright 
light upon returning home hoping that it would reduce their complaints of 
feeing `jet-lagged' upon returning home onshore. This may have led them to 
provide more positive scores following bright light treatment. By contrast 
statistical significance between the light and the no light condition was 
observed in the objective measures e. g. actigraphy and not in the subjective 
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measures, such as sleep diaries and mood assessment. This finding argues 
against a "placebo" effect of light. 
As with any field study, certain conditions such as natural light exposure 
cannot be controlled. There was no control of the seasonal and daily 
changes in outdoor levels of light; though participating subjects completed 
both legs in the same season, either summer or winter. Subjects were asked 
when participating in the light treatment leg to wear the sunglasses provided 
at certain times; however there was no way of checking that this had actually 
occurred. 
5.5.3.2. Individual differences 
Individual differences in sleep-wake cycles have been widely reported 
(Mongrain et al., 2004). Differences between individuals in the timing of the 
aMT6s rhythm whilst offshore were observed, with a larger variation in 
aMT6s in the 19.00-07.00h shift schedule compared to the 18.00-06.00h shift 
schedule 
5.5.3.3. Light treatment protocol 
This study demonstrated that appropriately timed light can be used to hasten 
the adaptation to day life at home, as evidenced by improved sleep. In both 
shift schedules rate of adaptation was faster (though not significantly so) 
back to day life after working the night shift, in the light treatment leg 
compared to the no light treatment. There is the possibility to either phase 
advance the circadian system, if light exposure is timed on the declining 
phase of the melatonin rhythm. There is also the possibility to phase delay 
the circadian system if light exposure is timed on the rising phase of the 
melatonin rhythm (section 1.6.1). Thus if bright light exposure occurs at the 
`wrong' time, this may lengthen the time in which it takes to readapt back to 
day life, though if subjects are very delayed it may be better to phase delay 
the melatonin rhythm rather than impose phase advances. 
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There was a clear beneficial effect of light treatment on sleep parameters, 
however due to the study design using both light and sunglasses it cannot be 
determined if it was light treatment, the avoidance of light or a combination of 
the two which was responsible for the observed effect. This ambiguity could 
only be resolved if a third leg was carried out with subjects just wearing 
sunglasses. 
5.5.3.4. Adaptation and seasonal differences 
Though it is hard to establish due to the two study groups working two 
different time schedules offshore (18.00-06.00h and 19.00-07.00h) it could be 
predicted that there would be seasonal differences in adaptation back to 
home life. In theory it should be quicker to adapt in the summer months due 
to higher intensity of the natural light exposure. However, in summer the 
likelihood of light exposure at a time conflicting with desired phase change is 
greater than in winter. 
5.5.4. Future work 
More recently the use of light and melatonin separately and in combination 
for adaptation offshore and onshore has been successfully demonstrated by 
Bjorvatn et al. (2007). This was a study of those working one week of nights 
(19.00-07.00h) followed by one week of days (07.00-19.00h). It would be 
interesting to look at subjects who work two weeks of nights on a similar 
regime, as these subjects are more likely, or have an increased opportunity 
to adapt to the night shift. Therefore this population of subjects are more 
likely to have greater problems returning home. The current work has 
investigated the aMT6s rhythm, and how this changes with light treatment, 
other researchers have only looked at the effects of light treatment and/or 
melatonin on sleep (Bjorvatn et al., 1998; Bjorvatn et al., 1999; Bjorvatn et 




The underlying cause of many of the health effects that are associated with 
working night shifts is thought to be desynchronisation of the circadian 
system with detrimental effects on sleep. If light treatment, appropriately 
timed, can hasten circadian readaptation, the time in which the body is in 
misalignment will be reduced. This study has demonstrated that 
appropriately timed light administered to hasten adaptation to day life after 
working night shift significantly improved actigraphic sleep duration, together 
with non-significant but beneficial effects on some other aspects of objective 
and subjective sleep. To confirm these observations, it would be highly 




6. THE EFFECT OF LIGHT ON MELATONIN SUPPRESSION 
6.1. Introduction 
Attempted suppression of human melatonin production at night by light was 
first reported in 1978 by Arendt and Wetterberg. In 1980 Lewy and 
colleagues using much brighter light than previously examined, described 
complete suppression with 2500 lux but not with 500 lux. Subsequently 
Bojkowski et al. (1987) showed that dim `domestic intensity' light of 300 lux 
as well as bright light of 2500 lux could suppress both melatonin and aMT6s 
in humans. In a very thorough re-examination, Zeitzer et al. (2000) reported 
a complete dose response of melatonin suppression to light in young healthy 
volunteers. The response to light had a non-linear relationship to illuminance, 
with the maximal sensitivity of melatonin suppression being at approximately 
3000 lux. More importantly the minimum intensity for detectable melatonin 
suppression was found to be about 50 lux. 
6.2. Aims and hypotheses 
There is very little data on either light exposure or melatonin suppression on 
the night shift or any other shifts. In view of possible health implications 
(Davis et al., 2001; Schernhammer et al., 2001), I undertook an analysis of 
total aMT6s production when adapted to a night shift offshore and during the 
first 3 days at home, or on the day shift. The null hypotheses stated that 
there would be no effect of light exposure on aMT6s production. 
6.3. Methods 
6.3.1. Subjects 
Eight male subjects, mean age 43 ±7 years, (mean ± SD), with a BMI of 27.9 
± 2.6 kg/m2 working a 19.00-07.00h 2 or 3 week night shift in summer, 
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latitude 58°N were recruited. All subjects returned onshore after the 
completion of their night shift. 
A further seven male subjects, mean age 47 ±9 years with a BMI of 27.8 ± 
2.1 kg/m2, working a 18.00-06.00h shift schedule in winter, latitude 59°N, 
were recruited. Five of these worked a2 week night shift; whilst two subjects 
(CT-18 and CT-19) worked 7 nights followed by 7 days. 
6.3.2. Urinary 6-sulphatoxymelatonin collection 
Subjects were asked to collect sequential urines, approximately 4 hourly 
during the day and an overnight collection, for the last 3 days offshore, the 
first 3 days upon returning home onshore, or going onto the day shift offshore 
(Appendix G). aMT6s production was measured by RIA (section 2.2). Total 
24 h production of aMT6s was calculated and then compared between the 
last 3 days of the night shift and the following 3 days. aMT6s suppression 
was calculated using the following equation: 
% aMT6s suppression = 100 - (offshore aMT6s 24 h production / onshore 
aMT6s 24h production. 
6.3.3. Light exposure 
Subjects were asked to wear an Actiwatch-L on their non-dominant wrist for 
the last 3 days offshore and for the following 3 days to measure light 
exposure. Measurements of light were taken in one minute epochs and later 
analysed over the 24h day (section 2.3). Total 24h light exposure was 
calculated for each day and then averaged over the last 3 days offshore and 
the first 3 days onshore/working day shift. The light exposure on the last 3 





6.4.1. Subjects working 19.00-07.00h shift schedule in the summer 
6.4.1.1.24h total aMT6s production 
Individual mean total 24h production for the last 3 days of the night shift and 













CT-04 8527 4383 48.6 
CT-05 4804 3598 25.1 
CT-06 2515 808 67.9 
CT-07 2162 1829 15.4 
CT-08 2938 1089 62.9 
CT-09 3107 3444 -10.9 
NN 18 9720 5166 46.9 
NC23 4261 4027 5.5 
Mean ±SEM 4754±1078 3043±607 32.7±10.0 
Table 6-1: Average individual aMT6s production over 24h for the last 3 days of the night shift 
and for the first 3 days at home onshore (N=8). 
For subjects working the 19.00-07.00h shift schedule in the summer months, 
there was a significant suppression (p=0.03, paired Student's t-test) in the 
production of aMT6s over the 24h period for the first 3 days upon returning 
home onshore (3043.0 ± 606.5 ng/24h, mean ± SEM) compared to (4754 ± 
1078 ng/24h). This is illustrated in Figure 6-1. The overall mean melatonin 
















Figure 6-1: Average individual aMT6s production over 24h for the last 3 days of the 19.00- 
07.00h night shift and for the first 3 days at home onshore (N=8) in summer. 
Seven of the eight subjects illustrated in Figure 6-1 showed a decrease in 
their 24h production of aMT6s upon returning home onshore, whilst one 




6.4.1.2. Light exposure 
Individual mean 24h light exposure for the last 3 days of the night shift and 
the 3 days after the night shift (onshore) for the 19.00-07.00h shift schedule 








CT-04 59 659 
CT-05 118 229 
CT-06 130 139 
CT-07 105 533 
CT-09 62 108 
NC23 124 1151 
NN 18 84 728 
Mean ±SEM 98±11 507±143 
Table 6-2: Average individual light exposure per hour (lux/h) over the 24h day for the last 3 
days of the night shift and for the first 3 days at home onshore (N=7) in summer. 
Whilst offshore the average light exposure over 24h for the last 3 days 
offshore was 98 ± 11 lux/h (mean ± SEM) and this was significantly lower 
(p=0.03, paired Student's t-test) compared to the first 3 days onshore where 
light exposure was 507 ± 143 lux/h. This is illustrated in Figure 6-2. CT-08 














Figure 6-2: Individual mean light exposure over 24 hours for the last 3 days of the 19.00- 
07.00h night shift offshore and for the first 3 days onshore at home (N=7) in summer. 
As expected all subjects (N=7) showed increased levels of light exposure 
upon returning home, as shown in Figure 6-2. Unexpectedly there was no 
significant correlation observed between the percentage of melatonin 
suppression upon returning home onshore and the amount of light exposure 
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Figure 6-3: Correlation between mean light exposure onshore with aMT6s suppression. 
6.4.2. Subjects working 18.00-06.00h shift schedule in the winter 
6.4.2.1.24h total aMT6s production 
Individual mean 24h production for the last 3 days of the night shift and the 3 
days after the night shift is shown in Table 6-3. 
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CT-12 2255 2704 -19.9 
CT-13 13268 14097 -6.2 
CT-14 2738 2385 12.9 
CT-16 358 113 68.5 
CT-17 4075 1929 52.6 
CT-18 5100 4266 16.4 
CT-19 4591 4835 -5.3 
Mean 4626 ±1563 4333± 1730 17.0 ± 32.5 
Table 6-3: Average individual aMT6s production (ng/24h) over 24h for the last 3 days of the 
18.00-06.00h night shift and for the first 3 days at home onshore (N=7) and % aMT6s 
suppression. CT-18 and CT-19 worked one week of nights followed by one week of days. 
Subjects working the 18.00-06.00h shift schedule in the winter months 
showed no significant suppression in the production of aMT6s over the 24h 
period for the first 3 days upon returning home onshore (4333 ± 1730 ng/24h, 
mean ± SEM) compared to the last 3 days offshore (4653 ± 1563 ng/24h). 
These data are presented graphically in Figure 6-4. The overall mean aMT6s 
















Figure 6-4: Average individual 24h production of aMT6s for the last 3 days of the 18.00- 
06.00h night shift and for the first 3 days at home onshore or on the day shift offshore (N=7) 
in winter. 
Five of the seven subjects showed a small decrease in their production of 
aMT6s upon returning home onshore, whilst two subjects showed an 
increase in their aMT6s production over 24h. 
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6.4.2.2. Light exposure 
Individual mean 24h light exposure of the last 3 days of the night shift and the 








CT-12 27 46 
CT-13 108 112 
CT-14 40 161 
CT-16 55 21 
CT-17 26 210 
CT-18 15 12 
CT-19 208 178 
Mean±SEM 69±26 105±30 
Table 6-4: Average individual light exposure per hour over the 24h day for the last 3 days of 
the night shift and for the first 3 days at home onshore (N=7) in winter. 
No significant differences were observed between the last 3 days offshore 
and the first 3 days at home onshore, concerning light exposure with those 
working the 18.00-06.00h shift schedule. Whilst offshore the average light 
exposure over the 24h for the last 3 days offshore was 68.6 ± 26.0 lux, 
compared to the first 3 days onshore or on the day shift offshore, where light 

















Figure 6-5: Individual light exposure per hour over 24 hours for the last 3 days of the night 
shift offshore and for the first 3 days onshore at home or on the dayshift offshore (N=7) in 
winter. 
Five of the seven subjects as discussed in section 6.3.2.1 had an increased 
amount of light exposure upon returning home onshore, whilst the other two 
subjects had decreased amounts of light exposure upon returning home 
onshore. 
No significant correlation observed between the percentage of melatonin 
suppression upon returning home onshore and the amount of light exposure 
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Figure 6-6: Correlation between mean light exposure onshore with aMT6s suppression. 
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6.4.3. Summer versus winter differences 
As expected light exposure profiles change between seasons. These are 






Light exposure (lux/h) 98 ± 11 69 ± 26 NS 






Light exposure (lux/h) 507 ± 143 106 ± 30 p=0.04 
aMT6s production (ng/h) 3043 ± 607 4333 ± 1730 NS 
Table 6-5: Mean aMT6s production (ng/24h) and mean light exposure (lux/h) for 19.00- 
07.00h shift schedule in the summer and 18.00-06.00h shift schedule in the winter, (NS = 
non significant). 
No significant difference was observed in the light exposure between the two 
groups (summer versus winter) whilst the subjects were working offshore. 
Upon returning home onshore or working the day shift, significant differences 
(p=0.04) are observed between the two groups. Those working in the 
summer are exposed to an increased amount of light (507 ± 143 lux/h) over 
the 24 h day upon returning home or working the day shift in comparison to 
those who have been working in the winter (106 ± 30 lux/h). 
6.5. Discussion 
6.5.1. Subjects working 19.00-07.00h shift schedule in the summer 
For subjects working the 19.00-07.00h shift schedule in the summer, a 
significant (p=0.03) reduction in the 24h production of aMT6s was observed 
between the last 3 days offshore and the following 3 days onshore. Whilst 
subjects are working the night shift offshore their 24h aMT6s production 
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should not be affected by light as it is peaking whilst the subjects are 
sleeping (i. e if the subjects are adapted to the night shift) and therefore not 
exposed to bright light. When subjects return home onshore they are out of 
phase due to night shift adaptation (section 3.3). Therefore upon returning 
home, subjects are out of phase. They are exposed to a significantly higher 
amount of natural light (p=0.03) when endogenous melatonin levels and 
aMT6s are at their highest. This explains the observed significant 
suppression of aMT6s. 
6.5.2. Subjects working 18.00-06.00h shift schedule in the winter 
The differences observed in the 24h production of aMT6s and the average 
light exposure over the last 3 days of night shift offshore compared to the 
following 3 days onshore or on the day shift offshore in the winter 18.00- 
06.00h shift schedule are not as pronounced as those observed in the 
summer 19.00-07.00h shift schedule. The season (winter or summer) has a 
clear influence on the level of light exposure that the subjects are exposed to, 
and thus its suppressing effects are dependent upon season. 
6.5.3. Individual differences 
From the results presented there is a wide variation in both total 24h aMT6s 
production and light exposure profiles between individual subjects. 
Individuals respond differently to light, and repeated exposure to bright light, 
will lessen the sensitivity of the circadian system (Hebert et at., 2002). 
Therefore the greatest effects of light will be observed in the days 
immediately following the night shift, as the circadian system has been 
sensitised by low prior light exposure (Owen and Arendt, 1992; Guillemette et 
al., 1998). Age also will have a direct influence on the ability of the light to 
suppress melatonin (Herljevic et at., 2005). There is also a huge variation in 
the timing of circadian phase when subjects finish their night shift. In 
consequence it is hard to predict when subjects will be exposed to natural 
light in relation to individual circadian phase and how light exposure will 
influence their circadian rhythms. 
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6.5.4. The effect of light on the human circadian system 
Higher light levels occur in the summer months when returning home 
onshore or working the day shift. The increased amount of light therefore 
has a direct effect on the production of melatonin. 
Jewett et al. (1991) reported that exposure of humans to fewer cycles of 
bright light, centred around the time at which the human circadian pacemaker 
is most sensitive to light-induced phase shifts, can markedly attenuate 
endogenous circadian amplitude and large phase shifts may be observed. 
Therefore in some circumstances abrupt changes in phase would be more 
likely to happen when a subject finishes a night shift. In some cases this can 
result in an apparent loss of a circadian rhythm, which is observed in some of 
the subjects upon returning home onshore after working a night shift. One of 
the most mysterious properties of circadian rhythms is the loss of robust 
circadian rhythms following exposure to a stimulus such as a pulse of bright 
light. One recent theory states that desynchronization of individual cellular 
clocks underlies this response (Ukai et al., 2007). 
6.6. Conclusion 
The data clearly demonstrate the effect of natural light exposure on 
suppressing the aMT6s rhythm of the offshore shift workers who are either 
returning home onshore after working a 2- or 3-week night shift or who are 
going on to working the day shift. This study highlights the fact that light 
does not only suppress melatonin production during the night, but if the 
melatonin rhythm is desynchronised with the light-dark cycle, it can be 
suppressed during the day (Gibbs et al., 2007). Season plays an important 
role as natural light exposure especially in the summer months is greater 






In the oil and gas industry, shift work is key to the efficiency of the work 
place. A night and day work force enables optimal productivity of exploration 
and production activities. Shift work is undertaken by approximately 12-14% 
(HSE and Office of National Statistics) of the UK population; this is 
dependent on how the term `shift work' is defined. Many health problems are 
associated with shift work such as sleep problems (section 1.9.4), increased 
risk of heart disease (section 1.9.9) and recently a link with cancer (section 
1.9.7) has been proposed. Offshore oil and gas installations have some shift 
schedules which allow workers to adapt to the night shift. Certain shift 
schedules are better for sleep (Tucker et al., 1998) and circadian adaptation 
than others (Barnes et al., 1998a; Gibbs et al., 2002). 
The aims of this project were to investigate circadian adaptation in offshore 
shift workers and the use of light treatment to hasten circadian adaptation 
upon returning to day life at home. This chapter will discuss the schedules 
studied and strategies for improving adaptation to day life after working a 
night shift. Suggestions for further study will be presented. 
7.2. Shift schedule and its effects on circadian adaptation 
The 18.00-06.00h 2 week 12h night shift shows a better sleep quality in 
terms of sleep duration and sleep efficiency compared to the 19.00-07.00h 2 
week 12h night shift. This may be in part due to the increased light exposure 
in the morning, as discussed in chapter 3. Light exposure seems to be of 
major importance to circadian adaptation, and therefore the consequences 
for day time sleep. The current data and previous studies demonstrate that 
subjects working offshore adapt to the night shift (Barnes et al., 1998a). As a 
result problems in terms of sleep occur upon returning home due to the 
misalignment of circadian rhythms and the inappropriate relationship of 
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endogenous melatonin to the light-dark cycle. The results discussed in 
chapter 3 showed that the 18.00-06.00h shift schedule is better than the 
19.00-07.00h for circadian adaptation. However this may not be the case in 
winter, when those working the 19.00-07.00h shift would not be exposed to 
morning light countering adaptation. If time had allowed, it would have been 
interesting to see if there are any differences between sleep and circadian 
adaptation between these two shift schedules in the winter months. 
7.3. Use of the Litebook in healthy young volunteers 
Previous studies have shown that light is able to shift the circadian clock 
(section 1.6.1). The phase shifting ability of the Litebook in healthy 
volunteers was investigated in chapter 4. Results showed that the portable 
light box, used to give a single light pulse in the early morning, was capable 
of inducing a small phase advance in the DLMOff, though this was not 
significant (p=0.07). Though our study did not show a significant phase 
advance, a recent study by Paul et al. (2007) used the Litebook, in the 
evening and showed a significant phase delay compared with no-light control 
leg. A significant decrease in sleepiness with the Litebook compared to the 
control leg was also observed. From the Litebook study reported in chapter 4 
it was considered that its properties would be able to help those who are 
working shift work offshore, if repeated treatments were given. The 
laboratory study was conducted on normal, young, healthy volunteers. It was 
considered that they might be more resistant to shifting the phase of their 
internal circadian rhythm compared to those subjects working offshore who 
are used to adapting to the night shift and readapting back to day life. 
Therefore the Litebook treatment may have more of an effect on those who 
are used to working shift work compared to the normal non-shift working 
population. In addition, in the real life situation numerous other factors will 
intervene, to reinforce but also possibly to counteract phase adaptation. Thus 
a laboratory simulation is of limited value in predicting field responses. 
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For example the field study population was of an older age range. A study by 
Herjevic et al. (2005) showed that melatonin was more readily suppressed in 
younger subjects than older subjects. The implication of this finding would be 
that older people would show less of a phase shift to light treatment than 
younger subjects (Klerman et al., 2001; Duffy et al., 2007). 
7.4. Use of the Litebook in offshore shift workers 
The assumption of a greater effect of the Litebook in the field than in the 
laboratory seemed to be correct as the study investigating the use of the light 
box in offshore shift workers working the night shift showed improved sleep 
when the light treatment was correctly timed. Sleep, the major complaint of 
night shift workers returning home, was improved. If the circadian clock can 
be shifted to hasten circadian adaptation the length of time where shift 
workers circadian rhythms are misaligned to the light dark cycle is reduced. 
It is hypothesised that this misalignment may be an underlying cause of the 
increased risk of working night shifts. Therefore shifting the clock both to 
adapt to night shift and back to day shift, could be seen as beneficial to the 
health concerns of the shift worker (Eastman et al., 1994; Eastman and 
Martin, 1999; Rajaratnam and Arendt, 2001). 
The current research shows evidence for night shift adaptation offshore and 
the benefits of timed light treatment to in part aid circadian adaptation back to 
day life after working the night shift (Bjorvatn et al., 1999; Bjorvatn et al., 
2007). The reduced time of misalignment between circadian rhythms may 
aid in reducing risk factors which are associated with working night shift work. 
A recent hypothesis is that light at night and its ability to suppress melatonin 
is in part causal for the increased risk of breast cancer in shift workers 
(section 1.9.7). Light is known to be able to suppress nocturnal melatonin 
(section 1.5.4.1). Though in offshore night shift workers this does not occur 
as their melatonin rhythm is peaking during the day whilst 
they are sleeping. 
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This situation however is apparent when shift workers return home onshore 
especially in the summer months, when light exposure during the day causes 
suppression of their day time melatonin rhythm (present data and Gibbs et 
al., 2007). 
7.5. Benefits of adaptation 
Spontaneous adaptation to the night shift only occurs in extreme 
environments such as offshore oil rigs or for example in Antarctica (Midwinter 
and Arendt, 1991; Ross et al., 1995; Barnes et al., 1998b; Gibbs et al., 2002). 
Adaptation to the night shift is clearly advantageous in terms of sleep. Those 
who were adapted to the night shift as discussed in chapter 3, had 
significantly longer sleep duration than those who were not adapted. In 
addition the timing of the circadian clock was of importance, since those 
working 18.00-06.00h had a shorter phase angle difference between sleep 
onset and the aMT6s acrophase, and slept significantly longer than those 
with a longer phase angle difference. 
7.5.1. Advance v delay 
In principle there is no right or wrong direction of circadian phase shifting to 
enable adaptation to a night shift or back to day life. The circadian system 
can be either advanced (timing brought forwards in time), or delayed (timing 
brought backwards in time) to synchronise itself with a new time schedule. 
The response is affected by a combination of factors including individual 
circadian phase position, and the timing of the new sleep-wake schedule. 
Most rapid direction of readaptation to day life will depend on an individual's 
circadian phase at the end of the night shift. For example with a peak aMT6s 
at 13.00h, a 6-7h phase advance would theoretically be desirable compared 
to a 15-16h phase delay. Thus in theory to phase advance is the `shorter' 
option to get re-entrained, but this is harder to achieve than a phase delay 
(Monk et al., 2000). This is because the endogenous period of the body 
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clock is usually greater than 24h, so the body naturally phase delays 
(Middleton and Stone, 1996; Czeisler et al., 1999). 
Combinations of timed light and scheduled darkness/sleep have been 
reported by Czeisler et at. (1990) and Eastman et at. (1994). A `skeleton' 
light treatment was successful in adapting subjects back to day work in 
Antarctica (Midwinter and Arendt, 1991). Another method of shifting the 
timing of the internal circadian clock is by melatonin administration, examples 
include Burgess et at. (2002) and Crowley et at. (2003) who used melatonin 
to facilitate circadian adaptation of those working shift work. All of these 
studies have been successful in shifting the internal phase of those subjects 
investigated. 
Studies by Bjorvatn et al. (1998) have used phase delaying strategies to 
hasten circadian adaptation. These studies have been successful, but they 
have only measured sleep, both subjective (sleep diaries) and objective 
(actigraphy). Bjorvatn et al. (1998) did not determine circadian phase during 
their studies unlike the current study reported in chapter 5. 
7.5.1.1. Diurnal preference 
The ability to shift the clock in a certain direction may be influenced by an 
individual's diurnal preference. Dumont et al. (2001) reported that 
"morningness" and "eveningness" were strongly associated with phase 
advance and phase delay respectively. This study highlights the importance 
of individual differences and therefore certain strategies implemented to help 
aid circadian adaptation to the night shift, and afterwards when readapting 
back to day life. It is the combination of individual preferences, unscheduled 
zeitgebers and irregularity of daily routines, that means that adaptation in any 
direction is difficult in a home and family environment. The more isolated and 
controlled environment offshore confers a huge advantage as adaptation 
strategies can be implemented more readily. 
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The clock gene per3 has been associated with diurnal preference (Archer et 
al., 2003), and more recently those who are homozygous for the long repeat 
polymorphism per3 5/5, have been shown to cope less well with sleep 
deprivation in terms of cognitive performance than those who are 
homozygous with the short repeat of the polymorphism per3 4/4 (Viola et al., 
2007). Firstly this polymorphism may affect diurnality (if subjects are morning 
types or evening types), and genotyping shift workers may be a good 
predicator of which way it might be best to shift the clock, for example to 
phase delay, or phase advance to adapt to the night shift or readapt back to 
day life. Secondly the implications of the study conducted by Viola et al. 
(2007) are that in the future, people might be genetically screened to see 
their suitability for coping with night work, though this in my view has serious 
ethical considerations. 
7.6. Strategies to aid shift work 
Adaptation to the night shift is appropriate for certain types of night shifts, but 
not for others. Those who are working offshore for 2 weeks of nights will 
favour adaptation, whilst those working one night of shift work for example 
will not. For those working a few consecutive nights partial adaptation would 
be appropriate. Therefore different strategies to coping with night shift will 
depend on the required outcome. The following section discusses some of 
the different options that can be undertaken. 
There are strategies that can shift the internal clock, and therefore help 
adaptation to the night shift; these include melatonin and light treatment. 
Other strategies are taken to alleviate the symptoms of tiredness associated 




7.6.1. Light treatment 
Light treatment has been shown to be able to successfully shift the internal 
circadian clock; it has been practically demonstrated in both laboratory 
(Dawson et al., 1991; Revell et al., 2005) and field studies (Midwinter and 
Arendt, 1991; Ross et al., 1995; Bjorvatn et al., 1999; Burgess et al., 2002; 
Thorne et al., 2008). 
7.6.2. Use of melatonin 
Bjorvatn et al. (2007) used light and melatonin in offshore shift workers. This 
study is the only study in offshore shift workers that has demonstrated the 
use of light and melatonin to hasten adaptation. Melatonin administration is a 
more convenient way to shift the clock and it is not a time consuming process 
as compared to light exposure. Therefore compliance to this treatment 
should be higher than to that of light treatment. However there are few 
guidelines as to the timing and dose of melatonin in field situations. 
7.6.3. Napping 
Alertness and performance capabilities of night workers are often impaired 
on the job. Field studies of actual shift worker performance are rare because 
of methodological difficulties. 
Taking a nap is a natural instinct to combat fatigue and tiredness. Napping 
as a strategy to temporarily relieve the urge for sleep has been investigated 
in those working shift work. Purnell et al. (2002) reported that the 
deterioration of performance associated with the first night shift can be 
counteracted by a 20 min nap taken in the workplace during the night shift. 
Sallinen et al. (1998) compared different lengths of naps (30,50 minute naps 
at 01.00h and 04.00h). All naps improved visual performance tests 
later in 
the night. They concluded that a short nap, around 30 minutes, early 
in the 
night would promote alertness without impairment of the subsequent sleep. 
Dinges et al. (1987) found that the circadian placement of a nap was not 
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important in terms of beneficial effects on reaction performance and 
suggested that placement of the nap just prior to the night of sleep loss will 
maximally aid performance that night. 
7.6.4. Caffeine 
Caffeine is the most widely used drug in the world: it is found in coffee, tea 
and many soft drinks and is available in tablet form. Muehlbach and Walsh 
(1995) indicated that caffeine at commonly used doses consumed at the 
appropriate time, reduces sleepiness and performance decrements during 
night time work hours. Other studies have reported these findings, but often 
in a combination with naps or bright light (Babkoff et al., 2002; Schweitzer et 
al., 2006). 
7.6.5. Modafinil 
Modafinil was originally developed as a drug used to treat narcolepsy, due to 
its wake promoting effect (Black and Houghton, 2006). Modafinil has been 
marketed as a drug for improving alertness and reducing excessive daytime 
sleepiness. Czeisler at al. (2005) demonstrated that treatment with 200 mg 
of modafinil before the start of each night shift reduced the extreme 
sleepiness observed in patients with shift-work sleep disorder and resulted in 
a small but significant improvement in performance as compared with 
placebo. 
7.7. Further work 
If time had permitted it would have been interesting to study subjects' aMT6s 
during the first week of their night shift to see if there was a trend between 
how subjects adapt to the night shift (either by advance or delay of aMT6s) 
and if this is related to how they readapt back to home life (either by 
advancing or delaying of aMT6s). Research by Gibbs et al. (2007) showed 
that circadian phase at the beginning of an offshore night shift is a 
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determining factor in the speed of circadian adaptation to nights and to the 
direction of adaptation (by advance or delay) to subsequent day shifts 
worked offshore. This knowledge could have helped to give subjects 
information to cope with both adaptation to the night shift and also adaptation 
back to day life upon returning to home onshore. 
7.8. Conclusions 
The results presented in this thesis contribute towards an understanding of 
shift schedules and adaptation to night shift and readaptation back to day life. 
The combined outcomes of the presented and suggested studies should 
further advance knowledge, and offer some reduction in the consequences of 
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SUBJECT CODE: DATE: 
INSTRUCTIONS 
a) Please read each question very carefully before answering. 
b) Answer all questions. 
c) Answer questions in numerical order. 
d) Each question should be answered independently of others. Do 
NOT go back and check your answers. 
e) For some questions, you are required to respond by placing a cross 
alongside your answer. In such cases, select ONE answer only. 
f) Please answer each question as honestly as possible. Both your 
answers and results will be kept in strict confidence. 
QUESTION 1 




Considering only your own feelings, at what time would you get up if you were entirely 






If there is a specific time you have to get up in the morning, to what extent are you dependent on 
being woken up by an alarm clock? 
a. Not at all dependent [ 
b. Slightly dependent [] 
c. Fairly dependent [] 
d. Very dependent [] 
QUESTION 4 
Assuming adequate environmental conditions, how easy do you find getting up in the morning? 
a. Not at all easy [] 
b. Slightly easy [] 
c. Fairly easy [] 




How alert do you feel during the first half hour after having woken in the morning? 
a. Not at all alert [] 
b. Slightly alert [] 
c. Fairly alert [] 
d. Very alert [] 
QUESTION 6 
How is your appetite during the first half hour after having woken in the morning? 
a. Not at all good [ 
b. Slightly good [l 
c. Fairly good [] 




During the first half hour after having woken in the morning, how tired do you feel? 
a. Very tired [J 
b. Slightly tired [ 
c. Fairly refreshed [ 
d. Very refreshed [j 
QUESTION 8 
When you have no commitments the next day, at what time do you go to bed compared to your 
usual bedtime? 
a. Seldom or never later [] 
b. Less than one hour later [] 
c. 1-2 hours later [] 




You have decided to engage in some physical exercise. A friend suggests that you do this one hour twice a week and the best time for him is between 0700 and 0800h. Bearing in mind 
nothing else but your own inclinations, how do you think you would perform? 
a. Would be on good form [] 
b. Would be on reasonable form [] 
c. Would find it difficult [] 
d. Would find it very difficult [] 
QUESTION 10 




You wish to be at your peak for a test which you know is going to be mentally exhausting and 
lasting for two hours. You are entirely free to plan your day, when would you do this task? 
a. 0800 -1000 
[1 
[ b. 1100-1300 
c. 1500 -1700 
[J 




If you went to bed at 2300h at what level of tiredness would you be? 
a. Not at all tired [ 
b. A little tired [ 
c. Fairly tired [ 
d. Very tired [ 
QUESTION 13 
For some reason you have gone to bed several hours later than usual, but there is no need to 
get up at any particular time the next morning. Will you: 
a. Wake up at the usual time and not go back to sleep [] 
b. Wake up at the usual time and doze [] 
c. Wake up at the usual time and go back to sleep [] 




One night you have to remain awake between 0400 and 0600h. You have no commitments the 
next day. Which suits you best: 
a. Not to go to bed until 0600h [] 
b. Nap before 0400h and sleep after 0600h [] 
c. Sleep before 0400h and nap after 0600h [] 
d. Sleep before 0400h and remain awake after 0600h [] 
QUESTION 15 
You have to do two hours physical work. Which hours would you prefer to do it between: 
a. 0800 -1000 [] 
b. 1100-1300 [l 
c. 1500 - 1700 [l 





You have decided to engage in some physical exercise. A friend suggests that you do this 
between 2200 and 2300h twice a week. How do you think you would perform: 
a. Would be on good form [ 
b. Would be on reasonable form [ 
c. Would find it difficult [ 
d. Would find it very difficult [ 
QUESTION 17 
Suppose that you can choose your own work hours, but had to work five hours in the day. 









One hears of "morning" and "evening" types. Which do you consider yourself to be? 
a. Morning type [] 
b. More morning than evening [] 
c. More evening than morning [] 




Subject code: .................................. Date:........... .............. 
This form is to be completed everyday when you awake during the study (24 
hour clock time). Please also fill in times and durations of any `cat-naps' taken 
on the day of form completion. 
What time did you go to bed? 
What time did you try starting to sleep at? 
How long did it take you to fall asleep (mins)? 
How many times did you wake up? 
How long were you awake for? (mins) 
Please estimate the time and duration of each night 
awakening 
What time did you wake up? 
What time did you get up? 
Would you describe this as a typical night? 
How would you rate your quality of sleep? 
123456 
Best sleep ever 
789 
Worst sleep ever 
Have you taken any `cat-naps' (on this day of form completion)? 
If yes, at approximately what time and for how long? 
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Appendix C 
SEQUENTIAL URINE SAMPLES 
1. EACH TIME YOU PEE 
2. Use calibrated jug (or 
bottle) 
bF 






volume to the 
nearest 50ml 
ý, ýýý' 
2. Record volume, time of pee and date on the tube provided 
3. Use a dropper to take a small 
sample iF 4. Put sample in 
the labelled tube 
for the time 
period 
5. Put stopper 6. Empty 
'-- in tube and remaining 
store in a urine down 
fridge or the loo 
preferably a 
freezer 
7. Rinse urine bottle or jug 3 times with tap water 
and use for the next collection. DO NOT USE 
DISINFECTANT OR BLEACH 
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Appendix D 
MEDICAL.. SCREENM QUESTION AIRS 
DATE ................. Y,.... SUBJECT CODE... 
Name: Date of Birth: 







Approx. Body Weight (leg): Height (cm): 
Eye Colour: 
i) Have you or a member of your family ever suffered from the following 
conditions? (Please circle YES/NO and if YES give details) 
a) High blood pressure YES NO 
b) Cardiovascular diseases YES / tiQ 
+c) Asthma YES 114D0 
d) Psychiatric conditions YES /'O 
e) Migraine YES, NO 
I) Endocrine disorders YES / . ýn 
g) Haematological conditions YES /NO 
h) Neurological conditions YES / NO 
i) Epilepsy YES NO 
j) Renal disease WSJ/ NO 
k) Gastrointestinal disease YES N 
1) Hepatic disease YES KU 
m) Drug or Alcohol Dependence YES ` ASU 
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If YES to any of the above please give details 
x Do you ever feel faint or have dizzy. spefls? YES NO 
3) Have you been in hospital at all in the last 2 years? YES NO 
If YES please give details 
ifa#l1.!!!! a*.. 441t1**I. ltlf4., 041.1!!!!! l/f1lt6l4!! 6l9Ii!! 4! l*0*64*. 1!!! lýýfý a.! l.. 1!!.!!! l I. 4!! 4 !! ý" 
f. e\**ýýýfý*Y64,.. ý*1f"0""**l*6I*... 40t.. 4. *0. b. 146. *. 1ls0Ola. "S*. *%........ 1 .. 11....... I..... I. I..... " 
4) Do you anticipate any treatment in the next 2 -- 3 months (e. g. surgery, dental 
treatments, physiotherapy) YES/sd 
If YES please give details 
" ................... "... "e"t....... w. s............................... 
s. 4.4... s*. <.......... 4rar 4« r. <4. "<". <". ***. #*. * "r. 4s. 44st. 4r6 sr".. 40.. "r< r. ".. ss ". " a......... "".. 
5) Have you suffered any major illnesses in the past 6 months? YES / NO 
I1' r'ES please give details ..................................................................... 
rtrwrtrrr r04..... rrattttttg,. tttta4$trtrtl0tt. tratttt 44 tt0 40 .4 r4 s4 Ittrrt4 -***... to rrr rýrr 6 tt l410r0tIrr, " 
6) Are you undergoing treatment at the moment? YES.. NO 
If YES please give details ...................................................................... 
".... 040 MS. rsr.. 4.10 <"e... s. º"r. "º... ".. 4. "e". "º". """... I........ . º.... u ... . ºº. ". 4............ 
4..... I.. 
7) Are you taking regular medication tit the moment or have you taken any 
meditation in the last six Weeks? YES KU 
lt YES please give details (Name, Dose, Frequency, When started and stopped) 
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...... 1it........,...... t.. fº.,. I.. l<.. iR{! t. l. 1... 11.1.. t. 0. II.,.... 1...... r ....................... 
8) Are you taking or have you ever taken any or the following medicatons? 
a) Anti depressants (including MMAO) YES / NO 
b) Tranquilisers YES / NO 
c) Sleeping tablets ! Hypnotics (e. g. Benzodiazepines) YES hü 
d) a blockers YES l NO 
e) Anti hypertensives (ß-blockers, Ca 4 channel blockers) YES 1 (0 
0 N'SAmßs YES / NO 
g) Anti epileptics YES 12 M 
h) Vitamins BI2 and B6 YES It«J 
i) Selective serotonin uptake inhibitors (e. g, Lithium, Prozac) C'ES` NO 
j) Anti psychotics YES / , tta 
IF YES to any of the above please give the name of the medication and the dates 
when it was taken ... .......................................................................... 
fv0ýrr: s4........ "........ t... aýa 0**44-4, w... **. t. r. e".. ý"4............. *........... ".. "... "........... 
Fº*rita. srr. rrfsrflearsiIrr0oraai s"*** $*****al"l. bra.. *... lb#rMaýr 0.. Y. *. ofr... r. t r..... a t. IRrar. ra" 
9) Do you have any physical disabilities of any kind? II'ES, N'0 
If YES Please give details.......,. 
................................................. . ".......... 
... "....... f .................. ""...... ".. $. +Y"s...... *. *. A.. ". d*004il1.1" ". "ý.. 4...... "....... "...... 
10) Do you suffer from any allergies? YES NO 
IF 'ES please give details ..................................................................... 
fs".... "r. r4. w. "w. "4#..... r6.. t.. **. 141al 4. r. 1 ala4.. 4............. 4.4.4 11.. 4 4. r......... "......... I r.... 
11) What is your weekly intake of alcohol? 
*, *. I tr ti r v" ý* r. r 
units per 
week 
(One unit is hair a pint of beer/ one glass orwine/one measure of spirits) 
12) What is your average cº Te ne consumption per day? 
4 t"... a......... ". . f,... .... a.. F: r. "rrlasý. r"*. 
*.. . *. r. sr"a.. ".... a. 4 ".. rf"" ................. 
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